≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

Cluster headache, strict

Endpoint Browser

G6_CLUSTHEADACHE_STRICT

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — G44.0
  • Cause of death: ICD-10 — G44.0

2 out of 7 registries used, show all original rules.

1588

4. Check minimum number of events

None

1588

5. Include endpoints

None

1588

6. Filter based on genotype QC (FinnGen only)

1520

Control definitions (FinnGen only)

Control exclude
G6_EPIPAROX

Extra metadata

Level in the ICD hierarchy
5
First used in FinnGen datafreeze
DF6

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 1520 908 612
Unadjusted period prevalence (%) 0.31 0.32 0.28
Median age at first event (years) 46.04 44.24 48.70

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1588
Matched controls
15880
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C08DA01
ATC
verapamil; systemic
103.1
307.7
782
148
G43.9
ICD-10 Finland
Migraine, unspecified
29.8
307.7
445
205
3007
Kela drug reimbursment
Erenumab and fremanezumab
184.0
307.7
194
12
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
19.4
307.7
369
244
G43.3
ICD-10 Finland
Complicated migraine
178.3
307.7
242
16
N03AX11
ATC
topiramate; oral
100.6
307.7
417
56
N02CC04
ATC
rizatriptan; oral
13.3
307.7
367
350
N02CC07
ATC
frovatriptan; oral
17.0
307.7
310
223
R51.80
ICD-10 Finland
Headache
13.8
307.7
830
1168
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
36.2
307.7
1160
1107
N02CC03
ATC
zolmitriptan; nasal, oral
20.0
307.7
484
341
G44.0
ICD-10 Finland
Cluster headache syndrome
+∞
307.7
1588
11
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
28.1
307.7
454
223
G47.3
ICD-10 Finland
Sleep apnoea
13.9
307.7
400
375
N03AG01
ATC
valproic acid; systemic, rectal
16.6
307.7
334
251
G44.2
ICD-10 Finland
Tension-type headache
12.2
307.7
556
674
G44.8
ICD-10 Finland
Other specified headache syndromes
43.7
285.7
172
44
N03AX12
ATC
[U] gabapentin; oral
7.0
277.3
547
1106
N02CC06
ATC
eletriptan; oral
15.3
264.3
245
187
G43.8
ICD-10 Finland
Other migraine
42.5
243.0
147
38
H02AB06
ATC
prednisolone; systemic
5.6
231.4
1121
4775
N06CA01
ATC
amitriptyline and psycholeptics; systemic
8.2
230.6
352
535
N89
ICPC
Migraine
13.5
229.1
228
195
N06AA09
ATC
amitriptyline; systemic
8.4
209.8
305
436
N02CC05
ATC
almotriptan; oral
12.0
201.5
215
204
N01
ICPC
Headache
5.9
199.9
444
979
N03AX16
ATC
[U] pregabalin
4.9
194.2
589
1691
G43
ICD-10 Finland
Migraine
8.4
186.0
266
371
AA1AD
NOMESCO Finland
CT of head and brain
4.8
183.1
571
1666
N02AX02
ATC
tramadol; systemic, rectal
4.2
175.3
941
4060
N02CC02
ATC
naratriptan; oral
22.7
175.3
130
62
R5140
NOMESCO Finland
Monitoring the use of the aid
13.3
168.7
166
138
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
7.1
161.4
270
446
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
35.5
158.1
100
30
C07AA05
ATC
propranolol; systemic
4.2
154.7
581
1918
N03AF01
ATC
carbamazepine; oral, rectal
11.3
154.6
169
165
R51
ICD-10 Finland
Headache
7.2
151.0
246
394
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
6.1
148.8
294
572
N02CD06
ATC
rimegepant; oral
76.5
148.8
80
11
N03AX09
ATC
lamotrigine; oral
7.8
144.2
215
312
C09CA06
ATC
candesartan; oral
4.0
143.4
586
2038
N06AX21
ATC
duloxetine; oral
5.0
139.9
355
860
H02AB07
ATC
prednisone; oral
4.8
136.9
370
943
M03AX01
ATC
botulinum toxin; parenteral
17.6
135.8
113
69
R51.81
ICD-10 Finland
Facial pain NOS
12.8
131.1
131
111
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.5
129.5
834
3842
A03FA01
ATC
metoclopramide; systemic, rectal
3.8
129.3
537
1870
N02CD03
ATC
fremanezumab; systemic
235.7
127.9
130
6
N06AX16
ATC
venlafaxine; oral
4.3
127.6
419
1235
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
6.0
125.1
246
473
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
7.0
124.9
205
329
N02CD01
ATC
erenumab; parenteral
229.8
124.7
127
6
N02CX04, ,
ATC
17.8
123.7
102
61
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
5.3
121.5
279
617
G50.1
ICD-10 Finland
Atypical facial pain
17.4
110.5
92
56
M03BX01
ATC
baclofen; systemic
12.5
110.2
111
95
N02BF01
ATC
gabapentin; oral
4.6
104.2
286
728
G50.0
ICD-10 Finland
Trigeminal neuralgia
14.6
103.9
95
69
N03AF02
ATC
oxcarbazepine; oral
17.9
103.8
85
50
N06AA10
ATC
nortriptyline; systemic
12.8
102.8
102
85
A02BC02
ATC
pantoprazole; systemic
3.5
100.4
1231
7847
M01AE02
ATC
naproxen; oral, rectal
3.2
97.3
1135
6966
M03BX02
ATC
tizanidine; oral
3.4
96.0
1226
7897
C07AB07
ATC
bisoprolol; oral
2.9
95.7
759
3768
M01AE03
ATC
ketoprofen; systemic, rectal
3.0
95.6
690
3255
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.9
93.3
867
4665
R06.0
ICD-10 Finland
Dyspnoea
3.2
92.7
505
2027
N06AX11
ATC
mirtazapine; oral
2.9
92.7
697
3349
M03BC01
ATC
orphenadrine (citrate); systemic
3.1
92.2
534
2220
N02CA52
ATC
ergotamine, combinations excl. psycholeptics; oral
20.0
91.6
71
37
N90
ICPC
Cluster headache
324.1
90.8
91
*
N05BA01
ATC
diazepam; systemic, rectal
4.0
90.2
292
837
R07.4
ICD-10 Finland
Chest pain, unspecified
3.1
89.3
533
2248
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
5.8
87.9
172
326
M01AG02
ATC
tolfenamic acid; oral, rectal
3.5
87.6
377
1307
A02BC05
ATC
esomeprazole; systemic
2.8
86.6
767
3981
M79.7
ICD-10 Finland
Fibromyalgia
7.9
86.1
122
165
N05AN01
ATC
lithium; oral
8.0
84.9
119
159
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.9
83.3
567
2555
M79.6
ICD-10 Finland
Pain in limb
2.7
83.1
856
4767
G44
ICD-10 Finland
Other headache syndromes
35.8
82.6
52
15
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
79.7
780
4209
N05AH04
ATC
quetiapine; oral
3.1
79.1
419
1637
N02CD02
ATC
galcanezumab; parenteral
277.5
78.2
79
*
R42
ICD-10 Finland
Dizziness and giddiness
3.1
77.6
412
1610
N03AE01
ATC
clonazepam; systemic
5.7
77.5
152
288
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
5.6
77.5
156
303
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
12.0
77.1
79
69
M54.5
ICD-10 Finland
Low back pain
2.6
76.7
746
3994
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.8
76.2
516
2301
M03BC51
ATC
orphenadrine, combinations; systemic
2.8
76.0
566
2651
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
8.4
75.7
101
127
N05BA04
ATC
oxazepam; oral
2.8
75.4
514
2298
M79.0
ICD-10 Finland
Rheumatism, unspecified
8.6
75.0
98
120
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.3
74.6
339
1205
R03AC02
ATC
salbutamol; inhalant
2.6
74.0
1020
6415
C07AB02
ATC
metoprolol; systemic
3.5
73.8
301
1000
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
4.4
73.8
201
503
M54.9
ICD-10 Finland
Dorsalgia, unspecified
3.4
73.2
314
1077
A02BC03
ATC
lansoprazole; oral
2.8
72.6
509
2303
TPH04
NOMESCO Finland
Cathetrisation of vein
2.9
71.3
428
1781
A01
ICPC
Pain general/multiple sites
3.9
71.3
240
701
J45.9
ICD-10 Finland
Asthma, unspecified
3.1
70.7
378
1475
WX780
NOMESCO Finland
Remote monitoring CPAP
719.2
70.6
69
*
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.8
69.8
242
721
M54.4
ICD-10 Finland
Lumbago with sciatica
2.9
69.7
413
1704
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.6
69.2
267
854
R53
ICD-10 Finland
Malaise and fatigue
2.7
68.1
498
2290
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.6
68.0
251
779
H57.1
ICD-10 Finland
Ocular pain
5.4
67.6
142
286
N02AJ06
ATC
codeine and paracetamol; systemic
2.5
67.3
826
4843
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.9
67.3
392
1600
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
+∞
67.2
64
*
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
13.8
64.2
60
45
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
3.1
62.4
319
1206
N06AB04
ATC
citalopram; systemic
2.8
62.4
388
1633
WX723
NOMESCO Finland
CPAP therapy
325.3
61.8
62
*
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
3.2
60.9
280
994
R03BB04
ATC
tiotropium bromide; inhalant
4.1
60.9
181
482
G43.2
ICD-10 Finland
Status migrainosus
+∞
60.8
58
*
TAB00
NOMESCO Finland
Lumbar puncture
5.4
60.4
125
248
N05CF01
ATC
zopiclone; oral
2.5
59.4
534
2685
A02BC01
ATC
omeprazole; systemic
2.6
58.5
462
2183
PA6AD
NOMESCO Finland
CT of neck arteries
7.3
58.4
88
127
R02
ICPC
Shortness of breath/dyspnoea
3.3
58.3
248
839
R52.2
ICD-10 Finland
Other chronic pain
5.7
57.3
111
207
N02BF02
ATC
pregabalin; oral
4.1
56.4
169
452
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.7
56.3
196
582
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.4
56.1
548
2847
XA800
NOMESCO Finland
Neuropsychological investigation
5.5
55.7
113
220
XF400
NOMESCO Finland
ECG with 12 standard connections
3.1
55.5
264
953
K07.60
ICD-10 Finland
Snapping jaw
4.2
55.3
156
399
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
8.2
55.2
75
96
M35.7
ICD-10 Finland
Hypermobility syndrome
9.2
55.2
68
77
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.0
54.8
293
1130
R20.2
ICD-10 Finland
Paraesthesia of skin
3.9
54.4
174
487
Z01.8
ICD-10 Finland
Other specified special examinations
2.6
53.1
410
1905
H53.1
ICD-10 Finland
Subjective visual disturbances
4.1
53.0
157
416
N06AB10
ATC
escitalopram; oral
2.5
52.9
438
2103
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.7
52.7
333
1401
N02BE01
ATC
paracetamol; systemic, rectal
4.1
52.5
1475
12064
L03
ICPC
Low back symptom/complaint
2.3
52.3
561
3018
R52.9
ICD-10 Finland
Pain, unspecified
3.2
52.2
229
787
M01AB05
ATC
diclofenac; systemic, rectal
2.4
51.7
1150
8321
M54.2
ICD-10 Finland
Cervicalgia
3.5
51.5
196
616
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
17.0
51.5
43
26
L01
ICPC
Neck symptom/complaint
2.6
51.1
353
1552
M01AB01
ATC
indometacin; systemic, rectal
4.4
50.9
136
333
N02AA05
ATC
oxycodone; systemic
2.9
50.3
285
1131
F45.8
ICD-10 Finland
Other somatoform disorders
3.4
50.0
201
654
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.6
49.9
368
1667
A02BA02
ATC
ranitidine; systemic
2.8
49.9
305
1259
M25.5
ICD-10 Finland
Pain in joint
2.2
49.7
644
3731
Z2445
NOMESCO Finland
Psychologist
4.9
48.9
112
242
R07.3
ICD-10 Finland
Other chest pain
3.2
48.6
215
741
H02AB04
ATC
methylprednisolone; systemic
2.8
48.1
273
1082
Z3231
NOMESCO Finland
Registered nurse
2.4
48.0
455
2308
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.8
47.9
154
432
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
4.3
47.3
127
312
R03DC03
ATC
montelukast; oral
2.6
47.2
340
1519
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
4.2
47.0
133
340
J01AA02
ATC
doxycycline; systemic
2.5
47.0
1259
9648
N06AX26
ATC
vortioxetine; oral
3.3
46.7
191
627
Z76.0
ICD-10 Finland
Issue of repeat prescription
2.2
46.6
532
2912
P06
ICPC
Sleep disturbance
2.9
46.5
249
956
P01AB01
ATC
metronidazole; oral, rectal
2.1
46.4
707
4335
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.2
45.9
127
319
J01FF01
ATC
clindamycin; systemic
2.3
45.4
476
2510
SHA03
NOMESCO Finland
Stomatognathic treatment, demanding
5.0
45.4
102
217
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
45.2
448
2307
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
5.2
45.1
95
191
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
8.6
44.7
58
70
M01AH05
ATC
etoricoxib; oral
2.2
43.9
1093
7999
M79.1
ICD-10 Finland
Myalgia
2.5
43.8
320
1435
UJF32
NOMESCO Finland
Coloscopy
2.3
43.4
402
2006
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
3.2
43.2
183
613
N06AX12
ATC
bupropion; oral
3.1
41.8
190
663
N06AX22
ATC
agomelatine; oral
6.0
41.7
75
130
A06AC01
ATC
ispaghula (psylla seeds); oral
2.3
41.2
400
2032
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.0
40.7
928
6490
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.1
40.7
1000
7184
A11
ICPC
Chest pain NOS
3.3
40.6
165
538
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.2
40.5
112
281
N05AB04
ATC
prochlorperazine; systemic, rectal
10.5
39.7
44
43
A04
ICPC
Weakness/tiredness general
2.5
39.3
288
1289
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
5.3
39.2
80
156
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
3.1
39.2
178
620
R4110
NOMESCO Finland
Physiotherapy
2.2
39.2
468
2577
Z3226
NOMESCO Finland
Physiotherapist
2.4
39.0
310
1439
D06
ICPC
Abdominal pain localized other
3.0
39.0
190
689
G44.1
ICD-10 Finland
Vascular headache, not elsewhere classified
205.0
39.0
40
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
88.4
39.0
43
5
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
2.0
39.0
962
6874
ZX114
NOMESCO Finland
Intramuscular
7.8
38.8
54
71
XF402
NOMESCO Finland
ECG with work load test
3.3
38.4
159
524
D01
ICPC
Abdominal pain/cramps general
2.6
38.3
258
1108
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
38.3
558
3308
M53.0
ICD-10 Finland
Cervicocranial syndrome
2.8
37.8
205
788
G81.9
ICD-10 Finland
Hemiplegia, unspecified
12.1
37.7
38
32
J01FA06
ATC
roxithromycin; oral
2.0
37.7
651
4094
J01MA02
ATC
ciprofloxacin; systemic
2.0
37.7
587
3560
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
5.0
37.5
83
174
G54.0
ICD-10 Finland
Brachial plexus disorders
4.9
37.2
83
175
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.0
37.2
717
4680
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
2.0
36.9
832
5720
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
3.8
36.9
117
324
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.6
36.8
252
1089
S06.0
ICD-10 Finland
Concussion
2.8
36.8
200
769
R55
ICD-10 Finland
Syncope and collapse
3.0
36.6
174
622
F43.1
ICD-10 Finland
Post-traumatic stress disorder
4.6
36.5
88
198
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.4
36.4
137
425
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
3.0
36.4
174
624
J45.1
ICD-10 Finland
Nonallergic asthma
3.4
36.3
136
421
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.3
36.2
323
1573
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
6.1
36.2
64
109
L17
ICPC
Foot/toe symptom/complaint
2.1
36.0
497
2876
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
2.0
36.0
552
3318
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
6.8
35.9
57
87
N05CF02
ATC
zolpidem; oral
2.3
35.8
315
1525
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.3
35.7
317
1541
J01FA10
ATC
azithromycin; systemic
2.0
35.2
1011
7489
R05
ICPC
Cough
2.1
35.1
436
2422
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
354.8
35.1
35
*
J02AC01
ATC
fluconazole; systemic
1.9
35.0
677
4397
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
5.3
34.9
72
142
P76
ICPC
Depressive disorder
3.0
34.8
162
572
N06AB06
ATC
sertraline; oral
2.5
34.7
242
1054
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
8.0
34.6
47
60
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.5
34.6
248
1094
R06AE07
ATC
cetirizine; oral
1.9
34.6
756
5107
WX290
NOMESCO Finland
Other blockage of nerve
1.9
34.5
910
6534
R11
ICD-10 Finland
Nausea and vomiting
3.0
34.2
164
588
JN3AD
NOMESCO Finland
Abdominal CT examination
2.6
34.2
229
978
D11
ICPC
Diarrhoea
2.5
34.1
254
1140
K30
ICD-10 Finland
Functional dyspepsia
2.6
34.1
221
929
H53.2
ICD-10 Finland
Diplopia
5.2
34.1
72
145
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.5
34.0
234
1012
M01AH01
ATC
celecoxib; oral
2.4
34.0
278
1302
J01DB01
ATC
cefalexin; oral
2.4
33.7
1355
11253
N06AB03
ATC
fluoxetine; oral
2.6
33.6
225
960
SHA04
NOMESCO Finland
Stomatognathic treatment, very demanding
7.6
33.6
48
65
M54.6
ICD-10 Finland
Pain in thoracic spine
2.9
33.6
170
628
WX110
NOMESCO Finland
Infiltration anesthesia
2.1
33.4
1214
9667
M53.1
ICD-10 Finland
Cervicobrachial syndrome
2.4
33.2
250
1127
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
5.2
33.2
69
137
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.2
33.1
351
1829
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
4.1
33.1
95
245
N02CD07, ,
ATC
173.6
32.8
34
*
N02CA01
ATC
dihydroergotamine; nasal, systemic
119.2
32.8
35
*
R01AD09
ATC
mometasone; nasal
1.9
32.6
785
5438
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
32.3
229
1003
R01AD08
ATC
fluticasone; nasal
2.0
32.3
505
3034
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.1
32.2
92
236
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
41.0
32.2
40
10
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.7
32.2
188
749
N04BC05
ATC
pramipexole; oral
3.5
32.0
118
361
M70.6
ICD-10 Finland
Trochanteric bursitis
2.6
32.0
212
899
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
5.6
31.9
61
112
R21
ICPC
Throat symptom/complaint
2.0
31.8
433
2476
R96
ICPC
Asthma
2.8
31.7
168
636
R01BA52
ATC
pseudoephedrine, combinations; oral
2.0
31.7
496
2977
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.9
31.5
97
263
J01DA01
ATC
[U] cefalexin
1.9
31.5
983
7359
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
8.4
31.3
41
50
N03AX14
ATC
levetiracetam; systemic
9.9
31.3
36
37
R50.9
ICD-10 Finland
Fever, unspecified
2.3
31.1
271
1300
WZC00
NOMESCO Finland
Treatment plan or consultation
1.9
31.1
622
4045
A06AD11
ATC
lactulose; oral
2.7
31.0
187
757
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
5.2
31.0
65
130
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
8.5
30.9
40
48
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.3
30.9
81
195
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.9
30.9
510
3113
R03BA05
ATC
fluticasone; inhalant
2.2
30.8
309
1571
R01AD58
ATC
fluticasone, combinations; nasal
2.0
30.8
487
2929
M89.0
ICD-10 Finland
Algoneurodystrophy
9.0
30.8
38
43
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.5
30.8
110
330
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.0
30.8
408
2307
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
5.4
30.7
61
116
R06.5
ICD-10 Finland
Mouth breathing
3.2
30.5
129
430
X59
ICD-10 Finland
Exposure to unspecified factor
2.1
30.5
348
1861
Z2446
NOMESCO Finland
Social worker
3.1
30.4
134
457
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.2
30.2
127
422
SAA01
NOMESCO Finland
Simple examination of mouth
2.0
29.9
1231
10003
N05BA12
ATC
alprazolam; oral
2.7
29.8
176
704
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
3.2
29.6
123
405
B01AC04
ATC
clopidogrel; oral
2.7
29.5
171
678
N03AX15
ATC
zonisamide; oral
+∞
29.3
28
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
29.2
565
3619
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.4
29.2
234
1082
Z71.8
ICD-10 Finland
Other specified counselling
1.9
29.0
598
3903
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.1
29.0
125
421
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
9.6
28.9
34
36
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
5.2
28.9
60
119
WX402
NOMESCO Finland
General anaesthesia
2.0
28.7
400
2294
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.3
28.7
236
1103
P01
ICPC
Feeling anxious/nervous/tense
2.2
28.6
286
1449
XCK00
NOMESCO Finland
Perimetry
3.7
28.6
93
262
H01
ICPC
Ear pain/earache
2.3
28.5
235
1099
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.7
28.4
163
642
N17
ICPC
Vertigo/dizziness
2.5
28.3
194
834
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.3
28.1
238
1125
SPAT1050
SPAT
Extensive neurological examination
6.8
28.1
44
66
J01FA09
ATC
clarithromycin; systemic
1.9
28.1
521
3284
P03
ICPC
Feeling depressed
2.4
28.0
216
981
WX002
NOMESCO Finland
Sedation and analgesia
2.2
28.0
284
1447
SAA04
NOMESCO Finland
Special examination of mouth
3.3
27.9
112
361
XG466
NOMESCO Finland
Sleep oxymetry
9.1
27.8
34
38
E66.8
ICD-10 Finland
Other obesity
3.3
27.6
107
338
Z00.0
ICD-10 Finland
General medical examination
2.1
27.4
316
1689
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
6.1
27.4
48
81
R03AK07
ATC
formoterol and budesonide; inhalant
2.0
27.3
379
2166
SPAT1254
SPAT
Administration of medicine
2.4
27.2
211
960
N30.0
ICD-10 Finland
Acute cystitis
2.2
27.1
275
1399
N06AA12
ATC
doxepin; systemic
3.8
27.1
86
238
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
3.1
27.1
116
389
R03BA01
ATC
beclometasone; inhalant
2.3
27.1
226
1061
SHA01
NOMESCO Finland
Stomatognathic treatment, simple
2.3
27.0
222
1035
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.8
26.9
598
3972
F51.0
ICD-10 Finland
Nonorganic insomnia
2.0
26.7
340
1884
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.2
26.6
247
1212
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.8
26.5
84
232
C01CA24
ATC
epinephrine; parenteral
2.8
26.5
142
540
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.6
26.5
90
261
H04.10
ICD-10 Finland
Dry eye syndrome
2.3
26.4
215
999
R05
ICD-10 Finland
Cough
2.0
26.3
351
1975
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
3.3
26.3
103
327
M54.3
ICD-10 Finland
Sciatica
3.2
26.3
111
369
R25.2
ICD-10 Finland
Cramp and spasm
5.2
26.3
54
106
ZXA10
NOMESCO Finland
Bilateral
2.2
26.3
255
1274
J45
ICD-10 Finland
Asthma
2.4
26.2
192
850
XF600
NOMESCO Finland
Bloodpressure measurement
3.3
26.2
105
338
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.4
26.1
193
858
E66.01
ICD-10 Finland
Obesity due to excess calories
2.6
26.1
168
700
L28
ICPC
Limited function/disability (L)
2.3
26.1
229
1097
G44.4
ICD-10 Finland
Drug-induced headache, not elsewhere classified
+∞
26.1
25
*
R01AD12
ATC
fluticasone furoate; nasal
1.8
26.1
567
3734
WX722
NOMESCO Finland
PEEP
7.8
26.0
36
47
N06AX03
ATC
mianserin; oral
3.7
25.8
83
232
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
25.7
338
1890
R74
ICPC
Upper respiratory infection acute
1.8
25.5
639
4379
K08.80
ICD-10 Finland
Toothache NOS
2.4
25.5
189
841
M54.1
ICD-10 Finland
Radiculopathy
3.6
25.5
86
248
AA1AA
NOMESCO Finland
Head X-ray examination
10.5
25.4
28
27
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.6
25.3
153
618
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
5.1
25.3
53
106
A03
ICPC
Fever
2.0
25.2
344
1948
M01AC06
ATC
meloxicam; systemic, rectal
1.8
25.2
525
3406
R1250
NOMESCO Finland
Evaluation of functional capability
5.0
25.2
54
110
R03AC03
ATC
terbutaline; inhalant
2.2
25.2
231
1127
L02
ICPC
Back symptom/complaint
2.3
25.1
207
965
R52.1
ICD-10 Finland
Chronic intractable pain
9.0
25.1
31
35
S18
ICPC
Laceration/cut
1.7
25.1
691
4860
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
+∞
25.1
24
*
Z3229
NOMESCO Finland
Other healthcare associate professional
2.9
25.1
125
457
ZY010
NOMESCO Finland
Hospital outpatient
2.9
25.0
121
435
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.5
25.0
174
753
L86
ICPC
Back syndrome with radiating pain
3.0
24.8
111
382
R4120
NOMESCO Finland
Occupational therapy
2.9
24.5
124
457
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
2.4
24.4
183
818
C10AA05
ATC
atorvastatin; oral
1.8
24.4
499
3215
SPAT1377
SPAT
Polysomnography
5.8
24.4
45
80
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.8
24.3
132
505
B01AB05
ATC
enoxaparin; parenteral
1.9
24.2
426
2620
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
9.8
24.2
28
29
3AX01, ,
NOMESCO Finland
29.7
24.1
32
11
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
2.3
24.1
209
995
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.4
24.1
183
823
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
3.2
24.1
99
324
ZXE00
NOMESCO Finland
One hour or less
1.8
24.1
601
4099
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
6.4
24.1
40
64
N07BA03
ATC
varenicline; oral
3.0
24.1
112
394
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
3.2
24.0
98
319
Z2221
NOMESCO Finland
Medical doctor
1.8
24.0
440
2738
SPAT1263
SPAT
Sampling
1.7
23.9
617
4245
X58
ICD-10 Finland
Exposure to other specified factors
2.0
23.8
284
1530
M48.0
ICD-10 Finland
Spinal stenosis
2.6
23.8
150
618
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.9
23.8
113
402
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.5
23.8
167
725
R03BA02
ATC
budesonide; inhalant
2.0
23.7
293
1600
K10.3
ICD-10 Finland
Alveolitis of jaws
3.0
23.7
109
381
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
3.4
23.6
89
276
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.8
23.6
445
2792
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
5.2
23.4
48
94
ZXA05
NOMESCO Finland
Left side
2.0
23.2
323
1837
J01EA01
ATC
trimethoprim; systemic
1.9
23.0
363
2150
U01
ICPC
Dysuria/painful urination
2.7
23.0
135
537
SAA03
NOMESCO Finland
Extended examination of mouth
1.7
23.0
668
4736
K02.1
ICD-10 Finland
Caries of dentine
1.7
23.0
1008
7979
S01EC01
ATC
acetazolamide; systemic
5.8
23.0
42
74
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.7
22.9
126
485
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
4.4
22.9
58
136
M01AH02
ATC
rofecoxib; oral
2.4
22.7
165
727
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
233.2
22.7
23
*
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
2.1
22.6
244
1265
Z01.2
ICD-10 Finland
Dental examination
1.7
22.6
783
5807
J46
ICD-10 Finland
Status asthmaticus
4.5
22.6
56
129
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.2
22.5
93
305
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.9
22.5
369
2212
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.8
22.5
427
2679
H92.0
ICD-10 Finland
Otalgia
2.6
22.4
135
544
C03CA01
ATC
furosemide; systemic
2.0
22.3
268
1446
N80.0
ICD-10 Finland
Endometriosis of uterus
4.6
22.3
53
118
F32.1
ICD-10 Finland
Moderate depressive episode
2.6
22.3
137
558
K80
ICPC
Cardiac arrhythmia NOS
2.6
22.3
135
546
D02
ICPC
Abdominal pain epigastric
2.7
22.2
122
469
SPAT1301
SPAT
No procedures
1.8
22.2
423
2654
R10.0
ICD-10 Finland
Acute abdomen
3.6
22.2
73
207
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.3
22.0
176
809
SPAT1060
SPAT
Administration of oxygen
29.5
21.9
29
10
F61.0
ICD-10 Finland
Mixed personality disorders
5.3
21.8
44
85
XF404
NOMESCO Finland
Ambulatory ECG
2.8
21.8
117
445
SBB10
NOMESCO Finland
Dental impressions
2.6
21.7
128
511
A03CA02
ATC
clidinium and psycholeptics; oral
3.4
21.7
81
250
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.3
21.6
174
801
L12
ICPC
Hand/finger symptom/complaint
1.9
21.4
296
1675
UJF30
NOMESCO Finland
Ileoscopy through colon
2.3
21.4
173
799
OAB72
NOMESCO Finland
Weight control and weight loss guidance
9.1
21.2
26
29
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
4.5
21.1
52
119
D09
ICPC
Nausea
2.9
21.1
100
355
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.5
21.1
134
554
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.5
21.0
146
630
A01AB09
ATC
miconazole; local oral
2.6
21.0
123
489
K59.09
ICD-10 Finland
Constipation, unspecified
2.9
21.0
99
351
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
3.2
20.9
85
276
J01.1
ICD-10 Finland
Acute frontal sinusitis
4.6
20.9
50
112
N02CD05
ATC
eptinezumab; parenteral
+∞
20.9
20
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
20.9
316
1842
SPAT1104
SPAT
Monitoring of emergency patient
3.0
20.7
96
337
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
212.7
20.6
21
*
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
3.7
20.5
67
189
SFA10
NOMESCO Finland
One-surface restoration
1.7
20.5
916
7182
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.7
20.5
113
435
WX892
NOMESCO Finland
Monitored bed care
2.7
20.5
116
453
J01MA14
ATC
moxifloxacin; systemic
2.4
20.5
142
612
M50.3
ICD-10 Finland
Other cervical disc degeneration
4.6
20.4
49
110
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
2.4
20.4
151
670
R06AX27
ATC
desloratadine; oral
1.7
20.3
509
3438
N05CD07
ATC
temazepam; oral
2.5
20.3
134
564
J01MA12
ATC
levofloxacin; systemic
2.0
20.3
248
1344
J01DA06
ATC
[U] cefuroxime
2.0
20.1
231
1223
IGY02
NOMESCO Finland
Psychiatric monitoring contact
3.2
20.1
82
267
ABD99
NOMESCO Finland
Other operation on spinal cord or nerve for pain or impaired function
27.4
20.1
27
10
L08
ICPC
Shoulder symptom/complaint
1.8
20.0
350
2131
S93.4
ICD-10 Finland
Sprain and strain of ankle
2.0
20.0
229
1211
M02AA07
ATC
piroxicam; topical
1.7
19.9
466
3087
M01AX17
ATC
nimesulide; oral
1.9
19.9
297
1721
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.7
19.9
464
3072
3468X
ICD-9 Finland
Migraine, Other forms of migraine
+∞
19.8
19
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
19.8
403
2566
SPAT1260
SPAT
Consultation of another employee
2.0
19.7
243
1319
XKD00
NOMESCO Finland
Uroflowmetry
2.2
19.6
174
834
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.0
19.5
220
1157
U07
ICPC
Urine symptom/complaint other
2.5
19.4
129
545
ZYC01
NOMESCO Finland
Remote contact by phone
2.6
19.4
115
460
R60.9
ICD-10 Finland
Oedema, unspecified
3.0
19.3
86
295
C07AB03
ATC
atenolol; systemic
3.5
19.3
68
202
KH1AD
NOMESCO Finland
CT of urinary organs
3.4
19.3
71
217
N06BA04
ATC
methylphenidate; oral
3.0
19.1
89
313
A07AA02
ATC
nystatin; oral
3.1
19.1
81
270
R13
ICD-10 Finland
Dysphagia
2.7
19.1
108
422
B02AA02
ATC
tranexamic acid; systemic
2.0
19.0
249
1380
R05FB02
ATC
cough suppressants and expectorants; systemic
1.7
19.0
493
3351
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.8
19.0
95
348
K04.0
ICD-10 Finland
Pulpitis
2.1
18.9
184
914
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.1
18.9
201
1034
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.2
18.9
172
833
R07.0
ICD-10 Finland
Pain in throat
2.4
18.9
138
609
J20
ICD-10 Finland
Acute bronchitis
2.2
18.8
176
861
UKC02
NOMESCO Finland
Cystoscopy
2.1
18.8
187
937
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.1
18.8
208
1085
M94.0
ICD-10 Finland
Chondrocostal junction syndrome [Tietze]
4.1
18.8
51
126
N03
ICPC
Pain face
8.2
18.8
25
31
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
+∞
18.8
18
*
K04.08
ICD-10 Finland
Other specified pulpit
2.2
18.7
165
789
G90.2
ICD-10 Finland
Horner syndrome
24.0
18.7
26
11
XQ800
NOMESCO Finland
Prick test
2.3
18.6
142
638
N02AC04
ATC
dextropropoxyphene; oral
4.4
18.6
46
106
T78.4
ICD-10 Finland
Allergy, unspecified
2.9
18.5
90
324
G04CA02
ATC
tamsulosin; oral
1.9
18.5
249
1391
SPAT1240
SPAT
Therapeutic discussion
2.1
18.5
193
985
F01
ICPC
Eye pain
3.5
18.5
65
193
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
4.3
18.4
48
115
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
2.2
18.4
165
794
N05AH03
ATC
olanzapine; systemic
2.5
18.3
125
534
M01AE51
ATC
ibuprofen, combinations; systemic
6.7
18.3
29
44
M75.9
ICD-10 Finland
Shoulder lesion, unspecified
2.7
18.3
101
389
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
4.2
18.3
49
120
A02BA03
ATC
famotidine; systemic
4.2
18.3
49
120
N05AA02
ATC
levomepromazine; systemic
3.2
18.3
74
240
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
3.3
18.2
68
210
C08CA05
ATC
nifedipine; systemic
3.2
18.2
75
246
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
2.6
18.1
106
421
N06AX05
ATC
trazodone; oral
4.0
18.1
51
130
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
2.2
18.0
153
720
SPAT1283
SPAT
Restricted health certificate
1.8
18.0
335
2072
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
2.6
17.9
111
453
D20
ICPC
Mouth/tongue/lip symptom/complaint
2.9
17.8
85
303
P29
ICPC
Psychological sympt/compl other
2.2
17.8
156
743
T82
ICPC
Obesity
3.2
17.8
70
223
C07AB12
ATC
nebivolol; oral
3.8
17.7
55
150
H02AB09
ATC
hydrocortisone; systemic
4.3
17.7
46
110
M01AB55
ATC
diclofenac, combinations; oral
2.8
17.7
89
327
WZA90
NOMESCO Finland
Other medical or dental certificate
1.7
17.7
370
2366
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.5
17.6
112
463
N30.9
ICD-10 Finland
Cystitis, unspecified
2.6
17.6
105
421
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.7
17.6
429
2859
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.5
17.5
116
489
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
3.4
17.5
63
190
SGA01
NOMESCO Finland
Emergency treatment
1.8
17.5
300
1810
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
4.3
17.5
45
107
7840A
ICD-9 Finland
Symptoms involving head and neck, Headache
7.8
17.4
24
31
R00.0
ICD-10 Finland
Tachycardia, unspecified
3.0
17.4
79
274
M01AE01
ATC
ibuprofen; systemic, rectal
2.3
17.4
1476
13484
M77.1
ICD-10 Finland
Lateral epicondylitis
2.2
17.4
165
812
J01CA04
ATC
amoxicillin; systemic
1.8
17.3
1309
11482
R03BA08
ATC
ciclesonide; inhalant
2.3
17.3
142
658
S29
ICPC
Skin symptom/complaint other
1.8
17.3
301
1823
SPAT1255
SPAT
Intravenous administration of medicine
2.7
17.3
98
383
R06AX22
ATC
ebastine; oral
1.8
17.3
290
1737
R03AK08
ATC
formoterol and beclometasone; inhalant
3.0
17.2
78
270
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.3
17.2
66
207
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.8
17.2
334
2088
ZXD05
NOMESCO Finland
Urgent procedure
1.7
17.2
454
3085
J45.8
ICD-10 Finland
Mixed asthma
3.8
17.2
53
144
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.1
17.2
173
871
UJH02
NOMESCO Finland
Anoscopy
3.2
17.1
69
223
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
3.1
17.1
73
244
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.1
17.1
74
250
C10AC01
ATC
colestyramine; oral
3.9
17.1
50
131
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
4.2
17.1
45
109
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.2
17.0
149
709
R4110, ,
SPAT
2.1
17.0
181
930
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
3.5
17.0
58
169
R00.2
ICD-10 Finland
Palpitations
2.3
16.9
141
658
R60.0
ICD-10 Finland
Localized oedema
2.2
16.9
160
786
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.2
16.9
69
225
SPAT1097
SPAT
Recording of ECG
2.1
16.9
171
862
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
3.7
16.8
53
146
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
16.8
283
1695
Z50.1
ICD-10 Finland
Other physical therapy
2.9
16.7
80
286
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
16.7
204
1102
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.6
16.6
39
86
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.7
16.6
418
2802
N06AX17
ATC
milnacipran; oral
6.8
16.6
26
39
R06.2
ICD-10 Finland
Wheezing
2.8
16.6
83
304
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
3.0
16.5
72
244
SFA30
NOMESCO Finland
Three-surface restoration
1.6
16.4
660
4950
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
3.8
16.4
50
135
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
2.7
16.3
88
335
SFA20
NOMESCO Finland
Two-surface restoration
1.6
16.3
958
7820
I20.09
ICD-10 Finland
Unstable angina
3.2
16.3
66
214
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.1
16.3
160
797
ZXD35
NOMESCO Finland
Usual procedure
3.5
16.3
57
169
XKC03
NOMESCO Finland
Water cystometry
4.1
16.2
44
109
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.1
16.2
159
792
DHB50
NOMESCO Finland
Turbinoplasty
3.7
16.1
51
141
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
4.2
16.1
43
105
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.3
16.1
61
190
EB1VA, ,
NOMESCO Finland
1.8
16.1
297
1827
L16
ICPC
Ankle symptom/complaint
2.0
16.1
197
1064
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.7
16.1
421
2848
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.9
16.1
76
270
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.4
16.0
113
490
A02BA04
ATC
nizatidine; systemic
2.7
16.0
91
356
G47.9
ICD-10 Finland
Sleep disorder, unspecified
3.6
15.9
53
152
N02AJ13
ATC
tramadol and paracetamol; systemic
3.9
15.9
47
124
A28
ICPC
Limited function/disability NOS
2.1
15.9
171
882
C01DA14
ATC
isosorbide mononitrate; oral
2.4
15.8
115
506
SPAT1249
SPAT
Treatment-related counselling outside office
1.6
15.8
558
4055
S22.3
ICD-10 Finland
Fracture of rib
2.4
15.8
117
519
K07.69
ICD-10 Finland
Dislocation of the jaw joint UNS
4.3
15.8
40
94
U02
ICPC
Urinary frequency/urgency
1.9
15.7
212
1182
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.2
15.7
139
664
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.9
15.7
235
1356
R12
ICD-10 Finland
Heartburn
2.2
15.6
141
679
S01GX01
ATC
cromoglicic acid; ophthalmic
1.7
15.6
337
2164
79199
ICD-8 Finland
Headache
6.1
15.6
27
45
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
3.2
15.6
62
199
R03AC12
ATC
salmeterol; inhalant
3.2
15.6
62
199
N07CA01
ATC
betahistine; oral
2.5
15.6
96
391
K59.1
ICD-10 Finland
Functional diarrhoea
2.6
15.5
89
350
C10AX09
ATC
ezetimibe; oral
1.9
15.4
203
1123
J01DA09
ATC
[U] cefadroxil
1.6
15.4
399
2687
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.5
15.4
100
418
SPAT1058
SPAT
PEF monitoring instruction
2.4
15.4
105
449
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
14.9
15.4
25
17
A29
ICPC
General symptom/complaint other
2.0
15.4
181
964
IHZ05, ,
SPAT
2.5
15.3
95
388
M22.4
ICD-10 Finland
Chondromalacia patellae
3.0
15.3
68
233
WYA10
NOMESCO Finland
Emergency care or similar visit
2.2
15.3
127
591
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
2.0
15.3
169
879
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.5
15.3
639
4816
OAB93, ,
SPAT
2.2
15.2
142
693
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
4.7
15.2
35
76
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.2
15.2
131
620
SPAT1312
SPAT
General health counselling
1.6
15.1
451
3145
C08CA01
ATC
amlodipine; oral
1.6
15.0
404
2744
NA1BG, ,
SPAT
3.7
15.0
48
134
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
4.5
15.0
36
81
SGA02
NOMESCO Finland
Opening and preparing the root canals
1.9
15.0
217
1238
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.2
14.9
134
644
N06AA06
ATC
trimipramine; systemic
3.9
14.9
44
116
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.7
14.9
364
2413
P74
ICPC
Anxiety disorder/anxiety state
2.4
14.9
102
437
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.3
14.9
111
494
Z71.9
ICD-10 Finland
Counselling, unspecified
2.1
14.8
142
700
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.5
14.8
91
370
S80.0
ICD-10 Finland
Contusion of knee
2.2
14.8
134
646
R63.4
ICD-10 Finland
Abnormal weight loss
3.0
14.8
64
216
R09
ICPC
Sinus symptom/complaint
2.1
14.8
154
784
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.9
14.8
72
260
R75
ICPC
Sinusitis acute/chronic
2.5
14.8
94
389
L04
ICPC
Chest symptom/complaint
2.4
14.7
108
477
PA6AG
NOMESCO Finland
Limited MRI examination of neck vasculature with high intensity magnet
13.3
14.7
25
19
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.0
14.7
64
217
F90.0
ICD-10 Finland
Disturbance of activity and attention
2.5
14.7
91
372
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
3.8
14.7
45
122
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.5
14.6
97
409
L29
ICPC
Musculoskeletal sympt/complt other
2.2
14.6
132
636
K59.01
ICD-10 Finland
Constipation outlet obstruction type
5.2
14.6
30
59
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.4
14.6
102
441
J01CA08
ATC
pivmecillinam; oral
1.5
14.6
577
4284
SGB10
NOMESCO Finland
Root filling of tooth with one root canal
1.9
14.6
195
1084
L05
ICPC
Flank/axilla symptom/complaint
2.4
14.6
107
473
R01AD05
ATC
budesonide; nasal
2.2
14.5
124
584
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.5
14.5
92
380
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
5.5
14.5
28
52
R04.2
ICD-10 Finland
Haemoptysis
3.5
14.5
49
142
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.6
14.5
363
2420
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
15.5
14.4
23
15
WX882
NOMESCO Finland
High dependency care
4.3
14.4
37
88
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
3.2
14.4
57
183
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.0
14.3
153
786
R29
ICPC
Respiratory symptom/complaint other
2.3
14.2
106
471
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.1
14.1
141
706
J01FA15
ATC
telithromycin; oral
2.0
14.1
153
790
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.9
14.1
41
107
R01AD01
ATC
beclometasone; nasal
1.8
14.1
234
1392
J02AC02
ATC
itraconazole; systemic
1.8
14.1
250
1517
N94.6
ICD-10 Finland
Dysmenorrhoea, unspecified
3.3
14.0
52
160
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.1
14.0
57
186
C08DB01
ATC
diltiazem; oral
3.6
14.0
46
131
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.0
13.9
157
822
R04
ICPC
Breathing problem other
3.1
13.9
57
187
K11.2
ICD-10 Finland
Sialoadenitis
3.0
13.8
60
203
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.7
13.8
261
1611
G56.2
ICD-10 Finland
Lesion of ulnar nerve
2.7
13.8
72
270
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
3.5
13.8
47
137
A02BC04
ATC
rabeprazole; oral
2.1
13.7
136
679
SAA02
NOMESCO Finland
Basic examination of mouth
1.5
13.7
1094
9365
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
4.0
13.7
39
100
SXA20
NOMESCO Finland
Local application of medicine to mouth
2.3
13.7
112
518
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.3
13.7
106
479
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
1.9
13.7
174
950
D07AB02
ATC
hydrocortisone butyrate; topical
1.6
13.7
429
3013
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.9
13.7
191
1076
F34.1
ICD-10 Finland
Dysthymia
2.8
13.7
67
243
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.0
13.7
61
210
G03DC03
ATC
lynestrenol; oral
3.5
13.6
47
138
M54.8
ICD-10 Finland
Other dorsalgia
2.6
13.6
78
307
KMAK, ,
NOMESCO Finland
1.5
13.6
821
6631
L13
ICPC
Hip symptom/complaint
1.8
13.6
242
1469
M51.9
ICD-10 Finland
Intervertebral disc disorder, unspecified
4.6
13.6
32
71
183
Kela drug reimbursment
Lamotrigin and topiramate
+∞
13.6
13
*
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
5.5
13.6
26
48
E0000UV, ,
ATC
1.5
13.5
608
4619
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.3
13.5
107
488
H02.4
ICD-10 Finland
Ptosis of eyelid
3.6
13.5
45
129
SPAT1262
SPAT
Handing over of treatment supplies
1.9
13.5
191
1080
R83
ICPC
Respiratory infection other
1.6
13.5
466
3344
A99
ICPC
Disease/condition unspecnature/site
2.0
13.4
149
776
R03AK11
ATC
formoterol and fluticasone; inhalant
3.6
13.4
44
125
DFF00
NOMESCO Finland
Pure tone audiometry
2.1
13.4
132
658
R10.2
ICD-10 Finland
Pelvic and perineal pain
3.3
13.3
50
155
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
3.1
13.3
55
181
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
6.4
13.3
22
35
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.6
13.3
43
121
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
1.9
13.2
164
888
J31.0
ICD-10 Finland
Chronic rhinitis
2.1
13.2
136
689
S16
ICPC
Bruise/contusion
3.4
13.2
47
141
Z01.9
ICD-10 Finland
Special examination, unspecified
2.4
13.2
90
385
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
2.0
13.2
154
817
XA402
NOMESCO Finland
ENMG
3.6
13.1
43
122
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
2.8
13.1
68
254
F41.09
ICD-10 Finland
UNS Panic Syndrome
2.9
13.1
61
215
R31
ICD-10 Finland
Unspecified haematuria
2.2
13.1
116
555
L15
ICPC
Knee symptom/complaint
1.6
13.0
349
2358
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
4.0
13.0
37
95
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
10.1
13.0
25
25
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
3.2
13.0
52
168
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.2
13.0
115
550
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.3
12.9
100
452
K59.0
ICD-10 Finland
Constipation
2.7
12.9
70
268
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.9
12.9
167
918
A92
ICPC
Allergy/allergic reaction NOS
2.8
12.9
64
234
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.4
12.9
92
402
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
12.8
127
634
ZXA00
NOMESCO Finland
Right side
1.6
12.8
311
2049
C10AA07
ATC
rosuvastatin; oral
1.6
12.8
421
2983
A01AB04
ATC
amphotericin B; local oral
3.0
12.8
56
191
M47.82
ICD-10 Finland
Other spondylosis, cervical region
2.9
12.7
59
208
M19.0
ICD-10 Finland
Primary arthrosis of other joints
2.0
12.7
149
792
SGA03
NOMESCO Finland
Opening and preparing the root canals, complicated
1.9
12.6
174
975
K04
ICPC
Palpitations/awareness of heart
2.4
12.6
86
368
B34.9
ICD-10 Finland
Viral infection, unspecified
2.8
12.6
61
220
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.3
12.5
93
413
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
4.2
12.5
33
80
3460A
ICD-9 Finland
Migraine, Classical migraine
+∞
12.5
12
*
34609
ICD-8 Finland
Migraine, Unspecified
+∞
12.5
12
*
L20
ICPC
Joint symptom/complaint NOS
2.7
12.5
66
249
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.2
12.5
106
498
A97
ICPC
No disease
1.7
12.5
292
1906
G44.3
ICD-10 Finland
Chronic post-traumatic headache
131.0
12.4
13
*
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
3.6
12.4
41
117
AA1BG, ,
SPAT
3.5
12.4
42
122
M54.0
ICD-10 Finland
Panniculitis affecting regions of neck and back
4.5
12.4
30
68
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
2.7
12.4
68
262
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.2
12.3
105
494
D07AD01
ATC
clobetasol; topical
1.7
12.3
226
1381
AA1CG, ,
SPAT
5.4
12.3
24
45
SPAT1153
SPAT
Removal of sutures
1.6
12.3
384
2685
SPAT1310
SPAT
Counselling related to known health issue
1.5
12.2
418
2982
G45.3
ICD-10 Finland
Amaurosis fugax
37.8
12.2
15
*
AEA20
NOMESCO Finland
Removal of impulse generator of stimulation device in the nervous system
37.8
12.2
15
*
A04AA01
ATC
ondansetron; systemic, rectal
2.1
12.2
126
639
D10
ICPC
Vomiting
2.1
12.2
113
550
A85
ICPC
Adverse effect medical agent
5.0
12.2
26
53
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.9
12.2
174
987
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
12.1
668
5256
F29
ICPC
Eye symptom/complaint other
1.9
12.1
161
892
R35
ICD-10 Finland
Polyuria
2.3
12.1
89
394
WX704
NOMESCO Finland
Intubation
2.1
12.1
120
600
K04.00
ICD-10 Finland
Hyperemia of pulp
2.3
12.0
89
395
S83.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of knee
2.1
12.0
110
533
NB3AA
NOMESCO Finland
Clavicle X-ray examination
4.3
12.0
31
74
ZXD20
NOMESCO Finland
Day surgery
1.8
12.0
187
1089
M54
ICD-10 Finland
Dorsalgia
1.8
12.0
205
1227
N95
ICPC
Tension headache
10.1
12.0
23
23
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.3
12.0
87
383
R05FA02
ATC
opium derivatives and expectorants; systemic
1.5
12.0
531
4001
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
2.3
11.9
89
396
R03AC13
ATC
formoterol; inhalant
2.6
11.9
67
261
R03AK03
ATC
[U] fenoterol and ipratropium bromide
3.1
11.9
50
166
H03AA01
ATC
levothyroxine sodium; systemic
1.6
11.9
297
1968
N06AB05
ATC
paroxetine; oral
2.3
11.9
94
429
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.3
11.9
86
378
C10AA01
ATC
simvastatin; oral
1.6
11.8
369
2577
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.9
11.8
168
951
M01AX01
ATC
nabumetone; oral
2.9
11.8
54
189
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
4.0
11.8
33
84
N29
ICPC
Neurological sympt/complt other
4.3
11.8
30
71
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
5.2
11.8
24
47
LCA06
NOMESCO Finland
Biopsy of endometrium
1.9
11.7
168
953
Z01.7
ICD-10 Finland
Laboratory examination
1.7
11.7
253
1615
M76.0
ICD-10 Finland
Gluteal tendinitis
3.2
11.7
45
142
UJD02
NOMESCO Finland
Gastroscopy
2.7
11.7
62
235
I49.8
ICD-10 Finland
Other specified cardiac arrhythmias
3.0
11.6
51
174
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.1
11.6
116
581
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
2.4
11.6
80
344
G45.4
ICD-10 Finland
Transient global amnesia
19.1
11.6
17
9
R518, ,
ICD-10 Finland
19.1
11.6
17
9
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
2.7
11.5
60
225
E66
ICD-10 Finland
Obesity
2.3
11.5
88
396
R06.4
ICD-10 Finland
Hyperventilation
4.3
11.5
29
68
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
5.7
11.5
21
37
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
5.1
11.5
24
48
G40
ICD-10 Finland
Epilepsy
+∞
11.5
11
*
N88
ICPC
Epilepsy
+∞
11.5
11
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
+∞
11.5
11
*
SPAT1094
SPAT
Continuous Positive Airway Pressure
+∞
11.5
11
*
Z02.7
ICD-10 Finland
Issue of medical certificate
2.1
11.4
111
550
B01AA03
ATC
warfarin; systemic
1.9
11.4
152
842
SPAT1229
SPAT
Assessment of need for aid
2.5
11.4
71
291
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
2.3
11.4
87
391
P25
ICPC
Phase of life problem adult
2.4
11.4
81
353
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
3.0
11.4
51
176
L99
ICPC
Musculoskeletal disease other
3.3
11.4
42
129
N81.6
ICD-10 Finland
Rectocele
2.4
11.4
80
347
N80.3
ICD-10 Finland
Endometriosis of pelvic peritoneum
2.7
11.4
59
221
J01DC02
ATC
cefuroxime; systemic
2.2
11.3
91
418
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
2.2
11.3
102
491
D07AC01
ATC
betamethasone; topical
1.5
11.3
500
3754
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.5
11.3
443
3245
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
3.6
11.3
37
105
N05BE01
ATC
buspirone; oral
3.0
11.3
49
166
F45.0
ICD-10 Finland
Somatization disorder
15.2
11.3
18
12
JAH01
NOMESCO Finland
Laparoscopy
2.4
11.3
75
317
F43.00
ICD-10 Finland
Acute stress reaction mild
2.9
11.3
53
188
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.2
11.3
44
140
M47.9
ICD-10 Finland
Spondylosis, unspecified
3.2
11.3
44
140
U05
ICPC
Urination problems other
2.6
11.3
63
245
N06AX18
ATC
reboxetine; oral
5.2
11.3
23
45
N94.5
ICD-10 Finland
Secondary dysmenorrhoea
3.3
11.3
42
130
J34.3
ICD-10 Finland
Hypertrophy of nasal turbinates
3.3
11.3
41
125
H02BX01
ATC
methylprednisolone, combinations; systemic
2.8
11.3
56
205
R4190
NOMESCO Finland
Nutritional therapy
2.6
11.3
65
257
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
3.7
11.3
35
96
E66.9
ICD-10 Finland
Obesity, unspecified
2.8
11.2
54
194
D50.8
ICD-10 Finland
Other iron deficiency anaemias
4.5
11.2
27
61
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.1
11.1
109
542
K29.3
ICD-10 Finland
Chronic superficial gastritis
3.3
11.1
41
126
W22
ICD-10 Finland
Striking against or struck by other object(s)
2.0
11.1
119
612
PA2AD
NOMESCO Finland
CT angiography of brain
8.1
11.1
24
30
L29.9
ICD-10 Finland
Pruritus, unspecified
3.0
11.0
48
163
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
2.3
11.0
85
384
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
2.5
11.0
71
296
S00.0
ICD-10 Finland
Superficial injury of scalp
3.4
11.0
39
117
J35.0
ICD-10 Finland
Chronic tonsillitis
2.1
10.9
102
498
J01
ICD-10 Finland
Acute sinusitis
2.1
10.9
103
505
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
2.1
10.9
111
560
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
3.0
10.9
47
159
IGY99
NOMESCO Finland
Other psychiatric treatment contact
3.2
10.9
43
138
XA420
NOMESCO Finland
Extensive sleep examination
15.6
10.8
17
11
R06AE09
ATC
levocetirizine; oral
1.7
10.8
228
1445
G01AF05
ATC
econazole; vaginal
2.0
10.8
118
611
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.8
10.8
53
193
G04BD08
ATC
solifenacin; oral
2.5
10.8
69
287
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
2.3
10.8
83
375
F41.8
ICD-10 Finland
Other specified anxiety disorders
2.5
10.8
67
275
T74.1
ICD-10 Finland
Physical abuse
3.3
10.7
40
124
N02CA72
ATC
ergotamine, combinations with psycholeptics; oral
21.6
10.7
15
7
LCH00
NOMESCO Finland
Vacuum aspiration of products of conception from uterus
2.8
10.7
53
194
K04.09
ICD-10 Finland
Pulpit UNS
2.2
10.7
86
396
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
3.1
10.7
44
145
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
3.6
10.7
34
95
ZXE20
NOMESCO Finland
More than three and less than five hours
1.8
10.6
163
944
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.1
10.6
106
531
F31
ICD-10 Finland
Bipolar affective disorder
4.0
10.6
30
77
SPAT1216
SPAT
Assessment of functional ability
1.9
10.6
146
818
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
10.6
153
870
-1, ,
NOMESCO Finland
1.5
10.6
512
3904
EMB10
NOMESCO Finland
Tonsillectomy
2.0
10.6
108
546
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
2.8
10.6
51
184
WX702
NOMESCO Finland
Supraglottic ventilation device
2.2
10.5
90
425
N39.3
ICD-10 Finland
Stress incontinence
2.1
10.5
95
459
F41.00
ICD-10 Finland
Moderate panic disorder
3.5
10.5
35
101
L50.9
ICD-10 Finland
Urticaria, unspecified
2.4
10.5
69
291
W19
ICD-10 Finland
Unspecified fall
1.9
10.5
134
733
J05AB11
ATC
valaciclovir; oral
1.7
10.4
208
1298
M01AG01
ATC
mefenamic acid; oral
2.9
10.4
47
163
3461A
ICD-9 Finland
Migraine, Common migraine
+∞
10.4
10
*
NF1AA
NOMESCO Finland
Hip X-ray examination
2.1
10.4
94
454
WX400
NOMESCO Finland
Inhalation anesthesy
2.5
10.4
67
280
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.8
10.4
159
921
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
2.7
10.4
54
203
R52.0
ICD-10 Finland
Acute pain
2.6
10.3
61
244
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.4
10.3
36
107
R03DA04
ATC
theophylline; systemic, rectal
2.6
10.3
57
221
Z72.0
ICD-10 Finland
Tobacco use
2.8
10.2
51
187
J01MA06
ATC
norfloxacin; oral
1.8
10.2
159
925
A06AC51
ATC
ispaghula, combinations; oral
2.5
10.2
65
270
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.6
10.2
231
1491
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.3
10.2
73
320
SGC10
NOMESCO Finland
Pulp capping
1.8
10.2
158
919
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
3.0
10.1
44
150
EBA00
NOMESCO Finland
Extraction of tooth
1.4
10.1
543
4216
M01AB08
ATC
etodolac; oral
2.1
10.1
96
473
A03DA02
ATC
pitofenone and analgesics; systemic
4.4
10.1
25
58
M01AB51
ATC
indometacin, combinations; oral, rectal
3.5
10.0
34
99
M02AA10
ATC
ketoprofen; topical
1.7
10.0
190
1169
SXC05
NOMESCO Finland
Other oral or dental procedure
2.1
10.0
101
508
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
3.3
10.0
37
114
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
3.4
10.0
36
109
SGC00
NOMESCO Finland
Medication, disinfection of root canals
1.7
10.0
180
1092
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
4.1
10.0
27
67
L60.0
ICD-10 Finland
Ingrowing nail
2.3
9.9
72
317
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.5
9.9
62
255
K04.1
ICD-10 Finland
Necrosis of pulp
1.7
9.9
175
1056
L11
ICPC
Wrist symptom/complaint
1.8
9.9
145
829
O99.5
ICD-10 Finland
Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
5.2
9.8
20
39
L09
ICPC
Arm symptom/complaint
2.2
9.8
80
370
TPH07
NOMESCO Finland
Cathetrisation of artery
1.9
9.8
127
697
TKC20
NOMESCO Finland
Catheterisation of bladder
2.3
9.8
72
319
H81.0
ICD-10 Finland
Ménière disease
3.6
9.8
32
91
H53.8
ICD-10 Finland
Other visual disturbances
4.0
9.8
27
68
I49.4
ICD-10 Finland
Other and unspecified premature depolarization
2.6
9.7
56
222
S61.0
ICD-10 Finland
Open wound of finger(s) without damage to nail
1.8
9.7
158
932
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
2.0
9.7
110
578
TKC22
NOMESCO Finland
Catheterisation instruction
3.6
9.7
31
87
K07.62
ICD-10 Finland
Habitual dislocation of the jaw joint
5.3
9.6
19
36
WX725
NOMESCO Finland
Noninvasive ventilation
2.2
9.6
81
380
G04BD12
ATC
mirabegron; oral
1.9
9.6
120
651
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
3.3
9.6
35
107
M19.9
ICD-10 Finland
Arthrosis, unspecified
2.6
9.6
56
223
S01GX02
ATC
levocabastine; ophthalmic
2.1
9.5
94
469
AN1
HP
Coronary angiography
2.1
9.5
90
442
EC1VA, ,
NOMESCO Finland
2.2
9.5
76
349
XJH00
NOMESCO Finland
Transanal ultrasonography
2.6
9.5
56
224
XKD03
NOMESCO Finland
Urethral pressure profilometry
3.8
9.5
28
74
ZA1.0
ICD-10 Finland
Shoulder region
3.2
9.5
37
118
WZC00, ,
SPAT
1.7
9.5
202
1282
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.7
9.5
51
195
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
3.4
9.5
34
103
N05AX12
ATC
aripiprazole; systemic
2.2
9.5
76
350
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
3.7
9.4
29
79
K92.1
ICD-10 Finland
Melaena
2.5
9.4
60
249
A03FA02
ATC
cisapride; oral, rectal
2.2
9.4
79
370
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
17.6
9.4
14
8
WZC30
NOMESCO Finland
Teaching
1.6
9.4
215
1390
G40.39
ICD-10 Finland
Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures
+∞
9.4
9
*
3472A
ICD-9 Finland
Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]
+∞
9.4
9
*
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
+∞
9.4
9
*
B03BA03
ATC
hydroxocobalamin; parenteral
2.5
9.3
56
226
S21
ICPC
Skin texture symptom/complaint
1.7
9.3
195
1231
IBA03
NOMESCO Finland
Psychotherapy evaluation
3.8
9.3
28
75
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
3.0
9.3
40
135
R01AD11
ATC
triamcinolone; nasal
1.9
9.3
118
643
M47.1
ICD-10 Finland
Other spondylosis with myelopathy
4.9
9.3
20
41
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
4.5
9.3
22
49
DJD20
NOMESCO Finland
Plastic repair of septum of nose
2.6
9.3
51
197
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.4
9.3
65
282
J37.0
ICD-10 Finland
Chronic laryngitis
2.8
9.2
46
169
SGA04
NOMESCO Finland
Opening and preparing the root canals, extremely complicated
1.7
9.2
191
1203
PD5AD
NOMESCO Finland
CT of aorta
3.2
9.2
36
115
Z71
ICD-10 Finland
Persons encountering health services for other counselling and medical advice, not elsewhere classified
2.4
9.2
65
283
R07.1
ICD-10 Finland
Chest pain on breathing
3.5
9.2
31
90
S04
ICPC
Lump/swelling localized
1.7
9.2
163
984
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
3.2
9.2
35
110
K60.2
ICD-10 Finland
Anal fissure, unspecified
3.2
9.2
35
110
R01
ICPC
Pain respiratory system
3.2
9.2
35
110
X15
ICPC
Vaginal symptom/complaint other
2.2
9.2
74
341
D07AC13
ATC
mometasone; topical
1.5
9.2
394
2923
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
9.2
142
825
4700A
ICD-9 Finland
Deflected nasal septum[DEFORMATIO SEPTI NASI]
5.0
9.1
19
38
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
5.0
9.1
19
38
R49.08
ICD-10 Finland
Other specified dysphonia
3.2
9.1
36
116
M75.8
ICD-10 Finland
Other shoulder lesions
2.3
9.1
65
285
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
2.1
9.1
86
423
M79.9
ICD-10 Finland
Soft tissue disorder, unspecified
4.8
9.1
20
42
A09
ICPC
Sweating problem
4.6
9.1
21
46
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
4.0
9.1
25
63
E87.6
ICD-10 Finland
Hypokalaemia
2.7
9.1
49
188
R06AX13
ATC
loratadine; oral
1.6
9.1
229
1516
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.8
9.1
43
154
U71
ICPC
Cystitis/urinary infection other
2.0
9.0
91
458
G50.8
ICD-10 Finland
Other disorders of trigeminal nerve
15.7
9.0
14
9
D19
ICPC
Teeth/gum symptom/complaint
1.4
9.0
481
3712
R5110, ,
SPAT
2.0
9.0
94
479
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.1
9.0
79
378
R33
ICD-10 Finland
Retention of urine
2.2
8.9
74
345
C10AA03
ATC
pravastatin; oral
2.4
8.9
61
262
TNX00, ,
SPAT
3.7
8.9
27
73
SPA02
NOMESCO Finland
Preparation for dental prosthetics
2.7
8.9
48
184
J05AB01
ATC
aciclovir; systemic
1.5
8.9
298
2102
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.5
8.9
56
232
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
4.9
8.8
19
39
M01AH03
ATC
valdecoxib; oral
2.2
8.8
74
347
F51.9
ICD-10 Finland
Nonorganic sleep disorder, unspecified
2.8
8.8
44
162
F60.9
ICD-10 Finland
Personality disorder, unspecified
3.8
8.8
26
69
G57.1
ICD-10 Finland
Meralgia paraesthetica
3.8
8.8
26
69
A62
ICPC
General and Unspecified, Administrative procedure
3.0
8.8
37
124
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
2.3
8.8
68
309
J11.1
ICD-10 Finland
Influenza with other respiratory manifestations, virus not identified
2.8
8.7
43
157
J34.2
ICD-10 Finland
Deviated nasal septum
2.2
8.7
76
362
N06AG02
ATC
moclobemide; oral
2.4
8.7
56
234
F60.5
ICD-10 Finland
Anankastic personality disorder
3.9
8.7
25
65
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
3.2
8.7
33
104
J01CF05
ATC
flucloxacillin; systemic
1.9
8.7
107
579
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.8
8.6
43
158
M13.9
ICD-10 Finland
Arthritis, unspecified
1.9
8.6
106
572
R30.0
ICD-10 Finland
Dysuria
2.2
8.6
72
337
SBA00
NOMESCO Finland
Microbiological examinations
2.9
8.6
39
136
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.6
8.6
218
1443
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.9
8.6
117
653
J01CE02
ATC
phenoxymethylpenicillin; oral
1.4
8.6
1049
9260
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
2.2
8.6
74
351
LEF03
NOMESCO Finland
Posterior colporrpahy with sutures for primary rectocele
2.8
8.5
43
159
PA6BG
NOMESCO Finland
MRI examination of neck vasculature with high intensity magnet
7.0
8.5
20
29
SPAT1307
SPAT
Psychosocial counselling and guidance
1.9
8.5
105
567
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.4
8.5
55
230
SFA00
NOMESCO Finland
Small restoration
1.6
8.5
206
1348
N76.0
ICD-10 Finland
Acute vaginitis
1.8
8.5
118
662
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
1.9
8.5
112
618
SPAT1212
SPAT
Extensive examination of musculoskeletal system
1.9
8.5
103
553
T83
ICPC
Overweight
2.9
8.5
39
137
J30.3
ICD-10 Finland
Other allergic rhinitis
2.3
8.5
64
287
L50.0
ICD-10 Finland
Allergic urticaria
2.6
8.5
46
177
K29.7
ICD-10 Finland
Gastritis, unspecified
2.6
8.5
48
189
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.9
8.4
111
613
UJF92
NOMESCO Finland
Capsular endoscopy
3.1
8.4
34
111
AAW01
NOMESCO Finland
Implantation of intracranial stimulation device
90.5
8.4
9
*
J04.0
ICD-10 Finland
Acute laryngitis
2.3
8.4
65
295
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
2.0
8.4
86
436
S22.4
ICD-10 Finland
Multiple fractures of ribs
3.5
8.4
28
81
C05AA08
ATC
fluocortolone; rectal, topical
1.7
8.4
163
1010
119
Kela drug reimbursment
Trigeminal neuralgia or glossofaryngeusneuralgia
12.8
8.4
14
11
R78
ICPC
Acute bronchitis/bronchiolitis
3.4
8.4
29
86
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.1
8.4
77
375
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.8
8.3
136
802
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
+∞
8.3
8
*
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
+∞
8.3
8
*
G40.00
ICD-10 Finland
Benign childhood epilepsy with centrotemporal EEG spikes
+∞
8.3
8
*
M01AE52
ATC
naproxen and esomeprazole; oral
2.6
8.3
45
173
H53.4
ICD-10 Finland
Visual field defects
3.7
8.3
26
72
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
2.7
8.3
43
162
R07.2
ICD-10 Finland
Precordial pain
3.2
8.2
32
102
M53.3
ICD-10 Finland
Sacrococcygeal disorders, not elsewhere classified
3.4
8.2
29
87
O20.0
ICD-10 Finland
Threatened abortion
2.6
8.2
45
174
WZA00
NOMESCO Finland
Concise certificate
1.9
8.2
107
590
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
2.1
8.2
74
358
K07.58
ICD-10 Finland
Other abnormal function of teeth and jaws
3.9
8.2
23
59
N05AF03
ATC
chlorprothixene; systemic
2.8
8.2
40
146
E22.1
ICD-10 Finland
Hyperprolactinaemia
4.4
8.2
20
46
WX003
NOMESCO Finland
Sedation or analgesia orally, rectally or intramuscularly without general anesthesia
4.4
8.2
20
46
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
2.9
8.2
36
124
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
1.7
8.1
144
869
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
2.6
8.1
44
169
S20.2
ICD-10 Finland
Contusion of thorax
2.1
8.1
77
379
S02.51
ICD-10 Finland
Fracture of tooth, open
1.7
8.1
136
808
R23.3
ICD-10 Finland
Spontaneous ecchymoses
3.2
8.1
31
98
S43.4
ICD-10 Finland
Sprain and strain of shoulder joint
2.2
8.1
69
326
N20.1
ICD-10 Finland
Calculus of ureter
2.4
8.1
53
224
N63
ICD-10 Finland
Unspecified lump in breast
1.9
8.1
104
571
S01
ICPC
Pain/tenderness of skin
2.2
8.0
64
294
I49.3
ICD-10 Finland
Ventricular premature depolarization
1.9
8.0
97
521
I49.1
ICD-10 Finland
Atrial premature depolarization
2.5
8.0
47
188
ABC26
NOMESCO Finland
Open discectomy of lumbar spine
3.1
8.0
33
109
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
22.1
8.0
11
5
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.3
8.0
58
256
R04.0
ICD-10 Finland
Epistaxis
2.0
8.0
81
409
N20.0
ICD-10 Finland
Calculus of kidney
3.1
8.0
32
104
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.0
8.0
35
120
G03DB01
ATC
dydrogesterone; oral
1.6
8.0
179
1150
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
2.3
8.0
56
244
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
1.8
8.0
114
647
W10
ICD-10 Finland
Fall on and from stairs and steps
2.1
8.0
74
362
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
3.4
7.9
28
84
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
1.9
7.9
104
574
TLC02
NOMESCO Finland
Simple extraction of IUD
2.1
7.9
72
349
P20
ICPC
Memory disturbance
1.9
7.9
93
495
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.7
7.9
42
160
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
4.5
7.9
19
43
J43.9
ICD-10 Finland
Emphysema, unspecified
4.0
7.9
22
56
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
6.6
7.9
19
29
G93.3
ICD-10 Finland
Postviral fatigue syndrome
7.8
7.9
17
22
S10
ICPC
Boil/carbuncle
2.0
7.8
84
433
S82
ICPC
Naevus/mole
1.6
7.8
201
1334
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
2.4
7.8
52
221
I20.90
ICD-10 Finland
Angina pectoris, unspecified
3.3
7.8
29
90
M19.2
ICD-10 Finland
Other secondary arthrosis
4.1
7.8
21
52
J01FA01
ATC
erythromycin; systemic
1.6
7.8
208
1393
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
2.0
7.8
87
455
IFB02
NOMESCO Finland
Transcranial magnetic stimulation (TMS)
10.9
7.8
14
13
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
2.2
7.8
62
285
R5599
NOMESCO Finland
Other rehabilitation service
2.7
7.8
40
150
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.9
7.7
97
528
M25.2
ICD-10 Finland
Flail joint
3.6
7.7
25
71
JN4BD
NOMESCO Finland
Extensive body CT
1.8
7.7
116
669
R25.1
ICD-10 Finland
Tremor, unspecified
2.8
7.7
37
134
EB1MA
NOMESCO Finland
Cephalometry with X-ray
3.3
7.7
28
86
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.3
7.7
55
242
M50
ICD-10 Finland
Cervical disc disorders
4.5
7.7
18
40
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
4.5
7.7
18
40
N20.9
ICD-10 Finland
Urinary calculus, unspecified
2.7
7.7
41
157
C03AA03
ATC
hydrochlorothiazide; oral
2.1
7.6
72
354
SPAT1252
SPAT
Overall medication plan or its review
2.2
7.6
63
294
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
4.0
7.6
21
53
WVA40
NOMESCO Finland
Initiation and monitoring of intravenous hydration
4.0
7.6
21
53
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.1
7.6
71
348
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.0
7.6
86
452
S83.2
ICD-10 Finland
Tear of meniscus, current
1.8
7.6
108
612
A10BK03
ATC
empagliflozin; oral
1.8
7.6
112
642
1410
FHL
Laparoscopy
2.8
7.6
37
135
IHZ04, ,
SPAT
3.0
7.6
33
113
N80.9
ICD-10 Finland
Endometriosis, unspecified
2.6
7.6
41
158
K07.61
ICD-10 Finland
Cracking jaw joint
2.6
7.6
41
158
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.8
7.6
124
733
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
4.1
7.5
20
49
K05.0
ICD-10 Finland
Acute gingivitis
2.7
7.5
38
141
A02BX02
ATC
sucralfate; oral
2.7
7.5
38
141
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
3.3
7.5
28
87
M51.8
ICD-10 Finland
Other specified intervertebral disc disorders
3.8
7.5
22
58
LCD04
NOMESCO Finland
Laparoscopic hysterectomy
2.4
7.5
52
225
R2110
NOMESCO Finland
Giving the first information
1.9
7.5
97
533
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.5
7.5
280
2014
TAC99
NOMESCO Finland
Other blockade for chronic pain
7.1
7.5
17
24
N64.4
ICD-10 Finland
Mastodynia
2.3
7.5
55
245
XG410
NOMESCO Finland
Flow-volume spirometry
2.5
7.5
44
177
JEA00
NOMESCO Finland
Appendectomy
1.9
7.4
95
520
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
7.4
122
721
K29.1
ICD-10 Finland
Other acute gastritis
3.9
7.4
21
54
D06AX01
ATC
fusidic acid; topical
1.7
7.4
132
798
F43.9
ICD-10 Finland
Reaction to severe stress, unspecified
2.3
7.4
56
252
N05AD01
ATC
haloperidol; systemic
2.7
7.4
39
148
J39.9
ICD-10 Finland
Disease of upper respiratory tract, unspecified
6.5
7.4
18
28
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
3.2
7.4
28
88
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
3.5
7.4
25
73
S90.3
ICD-10 Finland
Contusion of other and unspecified parts of foot
2.4
7.4
48
202
ZX120
NOMESCO Finland
Intravenous
1.8
7.4
114
662
PA6CG
NOMESCO Finland
Extensive MRI examination of neck vasculature with high intensity magnet
13.4
7.4
12
9
PAW37
NOMESCO Finland
Biopsy of temporal artery
13.4
7.4
12
9
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.8
7.4
101
566
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.6
7.3
165
1061
SGA05
NOMESCO Finland
Opening and preparing the root canals, extremely complicated And time consuming
1.8
7.3
102
574
N05AX08
ATC
risperidone; systemic
1.9
7.3
91
494
UDC00
NOMESCO Finland
Ear microscopy
1.9
7.3
91
494
A05
ICPC
Feeling ill
1.9
7.3
94
516
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
2.4
7.3
47
197
P01BA02
ATC
hydroxychloroquine; oral
1.8
7.3
107
612
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
1.5
7.3
291
2119
F61
ICD-10 Finland
Mixed and other personality disorders
10.9
7.3
13
12
G40.10
ICD-10 Finland
Simple partial seizures
+∞
7.3
7
*
G41.9
ICD-10 Finland
Status epilepticus, unspecified
+∞
7.3
7
*
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
6.9
7.3
17
25
SPAT1139
SPAT
Nutrition survey
2.8
7.3
34
121
WVA20
NOMESCO Finland
Medicine administration
2.5
7.3
43
173
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
9.4
7.3
14
15
ZA6.0
ICD-10 Finland
Lower leg
4.2
7.3
19
46
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.5
7.3
262
1870
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.0
7.3
74
375
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
3.3
7.3
27
84
D68.8
ICD-10 Finland
Other specified coagulation defects
3.9
7.3
21
55
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.0
7.3
75
382
SGB30
NOMESCO Finland
Other complicated root filling
1.6
7.2
197
1325
W0A10
NOMESCO Finland
Mapping of psychosocial situation
15.8
7.2
11
7
F32
ICD-10 Finland
Depressive episode
1.9
7.2
83
439
SPAT1360
SPAT
Extensive global examination
2.0
7.2
73
369
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
2.3
7.2
55
249
M70.7
ICD-10 Finland
Other bursitis of hip
2.9
7.2
32
111
M23.8
ICD-10 Finland
Other internal derangements of knee
2.1
7.2
62
295
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.3
7.2
54
243
K05.31
ICD-10 Finland
Periodontitis pronounced
1.7
7.2
138
853
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
3.6
7.2
23
65
C08CA06
ATC
nimodipine; systemic
30.1
7.1
9
*
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.3
7.1
819
7065
T91.8
ICD-10 Finland
Sequelae of other specified injuries of neck and trunk
20.1
7.1
10
5
G93.2
ICD-10 Finland
Benign intracranial hypertension
20.1
7.1
10
5
E23.03
ICD-10 Finland
Lack of ACTH
20.1
7.1
10
5
NB1BG
NOMESCO Finland
Shoulder and humerus MRI examination with high intensity magnet
2.6
7.1
40
157
UJD10, ,
SPAT
2.6
7.1
40
157
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
3.2
7.1
27
85
N95.1
ICD-10 Finland
Menopausal and female climacteric states
1.5
7.1
202
1371
F31.8
ICD-10 Finland
Other bipolar affective disorders
2.7
7.1
36
134
K03.80
ICD-10 Finland
Irradiated enamel
1.9
7.1
91
499
XX2XT
NOMESCO Finland
Other injection with other radiological guidance
8.0
7.1
15
19
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.7
7.1
133
816
I20.99
ICD-10 Finland
Angina pectoris, unspecified
2.3
7.1
54
244
OAA65, ,
SPAT
1.4
7.1
342
2578
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
1.9
7.1
83
442
OAB50, ,
SPAT
1.9
7.1
88
478
R01BA51
ATC
phenylpropanolamine, combinations; oral
1.6
7.1
178
1176
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
3.1
7.1
29
96
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.7
7.0
117
695
L04AX03
ATC
methotrexate; systemic
1.7
7.0
131
803
G03DA02
ATC
medroxyprogesterone; systemic
1.9
7.0
85
458
S13
ICPC
Animal/human bite
2.3
7.0
53
239
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.6
7.0
162
1049
N05AF01
ATC
flupentixol; systemic
3.5
7.0
23
66
SPAT1059
SPAT
Spirometry at the office
2.2
7.0
55
252
L84
ICPC
Back syndrome without radiat pain
2.1
7.0
67
332
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
3.9
7.0
20
52
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
3.9
7.0
20
52
SPF00
NOMESCO Finland
Reparation of dental prosthesis without impressions
3.2
7.0
26
81
U08
ICPC
Urinary retention
3.4
7.0
24
71
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
3.4
7.0
24
71
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
3.0
7.0
30
102
RD210, ,
NOMESCO Finland
3.3
7.0
25
76
G01AF04
ATC
miconazole; vaginal
2.1
7.0
64
312
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.3
7.0
52
233
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.6
7.0
39
153
S90.1
ICD-10 Finland
Contusion of toe(s) without damage to nail
2.6
7.0
40
159
R03BC03
ATC
nedocromil; inhalant
1.9
6.9
83
445
A46
ICD-10 Finland
Erysipelas
1.6
6.9
153
979
-1, ,
ICPC
2.3
6.9
50
221
S33.5
ICD-10 Finland
Sprain and strain of lumbar spine
3.7
6.9
21
57
N30.8
ICD-10 Finland
Other cystitis
5.9
6.9
18
31
SPAT1211
SPAT
Application of soft bandage
1.8
6.9
98
555
F50.9
ICD-10 Finland
Eating disorder, unspecified
4.0
6.9
19
48
RK320, ,
NOMESCO Finland
13.8
6.9
11
8
GD1AA, ,
SPAT
1.5
6.9
266
1924
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.6
6.9
169
1110
N94.1
ICD-10 Finland
Dyspareunia
2.9
6.9
30
103
C03DA01
ATC
spironolactone; oral
1.7
6.9
113
669
A09AA02
ATC
multienzymes (lipase, protease etc.); oral
2.8
6.9
32
114
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
2.8
6.9
32
114
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.9
6.9
91
505
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
3.2
6.9
26
82
SPAT1130
SPAT
Esophagoscopy, gastroscopy and duodenoscopy
2.7
6.9
35
131
Z00.8
ICD-10 Finland
Other general examinations
1.8
6.9
109
639
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
6.8
480
3845
ND1AA
NOMESCO Finland
Wrist X-ray examination
1.9
6.8
89
491
-, ,
ICD-10 Finland
3.0
6.8
29
98
N41.0
ICD-10 Finland
Acute prostatitis
3.0
6.8
29
98
Z50.7
ICD-10 Finland
Occupational therapy and vocational rehabilitation, not elsewhere classified
6.7
6.8
16
24
D29
ICPC
Digestive symptom/complaint other
2.6
6.8
37
143
S89.9
ICD-10 Finland
Unspecified injury of lower leg
2.2
6.8
56
262
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
2.7
6.8
35
132
H81.3
ICD-10 Finland
Other peripheral vertigo
2.7
6.8
35
132
AEA27
NOMESCO Finland
Replacement of spinal stimulation electrode
40.2
6.8
8
*
N92
ICPC
Trigeminal neuralgia
16.8
6.7
10
6
XG474
NOMESCO Finland
Exhalation nntrogen oxide
2.6
6.7
36
138
M02AA15
ATC
diclofenac; topical
1.9
6.7
87
479
R1100, ,
SPAT
3.5
6.7
22
63
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.1
6.7
63
310
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.1
6.7
63
310
P99
ICPC
Psychological disorders other
2.2
6.7
52
237
H15.1
ICD-10 Finland
Episcleritis
3.0
6.7
29
99
LCA16
NOMESCO Finland
Destruction of endometrium
3.3
6.7
24
73
P17
ICPC
Tobacco abuse
3.3
6.7
24
73
SPAT1285
SPAT
Provision of consultation response
2.1
6.7
60
290
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
6.7
98
561
R01AD59
ATC
mometasone, combinations; nasal
1.7
6.7
117
705
IFA37
NOMESCO Finland
Ketamine treatment
22.6
6.7
9
*
M43.0
ICD-10 Finland
Spondylolysis
3.0
6.7
28
94
U13
ICPC
Bladder symptom/complaint other
2.7
6.7
35
133
H66.9
ICD-10 Finland
Otitis media, unspecified
1.8
6.6
100
577
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.1
6.6
27
89
SPAT1251
SPAT
Organisation of medication
2.5
6.6
39
157
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.2
6.6
55
258
4211
FHL
Transeptal septal resection and reconstruction
7.8
6.6
14
18
R20.0
ICD-10 Finland
Anaesthesia of skin
5.5
6.6
18
33
B37.08
ICD-10 Finland
Other candidal stomatitis
5.9
6.6
17
29
Z30.2
ICD-10 Finland
Sterilization
1.6
6.6
153
991
H53.9
ICD-10 Finland
Visual disturbance, unspecified
2.3
6.6
48
213
XCD10
NOMESCO Finland
Electrophysiological examination of eye
2.9
6.6
29
100
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
1.7
6.6
125
770
N04BC09
ATC
rotigotine; transdermal
12.3
6.6
11
9
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.1
6.6
57
272
I80.9
ICD-10 Finland
Phlebitis and thrombophlebitis of unspecified site
3.5
6.6
22
64
S30.1
ICD-10 Finland
Contusion of abdominal wall
3.4
6.6
23
69
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
3.8
6.5
19
50
H16.0
ICD-10 Finland
Corneal ulcer
1.9
6.5
75
397
G01AA10
ATC
clindamycin; vaginal
1.5
6.5
194
1330
N73.9
ICD-10 Finland
Female pelvic inflammatory disease, unspecified
3.0
6.5
27
90
N05BA06
ATC
lorazepam; systemic, sublingual
2.1
6.5
58
280
U06
ICPC
Haematuria
2.9
6.5
29
101
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
2.0
6.5
65
328
J32.4
ICD-10 Finland
Chronic pansinusitis
3.1
6.5
26
85
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
2.6
6.5
36
141
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
2.7
6.5
32
118
R03BB01
ATC
ipratropium bromide; inhalant
2.7
6.5
32
118
SPF02
NOMESCO Finland
Impression for dental prosthesis repair, restricted
5.7
6.5
17
30
T90
ICPC
Diabetes non-insulin dependent
1.5
6.4
235
1680
G55.1
ICD-10 Finland
Nerve root and plexus compressions in intervertebral disc disorders
3.9
6.4
18
46
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
3.0
6.4
28
96
NB2AT
NOMESCO Finland
Intra artrial injection of shoulder with ultrasound guidance
3.3
6.4
23
70
K08.3
ICD-10 Finland
Retained dental root
1.8
6.4
96
553
K89
ICPC
Transient cerebral ischaemia
14.4
6.4
10
7
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
2.2
6.4
50
229
L50.3
ICD-10 Finland
Dermatographic urticaria
2.9
6.4
29
102
A38
ICPC
General and Unspecified, Other laboratory test NEC
4.1
6.4
17
42
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
3.1
6.4
26
86
K58
ICD-10 Finland
Irritable bowel syndrome
2.4
6.4
43
185
M77.4
ICD-10 Finland
Metatarsalgia
1.8
6.3
89
503
EB1AA, ,
SPAT
1.8
6.3
101
593
ABD32
NOMESCO Finland
Implantation of temporary spinal stimulation device
8.2
6.3
13
16
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
8.2
6.3
13
16
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.4
6.3
41
173
SBA10
NOMESCO Finland
Measurement of salivary flow rate
3.6
6.3
20
56
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
6.0
6.3
16
27
E000001, ,
ATC
1.4
6.3
265
1946
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
11.1
6.3
11
10
NBF25
NOMESCO Finland
Operation for humeroscapular osteochondritis, arthroscopic
2.8
6.3
31
114
TNX34
NOMESCO Finland
Major custom molded cast, unspecified region
3.3
6.3
23
71
L73.2
ICD-10 Finland
Hidradenitis suppurativa
3.3
6.3
23
71
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
3.3
6.3
23
71
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
3.4
6.3
22
66
X18
ICPC
Breast pain female
3.0
6.3
27
92
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
3.0
6.3
27
92
D07AA02
ATC
hydrocortisone; topical
1.5
6.3
190
1308
SPAT1044
SPAT
Tympanometry
2.7
6.3
32
120
IAB13
NOMESCO Finland
Psychiatric sleep disorder consultation
18.1
6.3
9
5
G97.1
ICD-10 Finland
Other reaction to spinal and lumbar puncture
18.1
6.3
9
5
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.3
6.3
482
3907
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.8
6.3
97
565
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
1.6
6.2
135
860
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
2.2
6.2
51
238
EGC30
NOMESCO Finland
Prosthetic replacement of mandibular joint
26.8
6.2
8
*
N03AX18
ATC
lacosamide; systemic
26.8
6.2
8
*
T91
ICPC
Vitamin/nutritional deficiency
7.1
6.2
14
20
SPAT1106
SPAT
Acupuncture
7.1
6.2
14
20
S83.0
ICD-10 Finland
Dislocation of patella
2.6
6.2
35
138
L10
ICPC
Elbow symptom/complaint
1.8
6.2
88
499
K59.9
ICD-10 Finland
Functional intestinal disorder, unspecified
3.1
6.2
25
82
K96
ICPC
Haemorrhoids
2.4
6.2
42
181
R01BA01
ATC
phenylpropanolamine; oral
2.0
6.2
67
348
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.7
6.2
100
590
X11
ICPC
Menopausal symptom/complaint
2.8
6.2
29
104
XG405
NOMESCO Finland
Education on PEF monitoring
3.5
6.2
20
57
ABC30
NOMESCO Finland
Decompression of cervical nerve roots
5.4
6.2
17
32
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
2.4
6.1
39
163
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
5.8
6.1
16
28
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
5.8
6.1
16
28
N99.4
ICD-10 Finland
Postprocedural pelvic peritoneal adhesions
5.8
6.1
16
28
I82.9
ICD-10 Finland
Embolism and thrombosis of unspecified vein
3.3
6.1
22
67
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.6
6.1
34
133
M24.2
ICD-10 Finland
Disorder of ligament
3.0
6.1
26
88
M01AX05
ATC
glucosamine; oral
1.6
6.1
157
1042
K04.7
ICD-10 Finland
Periapical abscess without sinus
1.8
6.1
84
472
62660
ICD-8 Finland
Disorders of menstruation, Intermenstrual bleeding
3.8
6.1
18
48
K03.28
ICD-10 Finland
Other erosion of teeth
2.3
6.1
44
195
K07.68
ICD-10 Finland
Other disorders of the jaw joint
4.1
6.1
16
39
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
1.6
6.1
131
834
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.6
6.1
137
882
N95.0
ICD-10 Finland
Postmenopausal bleeding
1.8
6.1
84
473
H93.1
ICD-10 Finland
Tinnitus
1.8
6.1
93
540
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
1.7
6.1
103
616
S83
ICD-10 Finland
Dislocation, sprain and strain of joints and ligaments of knee
2.5
6.1
37
152
G04BD04
ATC
oxybutynin; oral, transdermal
2.2
6.0
47
215
R61.9
ICD-10 Finland
Hyperhidrosis, unspecified
3.6
6.0
19
53
M41.9
ICD-10 Finland
Scoliosis, unspecified
3.6
6.0
19
53
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.5
6.0
166
1119
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
10.1
6.0
11
11
H46
ICD-10 Finland
Optic neuritis
3.5
6.0
20
58

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
verapamil; oral, parenteral
C08DA01 [21601767]
4.1e+00
4.9e+00
—
1.0e+50
6.3e+00
5.8e+00
5.2e+00
cases:10.68%
controls:0.20%
cases:10.68%
controls:0.09%
—
—
cases:6.57%
controls:0.00%
cases:14.63%
controls:0.03%
cases:22.72%
controls:0.09%
cases:21.57%
controls:0.16%
169
31
1414
15801
169
14
1414
15818
—
104
0
1479
15832
231
5
1348
15799
352
14
1197
15488
300
22
1091
13804
sumatriptan; nasal, oral, parenteral, rectal
N02CC01 [21604376]
3.1e+00
3.6e+00
4.7e+00
1.0e+50
4.9e+00
3.8e+00
3.3e+00
cases:29.06%
controls:1.87%
cases:25.27%
controls:0.88%
cases:15.60%
controls:0.17%
cases:9.22%
controls:0.00%
cases:23.12%
controls:0.22%
cases:28.99%
controls:0.92%
cases:35.66%
controls:1.92%
460
296
1123
15536
400
139
1183
15693
247
27
1336
15805
146
0
1437
15832
365
34
1214
15770
449
142
1100
15360
496
265
895
13561
zolmitriptan; nasal, oral
N02CC03 [21604378]
2.8e+00
3.4e+00
4.5e+00
1.0e+50
4.5e+00
3.8e+00
3.4e+00
cases:7.52%
controls:0.51%
cases:6.89%
controls:0.25%
cases:4.55%
controls:0.05%
cases:1.83%
controls:0.00%
cases:5.19%
controls:0.06%
cases:8.91%
controls:0.23%
cases:11.86%
controls:0.46%
119
80
1464
15752
109
40
1474
15792
72
8
1511
15824
29
0
1554
15832
82
10
1497
15794
138
35
1411
15467
165
64
1226
13762
Headache
R51.80 [2000503603]
2.8e+00
3.5e+00
5.6e+00
1.0e+50
4.4e+00
3.5e+00
2.5e+00
cases:15.10%
controls:1.11%
cases:12.13%
controls:0.42%
cases:7.77%
controls:0.03%
cases:4.80%
controls:0.00%
cases:4.37%
controls:0.06%
cases:9.94%
controls:0.34%
cases:14.31%
controls:1.35%
239
176
1344
15656
192
66
1391
15766
123
5
1460
15827
76
0
1507
15832
69
9
1510
15795
154
53
1395
15449
199
187
1192
13639
Neurology
13 [38004458]
2.2e+00
2.8e+00
3.5e+00
—
4.5e+00
4.1e+00
2.8e+00
cases:29.69%
controls:4.29%
cases:23.56%
controls:1.86%
cases:9.67%
controls:0.32%
—
—
cases:21.41%
controls:0.32%
cases:51.52%
controls:1.77%
cases:44.14%
controls:4.65%
470
679
1113
15153
373
295
1210
15537
153
51
1430
15781
—
338
50
1241
15754
798
275
751
15227
614
643
777
13183
topiramate; oral
N03AX11 [21604433]
4.4e+00
4.7e+00
—
—
—
5.6e+00
4.7e+00
cases:6.76%
controls:0.09%
cases:4.42%
controls:0.04%
—
—
—
—
—
—
cases:8.13%
controls:0.03%
cases:8.41%
controls:0.08%
107
14
1476
15818
70
7
1513
15825
—
—
—
126
5
1423
15497
117
11
1274
13815
eletriptan; oral
N02CC06 [21604381]
2.9e+00
3.0e+00
3.5e+00
—
3.6e+00
3.1e+00
2.6e+00
cases:5.50%
controls:0.32%
cases:3.85%
controls:0.20%
cases:1.64%
controls:0.05%
—
—
cases:1.90%
controls:0.05%
cases:3.74%
controls:0.17%
cases:5.54%
controls:0.42%
87
50
1496
15782
61
31
1522
15801
26
8
1557
15824
—
30
8
1549
15796
58
26
1491
15476
77
58
1314
13768
frovatriptan; oral
N02CC07 [21604382]
3.0e+00
3.0e+00
3.1e+00
—
3.8e+00
2.7e+00
2.7e+00
cases:6.63%
controls:0.37%
cases:4.23%
controls:0.22%
cases:1.07%
controls:0.05%
—
—
cases:1.65%
controls:0.04%
cases:3.49%
controls:0.23%
cases:6.11%
controls:0.44%
105
58
1478
15774
67
35
1516
15797
17
8
1566
15824
—
26
6
1553
15798
54
36
1495
15466
85
61
1306
13765
rizatriptan; oral
N02CC04 [21604379]
2.3e+00
3.0e+00
3.8e+00
—
3.6e+00
2.7e+00
2.6e+00
cases:6.00%
controls:0.63%
cases:4.99%
controls:0.27%
cases:1.90%
controls:0.04%
—
—
cases:1.65%
controls:0.04%
cases:3.94%
controls:0.26%
cases:6.33%
controls:0.49%
95
100
1488
15732
79
42
1504
15790
30
7
1553
15825
—
26
7
1553
15797
61
41
1488
15461
88
68
1303
13758
Migraine without aura [common migraine]
G43.0 [45600784]
3.9e+00
5.1e+00
—
1.0e+50
—
5.0e+00
3.7e+00
cases:8.84%
controls:0.20%
cases:6.70%
controls:0.04%
—
—
cases:6.32%
controls:0.00%
—
—
cases:9.62%
controls:0.07%
cases:12.58%
controls:0.34%
140
32
1443
15800
106
7
1477
15825
—
100
0
1483
15832
—
149
11
1400
15491
175
47
1216
13779
Migraine, unspecified
G43.9 [45595943]
4.1e+00
4.8e+00
1.0e+50
1.0e+50
—
4.3e+00
3.4e+00
cases:10.04%
controls:0.18%
cases:5.69%
controls:0.05%
cases:2.84%
controls:0.00%
cases:1.77%
controls:0.00%
—
—
cases:5.04%
controls:0.07%
cases:8.20%
controls:0.30%
159
29
1424
15803
90
8
1493
15824
45
0
1538
15832
28
0
1555
15832
—
78
11
1471
15491
114
42
1277
13784
Emergency Room Visit
ER [9203]
1.1e+00
1.3e+00
2.3e+00
6.8e+00
2.1e+00
1.4e+00
1.2e+00
cases:52.24%
controls:26.54%
cases:25.77%
controls:8.65%
cases:9.67%
controls:1.02%
cases:22.62%
controls:0.03%
cases:7.60%
controls:0.97%
cases:25.37%
controls:7.88%
cases:48.74%
controls:23.04%
827
4202
756
11630
408
1369
1175
14463
153
161
1430
15671
358
5
1225
15827
120
154
1459
15650
393
1221
1156
14281
678
3186
713
10640
valproic acid; oral, parenteral, rectal
N03AG01 [21604422]
2.6e+00
2.2e+00
2.5e+00
1.0e+50
2.5e+00
3.0e+00
3.1e+00
cases:5.87%
controls:0.47%
cases:2.97%
controls:0.32%
cases:0.69%
controls:0.06%
cases:0.44%
controls:0.00%
cases:1.58%
controls:0.13%
cases:5.87%
controls:0.32%
cases:8.27%
controls:0.41%
93
75
1490
15757
47
51
1536
15781
11
9
1572
15823
7
0
1576
15832
25
20
1554
15784
91
50
1458
15452
115
56
1276
13770
Tension-type headache
G44.2 [45581495]
2.7e+00
3.6e+00
—
1.0e+50
3.6e+00
3.3e+00
2.5e+00
cases:8.65%
controls:0.63%
cases:5.24%
controls:0.15%
—
—
cases:2.59%
controls:0.00%
cases:1.14%
controls:0.03%
cases:6.20%
controls:0.25%
cases:9.06%
controls:0.78%
137
99
1446
15733
83
24
1500
15808
—
41
0
1542
15832
18
5
1561
15799
96
39
1453
15463
126
108
1265
13718
Migraine with aura [classical migraine]
G43.1 [45562086]
3.5e+00
4.1e+00
—
1.0e+50
—
4.5e+00
3.5e+00
cases:7.20%
controls:0.23%
cases:5.56%
controls:0.09%
—
—
cases:5.37%
controls:0.00%
—
—
cases:8.33%
controls:0.10%
cases:10.50%
controls:0.36%
114
37
1469
15795
88
15
1495
15817
—
85
0
1498
15832
—
129
15
1420
15487
146
50
1245
13776
Migraine
G43 [45566873]
3.1e+00
3.2e+00
3.5e+00
—
—
3.1e+00
2.6e+00
cases:6.06%
controls:0.30%
cases:3.73%
controls:0.16%
cases:1.07%
controls:0.03%
—
—
—
—
cases:4.26%
controls:0.20%
cases:7.33%
controls:0.57%
96
48
1487
15784
59
26
1524
15806
17
5
1566
15827
—
—
66
31
1483
15471
102
79
1289
13747
prednisone
A07EA03 [21600655]
1.7e+00
2.5e+00
3.5e+00
1.0e+50
3.5e+00
2.2e+00
2.0e+00
cases:5.62%
controls:1.03%
cases:4.04%
controls:0.34%
cases:1.20%
controls:0.04%
cases:1.01%
controls:0.00%
cases:2.09%
controls:0.06%
cases:2.91%
controls:0.33%
cases:6.11%
controls:0.86%
89
163
1494
15669
64
54
1519
15778
19
6
1564
15826
16
0
1567
15832
33
10
1546
15794
45
51
1504
15451
85
119
1306
13707
prednisone; oral
H02AB07 [21602735]
1.7e+00
2.5e+00
3.5e+00
1.0e+50
3.5e+00
2.2e+00
2.0e+00
cases:5.62%
controls:1.03%
cases:4.04%
controls:0.34%
cases:1.20%
controls:0.04%
cases:1.01%
controls:0.00%
cases:2.09%
controls:0.06%
cases:2.91%
controls:0.33%
cases:6.11%
controls:0.86%
89
163
1494
15669
64
54
1519
15778
19
6
1564
15826
16
0
1567
15832
33
10
1546
15794
45
51
1504
15451
85
119
1306
13707
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
2.4e+00
2.8e+00
3.5e+00
1.0e+50
—
3.0e+00
2.8e+00
cases:4.61%
controls:0.45%
cases:2.97%
controls:0.19%
cases:1.07%
controls:0.03%
cases:0.95%
controls:0.00%
—
—
cases:3.16%
controls:0.15%
cases:6.61%
controls:0.43%
73
72
1510
15760
47
30
1536
15802
17
5
1566
15827
15
0
1568
15832
—
49
24
1500
15478
92
59
1299
13767
amitriptyline; oral, parenteral
N06AA09 [21604696]
2.2e+00
2.4e+00
2.7e+00
1.0e+50
3.0e+00
2.2e+00
2.1e+00
cases:17.69%
controls:2.36%
cases:11.24%
controls:1.15%
cases:3.35%
controls:0.23%
cases:0.63%
controls:0.00%
cases:4.31%
controls:0.23%
cases:10.07%
controls:1.19%
cases:17.04%
controls:2.56%
280
373
1303
15459
178
182
1405
15650
53
37
1530
15795
10
0
1573
15832
68
37
1511
15767
156
184
1393
15318
237
354
1154
13472
Sleep apnoea
G47.3 [45562094]
3.5e+00
3.9e+00
—
—
—
3.9e+00
3.1e+00
cases:5.62%
controls:0.18%
cases:4.42%
controls:0.09%
—
—
—
—
—
—
cases:5.94%
controls:0.12%
cases:10.21%
controls:0.51%
89
28
1494
15804
70
15
1513
15817
—
—
—
92
19
1457
15483
142
71
1249
13755
indometacin; oral, parenteral, rectal
M01AB01 [21603941]
2.2e+00
2.7e+00
3.3e+00
1.0e+50
—
3.3e+00
2.9e+00
cases:4.49%
controls:0.51%
cases:2.46%
controls:0.18%
cases:0.88%
controls:0.03%
cases:0.63%
controls:0.00%
—
—
cases:4.07%
controls:0.16%
cases:6.04%
controls:0.36%
71
80
1512
15752
39
28
1544
15804
14
5
1569
15827
10
0
1573
15832
—
63
25
1486
15477
84
50
1307
13776
gabapentin; oral
N02BF01 [955005]
2.0e+00
2.2e+00
2.3e+00
—
2.9e+00
2.8e+00
2.2e+00
cases:8.15%
controls:1.24%
cases:6.13%
controls:0.73%
cases:2.08%
controls:0.21%
—
—
cases:4.12%
controls:0.23%
cases:10.33%
controls:0.72%
cases:15.60%
controls:1.96%
129
197
1454
15635
97
116
1486
15716
33
33
1550
15799
—
65
37
1514
15767
160
112
1389
15390
217
271
1174
13555
indometacin
C01EB03 [21600365]
2.2e+00
2.6e+00
3.3e+00
1.0e+50
—
3.3e+00
2.9e+00
cases:4.49%
controls:0.51%
cases:2.40%
controls:0.18%
cases:0.88%
controls:0.03%
cases:0.63%
controls:0.00%
—
—
cases:4.00%
controls:0.16%
cases:6.04%
controls:0.36%
71
80
1512
15752
38
28
1545
15804
14
5
1569
15827
10
0
1573
15832
—
62
25
1487
15477
84
50
1307
13776
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
1.8e+00
2.2e+00
3.0e+00
—
3.2e+00
2.2e+00
1.8e+00
cases:12.44%
controls:2.27%
cases:7.96%
controls:0.95%
cases:1.71%
controls:0.08%
—
—
cases:1.90%
controls:0.08%
cases:6.26%
controls:0.74%
cases:13.44%
controls:2.43%
197
360
1386
15472
126
150
1457
15682
27
13
1556
15819
—
30
13
1549
15791
97
114
1452
15388
187
336
1204
13490
nortriptyline; oral, parenteral
N06AA10 [21604697]
2.6e+00
2.6e+00
2.6e+00
—
2.1e+00
2.2e+00
2.0e+00
cases:5.87%
controls:0.45%
cases:3.47%
controls:0.26%
cases:0.88%
controls:0.07%
—
—
cases:0.57%
controls:0.07%
cases:2.97%
controls:0.34%
cases:5.03%
controls:0.68%
93
71
1490
15761
55
41
1528
15791
14
11
1569
15821
—
9
11
1570
15793
46
52
1503
15450
70
94
1321
13732
naratriptan; oral
N02CC02 [21604377]
2.7e+00
2.4e+00
2.6e+00
—
—
2.5e+00
2.9e+00
cases:2.21%
controls:0.15%
cases:1.01%
controls:0.09%
cases:0.51%
controls:0.04%
—
—
—
—
cases:1.03%
controls:0.08%
cases:2.08%
controls:0.12%
35
23
1548
15809
16
14
1567
15818
8
6
1575
15826
—
—
16
13
1533
15489
29
16
1362
13810
amitriptyline and psycholeptics
N06CA01 [21604789]
2.0e+00
2.2e+00
2.5e+00
—
2.1e+00
2.2e+00
2.1e+00
cases:6.89%
controls:0.99%
cases:3.92%
controls:0.46%
cases:1.20%
controls:0.09%
—
—
cases:1.01%
controls:0.12%
cases:3.62%
controls:0.41%
cases:5.75%
controls:0.77%
109
156
1474
15676
62
73
1521
15759
19
15
1564
15817
—
16
19
1563
15785
56
64
1493
15438
80
106
1311
13720
Headache
N01 [2002000720]
1.8e+00
2.7e+00
4.3e+00
1.0e+50
—
2.2e+00
2.1e+00
cases:6.06%
controls:1.05%
cases:4.17%
controls:0.30%
cases:3.10%
controls:0.04%
cases:0.76%
controls:0.00%
—
—
cases:3.03%
controls:0.33%
cases:8.20%
controls:1.04%
96
166
1487
15666
66
48
1517
15784
49
7
1534
15825
12
0
1571
15832
—
47
51
1502
15451
114
144
1277
13682
ergotamine; inhalant, oral, parenteral, rectal, sublingual
N02CA02 [21604367]
2.9e+00
3.2e+00
1.0e+50
—
—
3.4e+00
3.6e+00
cases:1.64%
controls:0.09%
cases:0.88%
controls:0.04%
cases:0.63%
controls:0.00%
—
—
—
—
cases:0.97%
controls:0.03%
cases:1.37%
controls:0.04%
26
15
1557
15817
14
6
1569
15826
10
0
1573
15832
—
—
15
5
1534
15497
19
5
1372
13821
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
1.9e+00
2.3e+00
2.3e+00
—
2.1e+00
2.3e+00
2.2e+00
cases:3.47%
controls:0.53%
cases:2.72%
controls:0.28%
cases:1.14%
controls:0.12%
—
—
cases:1.01%
controls:0.12%
cases:2.84%
controls:0.29%
cases:5.97%
controls:0.73%
55
84
1528
15748
43
45
1540
15787
18
19
1565
15813
—
16
19
1563
15785
44
45
1505
15457
83
101
1308
13725
Atypical facial pain
G50.1 [45542894]
2.7e+00
3.7e+00
1.0e+50
1.0e+50
—
3.7e+00
3.0e+00
cases:1.01%
controls:0.07%
cases:1.26%
controls:0.03%
cases:0.51%
controls:0.00%
cases:0.44%
controls:0.00%
—
—
cases:1.23%
controls:0.03%
cases:1.73%
controls:0.09%
16
11
1567
15821
20
5
1563
15827
8
0
1575
15832
7
0
1576
15832
—
19
5
1530
15497
24
12
1367
13814
Internal Medicine
11 [38004456]
9.5e-01
1.0e+00
1.7e+00
5.4e+00
1.6e+00
1.1e+00
1.2e+00
cases:30.76%
controls:14.62%
cases:14.91%
controls:5.96%
cases:5.12%
controls:0.93%
cases:6.82%
controls:0.03%
cases:4.50%
controls:0.98%
cases:15.43%
controls:5.64%
cases:33.86%
controls:13.40%
487
2315
1096
13517
236
943
1347
14889
81
148
1502
15684
108
5
1475
15827
71
155
1508
15649
239
874
1310
14628
471
1852
920
11974
Pharmacy visit
OMOP4822462 [581458]
1.5e+00
1.5e+00
1.5e+00
2.9e+00
1.7e+00
1.6e+00
1.9e+00
cases:97.98%
controls:91.37%
cases:93.43%
controls:76.37%
cases:68.79%
controls:33.07%
cases:23.94%
controls:1.67%
cases:74.16%
controls:33.29%
cases:94.25%
controls:77.18%
cases:98.92%
controls:93.48%
1551
14465
32
1367
1479
12091
104
3741
1089
5235
494
10597
379
264
1204
15568
1171
5261
408
10543
1460
11965
89
3537
1376
12925
15
901
Snapping jaw
K07.60 [2000502791]
1.4e+00
2.0e+00
2.8e+00
—
2.3e+00
2.0e+00
1.9e+00
cases:1.77%
controls:0.46%
cases:1.33%
controls:0.19%
cases:0.51%
controls:0.03%
—
—
cases:0.38%
controls:0.04%
cases:1.55%
controls:0.21%
cases:3.38%
controls:0.54%
28
73
1555
15759
21
30
1562
15802
8
5
1575
15827
—
6
6
1573
15798
24
33
1525
15469
47
75
1344
13751
Recurrent depression, moderate episode without somatic syndrome
F33.10 [2000501984]
1.7e+00
1.9e+00
2.2e+00
—
2.5e+00
2.3e+00
1.7e+00
cases:2.78%
controls:0.52%
cases:1.64%
controls:0.25%
cases:0.57%
controls:0.06%
—
—
cases:0.70%
controls:0.06%
cases:1.81%
controls:0.19%
cases:3.09%
controls:0.57%
44
83
1539
15749
26
40
1557
15792
9
10
1574
15822
—
11
9
1568
15795
28
30
1521
15472
43
79
1348
13747
Outpatient Visit
OP [9202]
8.2e-01
8.0e-01
1.2e+00
5.5e+00
1.5e+00
1.3e+00
1.1e+00
cases:78.21%
controls:61.14%
cases:58.94%
controls:39.24%
cases:21.48%
controls:7.79%
cases:44.03%
controls:0.31%
cases:26.98%
controls:7.92%
cases:69.98%
controls:38.61%
cases:87.28%
controls:69.73%
1238
9680
345
6152
933
6213
650
9619
340
1234
1243
14598
697
49
886
15783
426
1251
1153
14553
1084
5986
465
9516
1214
9641
177
4185
Migraine
N89 [2002000789]
3.2e+00
3.5e+00
—
—
—
2.6e+00
2.7e+00
cases:4.11%
controls:0.18%
cases:2.21%
controls:0.07%
—
—
—
—
—
—
cases:1.16%
controls:0.08%
cases:4.24%
controls:0.30%
65
28
1518
15804
35
11
1548
15821
—
—
—
18
13
1531
15489
59
41
1332
13785
Physiotherapist
Z3226 [2001311560]
1.3e+00
2.0e+00
2.7e+00
1.0e+50
2.7e+00
2.1e+00
1.2e+00
cases:5.37%
controls:1.58%
cases:2.46%
controls:0.34%
cases:0.63%
controls:0.04%
cases:0.44%
controls:0.00%
cases:0.76%
controls:0.05%
cases:2.52%
controls:0.32%
cases:3.95%
controls:1.19%
85
250
1498
15582
39
54
1544
15778
10
7
1573
15825
7
0
1576
15832
12
8
1567
15796
39
49
1510
15453
55
164
1336
13662
prednisolone
A07EA01 [21600653]
1.4e+00
1.8e+00
2.4e+00
—
2.9e+00
1.7e+00
1.6e+00
cases:24.45%
controls:7.21%
cases:14.78%
controls:2.87%
cases:5.87%
controls:0.54%
—
—
cases:7.41%
controls:0.43%
cases:15.04%
controls:3.04%
cases:29.83%
controls:7.62%
387
1142
1196
14690
234
454
1349
15378
93
86
1490
15746
—
117
68
1462
15736
233
472
1316
15030
415
1053
976
12773
prednisolone; oral, parenteral
H02AB06 [21602734]
1.4e+00
1.8e+00
2.4e+00
—
2.9e+00
1.7e+00
1.6e+00
cases:24.13%
controls:7.18%
cases:14.72%
controls:2.85%
cases:5.87%
controls:0.54%
—
—
cases:7.41%
controls:0.43%
cases:15.04%
controls:3.03%
cases:29.83%
controls:7.58%
382
1136
1201
14696
233
452
1350
15380
93
86
1490
15746
—
117
68
1462
15736
233
469
1316
15033
415
1048
976
12778
almotriptan; oral
N02CC05 [21604380]
2.6e+00
2.6e+00
2.5e+00
—
1.5e+00
2.3e+00
1.8e+00
cases:3.98%
controls:0.30%
cases:2.08%
controls:0.16%
cases:0.69%
controls:0.06%
—
—
cases:0.38%
controls:0.09%
cases:1.42%
controls:0.14%
cases:2.16%
controls:0.35%
63
48
1520
15784
33
25
1550
15807
11
9
1572
15823
—
6
14
1573
15790
22
22
1527
15480
30
48
1361
13778
duloxetine; oral
N06AX21 [21604749]
1.6e+00
2.0e+00
2.1e+00
—
1.9e+00
2.2e+00
2.0e+00
cases:4.80%
controls:1.00%
cases:3.73%
controls:0.51%
cases:1.26%
controls:0.16%
—
—
cases:1.33%
controls:0.20%
cases:4.26%
controls:0.50%
cases:7.19%
controls:1.08%
76
158
1507
15674
59
81
1524
15751
20
25
1563
15807
—
21
31
1558
15773
66
78
1483
15424
100
149
1291
13677
Monitoring the use of the aid
R5140 [2001310249]
2.8e+00
3.3e+00
—
—
—
2.6e+00
3.0e+00
cases:1.71%
controls:0.10%
cases:0.82%
controls:0.03%
—
—
—
—
—
—
cases:0.90%
controls:0.06%
cases:3.16%
controls:0.16%
27
16
1556
15816
13
5
1570
15827
—
—
—
14
10
1535
15492
44
22
1347
13804
baclofen; oral, parenteral
M03BX01 [21604115]
2.0e+00
2.0e+00
2.0e+00
—
2.6e+00
2.6e+00
2.6e+00
cases:1.26%
controls:0.18%
cases:0.95%
controls:0.13%
cases:0.32%
controls:0.04%
—
—
cases:0.51%
controls:0.04%
cases:1.81%
controls:0.14%
cases:3.16%
controls:0.24%
20
28
1563
15804
15
21
1568
15811
5
7
1578
15825
—
8
6
1571
15798
28
22
1521
15480
44
33
1347
13793
oxycodone; oral, parenteral
N02AA05 [21604260]
2.1e+00
1.9e+00
2.4e+00
—
1.9e+00
1.6e+00
1.8e+00
cases:3.60%
controls:0.45%
cases:1.77%
controls:0.27%
cases:0.69%
controls:0.06%
—
—
cases:0.51%
controls:0.08%
cases:1.68%
controls:0.35%
cases:5.25%
controls:0.95%
57
71
1526
15761
28
42
1555
15790
11
10
1572
15822
—
8
12
1571
15792
26
54
1523
15448
73
131
1318
13695
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
7.8e-01
1.0e+00
1.9e+00
4.5e+00
1.3e+00
1.1e+00
9.1e-01
cases:13.39%
controls:6.61%
cases:8.84%
controls:3.30%
cases:2.91%
controls:0.43%
cases:2.84%
controls:0.03%
cases:1.90%
controls:0.54%
cases:8.91%
controls:3.01%
cases:21.42%
controls:9.90%
212
1046
1371
14786
140
523
1443
15309
46
68
1537
15764
45
5
1538
15827
30
85
1549
15719
138
467
1411
15035
298
1369
1093
12457
pantoprazole; oral, parenteral
A02BC02 [21600097]
1.2e+00
1.3e+00
1.4e+00
3.2e+00
1.7e+00
1.4e+00
1.3e+00
cases:27.86%
controls:10.35%
cases:16.74%
controls:5.41%
cases:3.79%
controls:0.92%
cases:1.07%
controls:0.04%
cases:5.13%
controls:0.96%
cases:18.53%
controls:5.57%
cases:36.23%
controls:12.98%
441
1639
1142
14193
265
856
1318
14976
60
145
1523
15687
17
7
1566
15825
81
152
1498
15652
287
863
1262
14639
504
1794
887
12032
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
1.6e+00
1.9e+00
2.5e+00
—
2.2e+00
1.8e+00
1.5e+00
cases:20.40%
controls:5.11%
cases:11.05%
controls:1.85%
cases:3.22%
controls:0.28%
—
—
cases:3.04%
controls:0.34%
cases:9.55%
controls:1.75%
cases:20.27%
controls:5.24%
323
809
1260
15023
175
293
1408
15539
51
44
1532
15788
—
48
53
1531
15751
148
271
1401
15231
282
724
1109
13102
Other chronic pain
R52.2 [45568139]
2.8e+00
2.9e+00
—
—
—
3.4e+00
2.3e+00
cases:1.77%
controls:0.11%
cases:0.69%
controls:0.04%
—
—
—
—
—
—
cases:0.97%
controls:0.03%
cases:2.37%
controls:0.24%
28
18
1555
15814
11
6
1572
15826
—
—
—
15
5
1534
15497
33
33
1358
13793
Psychiatry
26 [38004469]
1.2e+00
1.3e+00
1.4e+00
3.0e+00
1.6e+00
1.6e+00
1.4e+00
cases:15.98%
controls:5.48%
cases:9.98%
controls:2.93%
cases:4.74%
controls:1.23%
cases:1.33%
controls:0.07%
cases:5.45%
controls:1.20%
cases:12.14%
controls:2.80%
cases:18.91%
controls:5.31%
253
868
1330
14964
158
464
1425
15368
75
194
1508
15638
21
11
1562
15821
86
190
1493
15614
188
434
1361
15068
263
734
1128
13092
pregabalin; oral
N02BF02 [955152]
1.9e+00
1.8e+00
2.1e+00
—
2.1e+00
1.9e+00
1.6e+00
cases:11.81%
controls:2.03%
cases:6.13%
controls:1.12%
cases:2.72%
controls:0.33%
—
—
cases:2.53%
controls:0.33%
cases:5.94%
controls:0.98%
cases:12.44%
controls:2.69%
187
322
1396
15510
97
177
1486
15655
43
53
1540
15779
—
40
52
1539
15752
92
152
1457
15350
173
372
1218
13454
lamotrigine; oral
N03AX09 [21604431]
2.0e+00
2.1e+00
2.0e+00
—
2.3e+00
2.2e+00
2.3e+00
cases:4.36%
controls:0.59%
cases:2.46%
controls:0.30%
cases:0.32%
controls:0.04%
—
—
cases:0.95%
controls:0.09%
cases:2.39%
controls:0.27%
cases:4.96%
controls:0.52%
69
93
1514
15739
39
48
1544
15784
5
7
1578
15825
—
15
15
1564
15789
37
42
1512
15460
69
72
1322
13754
INR in Blood by Coagulation assay
34714-6 [3032080]
9.9e-01
1.1e+00
1.3e+00
4.0e+00
1.3e+00
1.3e+00
1.0e+00
cases:9.79%
controls:3.88%
cases:6.44%
controls:2.29%
cases:1.77%
controls:0.51%
cases:1.96%
controls:0.04%
cases:1.84%
controls:0.50%
cases:7.23%
controls:2.03%
cases:14.59%
controls:5.76%
155
614
1428
15218
102
362
1481
15470
28
80
1555
15752
31
6
1552
15826
29
79
1550
15725
112
315
1437
15187
203
797
1188
13029
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
1.5e+00
1.7e+00
1.5e+00
—
2.2e+00
2.0e+00
1.9e+00
cases:7.77%
controls:1.85%
cases:4.80%
controls:0.88%
cases:0.88%
controls:0.20%
—
—
cases:1.71%
controls:0.19%
cases:5.23%
controls:0.72%
cases:9.71%
controls:1.52%
123
293
1460
15539
76
140
1507
15692
14
31
1569
15801
—
27
30
1552
15774
81
111
1468
15391
135
210
1256
13616
Trigeminal neuralgia
G50.0 [45581502]
3.5e+00
4.0e+00
1.0e+50
1.0e+50
1.0e+50
—
3.3e+00
cases:1.26%
controls:0.04%
cases:2.02%
controls:0.04%
cases:0.76%
controls:0.00%
cases:1.01%
controls:0.00%
cases:0.51%
controls:0.00%
—
—
cases:2.80%
controls:0.10%
20
6
1563
15826
32
6
1551
15826
12
0
1571
15832
16
0
1567
15832
8
0
1571
15804
—
39
14
1352
13812
Physical Medicine And Rehabilitation
25 [38004468]
1.4e+00
1.7e+00
1.8e+00
1.0e+50
2.5e+00
2.0e+00
1.4e+00
cases:16.11%
controls:4.47%
cases:8.91%
controls:1.74%
cases:1.96%
controls:0.34%
cases:3.16%
controls:0.00%
cases:3.29%
controls:0.27%
cases:10.20%
controls:1.52%
cases:17.90%
controls:5.03%
255
708
1328
15124
141
275
1442
15557
31
54
1552
15778
50
0
1533
15832
52
42
1527
15762
158
236
1391
15266
249
696
1142
13130
Fibromyalgia
M79.7 [45553272]
2.5e+00
2.7e+00
—
1.0e+50
—
2.9e+00
2.6e+00
cases:1.90%
controls:0.16%
cases:1.33%
controls:0.09%
—
—
cases:0.63%
controls:0.00%
—
—
cases:1.61%
controls:0.09%
cases:2.30%
controls:0.17%
30
26
1553
15806
21
14
1562
15818
—
10
0
1573
15832
—
25
14
1524
15488
32
23
1359
13803
Neurosurgery
14 [38004459]
1.5e+00
1.4e+00
2.0e+00
—
2.0e+00
1.9e+00
1.8e+00
cases:7.08%
controls:1.72%
cases:2.72%
controls:0.68%
cases:0.95%
controls:0.13%
—
—
cases:0.76%
controls:0.11%
cases:4.00%
controls:0.61%
cases:8.77%
controls:1.49%
112
273
1471
15559
43
107
1540
15725
15
20
1568
15812
—
12
17
1567
15787
62
95
1487
15407
122
206
1269
13620
Hypermobility syndrome
M35.7 [45601437]
2.7e+00
2.5e+00
—
1.0e+50
—
3.2e+00
2.2e+00
cases:1.39%
controls:0.09%
cases:0.63%
controls:0.05%
—
—
cases:0.38%
controls:0.00%
—
—
cases:1.10%
controls:0.05%
cases:1.08%
controls:0.12%
22
15
1561
15817
10
8
1573
15824
—
6
0
1577
15832
—
17
7
1532
15495
15
17
1376
13809
Generalized anxiety disorder
F41.1 [45571764]
1.5e+00
1.6e+00
2.3e+00
1.0e+50
2.4e+00
1.6e+00
1.1e+00
cases:2.27%
controls:0.53%
cases:1.45%
controls:0.29%
cases:0.63%
controls:0.06%
cases:0.38%
controls:0.00%
cases:0.76%
controls:0.07%
cases:1.68%
controls:0.34%
cases:2.44%
controls:0.82%
36
84
1547
15748
23
46
1560
15786
10
10
1573
15822
6
0
1577
15832
12
11
1567
15793
26
52
1523
15450
34
114
1357
13712
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
1.1e+00
1.3e+00
2.3e+00
1.0e+50
2.2e+00
2.0e+00
1.6e+00
cases:3.47%
controls:1.15%
cases:1.83%
controls:0.52%
cases:0.95%
controls:0.09%
cases:1.07%
controls:0.00%
cases:0.57%
controls:0.06%
cases:2.58%
controls:0.34%
cases:6.25%
controls:1.39%
55
182
1528
15650
29
82
1554
15750
15
15
1568
15817
17
0
1566
15832
9
10
1570
15794
40
53
1509
15449
87
192
1304
13634
carbamazepine; oral, rectal
N03AF01 [21604417]
2.5e+00
3.0e+00
—
—
—
2.5e+00
2.5e+00
cases:2.72%
controls:0.23%
cases:2.40%
controls:0.12%
—
—
—
—
—
—
cases:1.74%
controls:0.14%
cases:2.23%
controls:0.19%
43
37
1540
15795
38
19
1545
15813
—
—
—
27
22
1522
15480
31
26
1360
13800
pramipexole; oral
N04BC05 [21604477]
1.6e+00
1.8e+00
2.1e+00
—
1.8e+00
1.6e+00
1.4e+00
cases:1.96%
controls:0.39%
cases:1.77%
controls:0.30%
cases:0.51%
controls:0.06%
—
—
cases:0.44%
controls:0.08%
cases:1.36%
controls:0.29%
cases:2.37%
controls:0.57%
31
61
1552
15771
28
48
1555
15784
8
10
1575
15822
—
7
12
1572
15792
21
45
1528
15457
33
79
1358
13747
Depressive episode, unspecified
F32.9 [45571760]
1.4e+00
1.6e+00
2.1e+00
—
2.3e+00
1.4e+00
1.5e+00
cases:4.80%
controls:1.27%
cases:2.34%
controls:0.51%
cases:0.57%
controls:0.07%
—
—
cases:0.95%
controls:0.09%
cases:2.26%
controls:0.59%
cases:6.83%
controls:1.56%
76
201
1507
15631
37
80
1546
15752
9
11
1574
15821
—
15
15
1564
15789
35
91
1514
15411
95
215
1296
13611
Hospital outpatient
ZY010 [2001311599]
1.1e+00
1.8e+00
1.8e+00
—
2.0e+00
2.0e+00
1.6e+00
cases:1.90%
controls:0.66%
cases:1.64%
controls:0.28%
cases:0.76%
controls:0.13%
—
—
cases:0.70%
controls:0.09%
cases:1.48%
controls:0.21%
cases:1.87%
controls:0.38%
30
104
1553
15728
26
45
1557
15787
12
20
1571
15812
—
11
15
1568
15789
23
32
1526
15470
26
53
1365
13773
Dyspnoea
R06.0 [45558449]
1.4e+00
1.5e+00
1.9e+00
—
2.6e+00
1.3e+00
1.4e+00
cases:6.19%
controls:1.56%
cases:2.53%
controls:0.55%
cases:0.44%
controls:0.07%
—
—
cases:0.57%
controls:0.04%
cases:2.58%
controls:0.68%
cases:8.41%
controls:2.23%
98
247
1485
15585
40
87
1543
15745
7
11
1576
15821
—
9
7
1570
15797
40
106
1509
15396
117
308
1274
13518
Lumbar and other intervertebral disc disorders with radiculopathy
M51.1 [45562747]
1.5e+00
1.2e+00
1.9e+00
1.0e+50
2.4e+00
1.7e+00
1.4e+00
cases:5.43%
controls:1.31%
cases:1.96%
controls:0.61%
cases:0.57%
controls:0.08%
cases:0.57%
controls:0.00%
cases:0.76%
controls:0.07%
cases:2.52%
controls:0.46%
cases:5.25%
controls:1.34%
86
208
1497
15624
31
97
1552
15735
9
13
1574
15819
9
0
1574
15832
12
11
1567
15793
39
72
1510
15430
73
185
1318
13641
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
1.2e+00
1.6e+00
2.3e+00
—
2.1e+00
1.6e+00
1.3e+00
cases:7.14%
controls:2.30%
cases:4.80%
controls:1.00%
cases:1.26%
controls:0.13%
—
—
cases:0.95%
controls:0.12%
cases:4.91%
controls:0.99%
cases:11.65%
controls:3.46%
113
364
1470
15468
76
159
1507
15673
20
21
1563
15811
—
15
19
1564
15785
76
154
1473
15348
162
478
1229
13348
Ophthalmology
18 [38004463]
6.9e-01
8.9e-01
1.5e+00
3.8e+00
1.5e+00
9.3e-01
7.5e-01
cases:15.86%
controls:8.60%
cases:9.35%
controls:4.06%
cases:2.97%
controls:0.66%
cases:1.90%
controls:0.04%
cases:2.72%
controls:0.64%
cases:10.14%
controls:4.28%
cases:20.56%
controls:10.93%
251
1362
1332
14470
148
643
1435
15189
47
105
1536
15727
30
7
1553
15825
43
101
1536
15703
157
663
1392
14839
286
1511
1105
12315
Recurrent depression, moderate episode of somatic syndrome
F33.11 [2000501985]
2.0e+00
3.1e+00
—
1.0e+50
—
2.5e+00
2.4e+00
cases:0.69%
controls:0.09%
cases:0.82%
controls:0.04%
—
—
cases:0.32%
controls:0.00%
—
—
cases:0.77%
controls:0.06%
cases:1.87%
controls:0.17%
11
15
1572
15817
13
6
1570
15826
—
5
0
1578
15832
—
12
10
1537
15492
26
24
1365
13802
Asthma, unspecified
J45.9 [45562456]
1.3e+00
1.5e+00
1.7e+00
1.0e+50
2.3e+00
1.7e+00
1.3e+00
cases:5.87%
controls:1.64%
cases:2.84%
controls:0.64%
cases:0.82%
controls:0.15%
cases:1.20%
controls:0.00%
cases:1.01%
controls:0.10%
cases:4.26%
controls:0.80%
cases:7.76%
controls:2.24%
93
260
1490
15572
45
101
1538
15731
13
23
1570
15809
19
0
1564
15832
16
16
1563
15788
66
124
1483
15378
108
310
1283
13516
Cathetrisation of vein
TPH04 [2001309597]
9.4e-01
1.4e+00
2.6e+00
1.0e+50
2.1e+00
1.5e+00
1.3e+00
cases:4.30%
controls:1.72%
cases:2.84%
controls:0.70%
cases:0.76%
controls:0.06%
cases:0.76%
controls:0.00%
cases:0.70%
controls:0.09%
cases:3.03%
controls:0.68%
cases:6.76%
controls:1.87%
68
272
1515
15560
45
111
1538
15721
12
9
1571
15823
12
0
1571
15832
11
14
1568
15790
47
105
1502
15397
94
259
1297
13567
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
1.7e+00
1.9e+00
1.5e+00
—
2.1e+00
2.2e+00
1.9e+00
cases:2.78%
controls:0.51%
cases:1.64%
controls:0.24%
cases:0.44%
controls:0.09%
—
—
cases:0.70%
controls:0.08%
cases:1.94%
controls:0.22%
cases:3.95%
controls:0.64%
44
80
1539
15752
26
38
1557
15794
7
15
1576
15817
—
11
13
1568
15791
30
34
1519
15468
55
88
1336
13738
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
1.4e+00
1.8e+00
3.0e+00
—
—
2.1e+00
1.5e+00
cases:3.85%
controls:0.95%
cases:2.08%
controls:0.36%
cases:1.14%
controls:0.06%
—
—
—
—
cases:2.84%
controls:0.35%
cases:5.61%
controls:1.34%
61
151
1522
15681
33
57
1550
15775
18
9
1565
15823
—
—
44
55
1505
15447
78
185
1313
13641
Recurrent depressive disorder, current episode severe without psychotic symptoms
F33.2 [45547705]
1.7e+00
1.6e+00
1.5e+00
—
2.0e+00
2.2e+00
2.4e+00
cases:2.34%
controls:0.44%
cases:1.01%
controls:0.21%
cases:0.51%
controls:0.11%
—
—
cases:0.63%
controls:0.09%
cases:1.81%
controls:0.21%
cases:4.39%
controls:0.43%
37
70
1546
15762
16
33
1567
15799
8
18
1575
15814
—
10
14
1569
15790
28
33
1521
15469
61
60
1330
13766
orphenadrine (citrate); oral, parenteral
M03BC01 [21604112]
1.3e+00
1.8e+00
2.1e+00
—
2.0e+00
1.4e+00
1.2e+00
cases:18.95%
controls:6.01%
cases:8.91%
controls:1.67%
cases:1.58%
controls:0.19%
—
—
cases:1.39%
controls:0.20%
cases:6.52%
controls:1.73%
cases:17.61%
controls:5.97%
300
951
1283
14881
141
264
1442
15568
25
30
1558
15802
—
22
31
1557
15773
101
268
1448
15234
245
825
1146
13001
orphenadrine (chloride); oral, parenteral
N04AB02 [21604458]
1.3e+00
1.8e+00
2.1e+00
—
2.0e+00
1.4e+00
1.2e+00
cases:18.95%
controls:6.01%
cases:8.91%
controls:1.67%
cases:1.58%
controls:0.19%
—
—
cases:1.39%
controls:0.20%
cases:6.52%
controls:1.73%
cases:17.61%
controls:5.97%
300
951
1283
14881
141
264
1442
15568
25
30
1558
15802
—
22
31
1557
15773
101
268
1448
15234
245
825
1146
13001
Disturbance of activity and attention
F90.0 [45542870]
1.6e+00
1.6e+00
1.8e+00
—
1.7e+00
1.4e+00
1.4e+00
cases:1.45%
controls:0.28%
cases:1.39%
controls:0.29%
cases:0.63%
controls:0.10%
—
—
cases:0.51%
controls:0.09%
cases:1.48%
controls:0.35%
cases:3.02%
controls:0.77%
23
45
1560
15787
22
46
1561
15786
10
16
1573
15816
—
8
14
1571
15790
23
55
1526
15447
42
106
1349
13720
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
5.5e-01
8.9e-01
1.4e+00
3.8e+00
1.4e+00
9.9e-01
5.9e-01
cases:29.31%
controls:19.28%
cases:27.16%
controls:13.28%
cases:8.40%
controls:2.15%
cases:5.12%
controls:0.12%
cases:7.54%
controls:2.03%
cases:29.70%
controls:13.60%
cases:45.22%
controls:31.43%
464
3052
1119
12780
430
2103
1153
13729
133
341
1450
15491
81
19
1502
15813
119
321
1460
15483
460
2108
1089
13394
629
4346
762
9480
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
9.8e-01
1.1e+00
1.4e+00
2.6e+00
1.4e+00
1.1e+00
1.0e+00
cases:45.61%
controls:23.95%
cases:28.62%
controls:11.53%
cases:6.00%
controls:1.62%
cases:0.76%
controls:0.06%
cases:6.14%
controls:1.56%
cases:27.24%
controls:11.32%
cases:54.49%
controls:30.56%
722
3791
861
12041
453
1826
1130
14006
95
257
1488
15575
12
9
1571
15823
97
246
1482
15558
422
1755
1127
13747
758
4225
633
9601
melatonin; oral
N05CH01 [21604659]
1.0e+00
1.3e+00
2.0e+00
1.0e+50
1.9e+00
1.8e+00
1.5e+00
cases:4.36%
controls:1.57%
cases:3.60%
controls:0.96%
cases:1.07%
controls:0.15%
cases:0.51%
controls:0.00%
cases:1.46%
controls:0.22%
cases:5.87%
controls:1.06%
cases:11.65%
controls:2.94%
69
249
1514
15583
57
152
1526
15680
17
23
1566
15809
8
0
1575
15832
23
35
1556
15769
91
165
1458
15337
162
406
1229
13420
Headache
R51 [45558474]
2.4e+00
3.0e+00
1.0e+50
1.0e+50
—
2.4e+00
1.7e+00
cases:3.54%
controls:0.32%
cases:2.46%
controls:0.13%
cases:1.39%
controls:0.00%
cases:0.69%
controls:0.00%
—
—
cases:1.36%
controls:0.13%
cases:2.37%
controls:0.46%
56
50
1527
15782
39
20
1544
15812
22
0
1561
15832
11
0
1572
15832
—
21
20
1528
15482
33
64
1358
13762
Other and unspecified abdominal pain
R10.4 [45568113]
1.3e+00
1.2e+00
1.9e+00
1.0e+50
2.2e+00
1.4e+00
1.4e+00
cases:13.96%
controls:4.18%
cases:4.55%
controls:1.36%
cases:0.63%
controls:0.09%
cases:0.32%
controls:0.00%
cases:0.63%
controls:0.07%
cases:5.29%
controls:1.41%
cases:16.18%
controls:4.43%
221
661
1362
15171
72
215
1511
15617
10
15
1573
15817
5
0
1578
15832
10
11
1569
15793
82
219
1467
15283
225
612
1166
13214
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
5.5e-01
8.7e-01
1.4e+00
3.8e+00
1.3e+00
9.6e-01
5.8e-01
cases:29.56%
controls:19.48%
cases:27.16%
controls:13.49%
cases:8.46%
controls:2.22%
cases:5.12%
controls:0.13%
cases:7.54%
controls:2.08%
cases:29.50%
controls:13.86%
cases:45.22%
controls:31.70%
468
3084
1115
12748
430
2135
1153
13697
134
352
1449
15480
81
20
1502
15812
119
329
1460
15475
457
2148
1092
13354
629
4383
762
9443
Neuropsychological investigation
XA800 [2001300412]
1.9e+00
2.1e+00
—
—
—
3.1e+00
2.3e+00
cases:1.52%
controls:0.23%
cases:0.69%
controls:0.08%
—
—
—
—
—
—
cases:0.97%
controls:0.05%
cases:2.08%
controls:0.22%
24
36
1559
15796
11
13
1572
15819
—
—
—
15
7
1534
15495
29
30
1362
13796
methylphenidate; oral
N06BA04 [21604757]
1.6e+00
1.6e+00
1.6e+00
—
1.7e+00
1.3e+00
1.4e+00
cases:1.45%
controls:0.29%
cases:1.26%
controls:0.26%
cases:0.63%
controls:0.13%
—
—
cases:0.57%
controls:0.10%
cases:1.29%
controls:0.35%
cases:2.52%
controls:0.64%
23
46
1560
15786
20
41
1563
15791
10
21
1573
15811
—
9
16
1570
15788
20
54
1529
15448
35
88
1356
13738
buprenorphine; implant, parenteral, sublingual
N07BC01 [21604826]
2.3e+00
2.4e+00
—
—
—
2.4e+00
2.1e+00
cases:1.07%
controls:0.11%
cases:0.51%
controls:0.04%
—
—
—
—
—
—
cases:0.71%
controls:0.06%
cases:1.15%
controls:0.14%
17
18
1566
15814
8
7
1575
15825
—
—
—
11
10
1538
15492
16
20
1375
13806
Normoblasts [#/volume] in Blood
715-3 [3021589]
7.6e-01
7.3e-01
1.3e+00
3.6e+00
9.5e-01
9.5e-01
8.8e-01
cases:12.19%
controls:6.08%
cases:9.41%
controls:4.76%
cases:3.41%
controls:1.00%
cases:1.20%
controls:0.03%
cases:2.47%
controls:0.97%
cases:11.75%
controls:4.90%
cases:20.35%
controls:9.55%
193
962
1390
14870
149
753
1434
15079
54
158
1529
15674
19
5
1564
15827
39
154
1540
15650
182
760
1367
14742
283
1321
1108
12505
Oral Surgery
19 [38004464]
1.4e+00
1.5e+00
1.0e+50
—
2.8e+00
1.8e+00
1.6e+00
cases:2.27%
controls:0.54%
cases:1.07%
controls:0.23%
cases:0.57%
controls:0.00%
—
—
cases:0.51%
controls:0.03%
cases:1.48%
controls:0.24%
cases:2.73%
controls:0.58%
36
86
1547
15746
17
37
1566
15795
9
0
1574
15832
—
8
5
1571
15799
23
37
1526
15465
38
80
1353
13746
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
1.9e+00
2.3e+00
—
1.0e+50
—
2.8e+00
2.1e+00
cases:2.91%
controls:0.44%
cases:1.64%
controls:0.17%
—
—
cases:1.83%
controls:0.00%
—
—
cases:2.13%
controls:0.14%
cases:4.24%
controls:0.52%
46
70
1537
15762
26
27
1557
15805
—
29
0
1554
15832
—
33
21
1516
15481
59
72
1332
13754
Cervical spine MRI examination with high intensity magnet
NA1BG [2001306990]
2.0e+00
2.2e+00
—
—
—
2.6e+00
2.3e+00
cases:2.02%
controls:0.27%
cases:0.82%
controls:0.09%
—
—
—
—
—
—
cases:0.90%
controls:0.06%
cases:2.30%
controls:0.25%
32
43
1551
15789
13
15
1570
15817
—
—
—
14
10
1535
15492
32
34
1359
13792
lithium; oral
N05AN01 [21604556]
1.1e+00
1.3e+00
1.6e+00
—
2.2e+00
2.0e+00
2.5e+00
cases:0.88%
controls:0.29%
cases:0.76%
controls:0.21%
cases:0.32%
controls:0.06%
—
—
cases:0.44%
controls:0.05%
cases:1.55%
controls:0.22%
cases:3.31%
controls:0.27%
14
46
1569
15786
12
33
1571
15799
5
10
1578
15822
—
7
8
1572
15796
24
34
1525
15468
46
38
1345
13788
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
5.1e-01
7.7e-01
1.3e+00
3.7e+00
1.2e+00
8.9e-01
6.2e-01
cases:30.64%
controls:20.94%
cases:24.26%
controls:12.96%
cases:7.90%
controls:2.25%
cases:5.31%
controls:0.14%
cases:6.78%
controls:2.06%
cases:26.60%
controls:12.95%
cases:45.00%
controls:30.62%
485
3316
1098
12516
384
2052
1199
13780
125
357
1458
15475
84
22
1499
15810
107
326
1472
15478
412
2007
1137
13495
626
4234
765
9592
ibuprofen
R02AX02 [1588667]
9.0e-01
9.0e-01
1.4e+00
2.9e+00
1.3e+00
8.6e-01
7.6e-01
cases:56.66%
controls:34.77%
cases:31.71%
controls:15.91%
cases:7.64%
controls:1.98%
cases:0.95%
controls:0.05%
cases:6.46%
controls:1.93%
cases:31.57%
controls:16.28%
cases:56.87%
controls:38.16%
897
5505
686
10327
502
2519
1081
13313
121
313
1462
15519
15
8
1568
15824
102
305
1477
15499
489
2523
1060
12979
791
5276
600
8550
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
9.0e-01
9.0e-01
1.4e+00
2.9e+00
1.3e+00
8.6e-01
7.6e-01
cases:56.66%
controls:34.77%
cases:31.71%
controls:15.91%
cases:7.64%
controls:1.98%
cases:0.95%
controls:0.05%
cases:6.46%
controls:1.93%
cases:31.57%
controls:16.28%
cases:56.87%
controls:38.16%
897
5505
686
10327
502
2519
1081
13313
121
313
1462
15519
15
8
1568
15824
102
305
1477
15499
489
2523
1060
12979
791
5276
600
8550
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
1.1e+00
1.5e+00
2.5e+00
1.0e+50
1.5e+00
1.4e+00
9.8e-01
cases:8.78%
controls:3.03%
cases:6.00%
controls:1.36%
cases:1.52%
controls:0.13%
cases:1.45%
controls:0.00%
cases:0.89%
controls:0.20%
cases:5.23%
controls:1.34%
cases:12.58%
controls:5.14%
139
480
1444
15352
95
216
1488
15616
24
20
1559
15812
23
0
1560
15832
14
32
1565
15772
81
207
1468
15295
175
710
1216
13116
Algoneurodystrophy
M89.0 [45548604]
3.3e+00
—
—
—
—
2.3e+00
3.3e+00
cases:0.88%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.45%
controls:0.05%
cases:1.01%
controls:0.04%
14
5
1569
15827
—
—
—
—
7
7
1542
15495
14
5
1377
13821
Medical doctor
Z2221 [2001311556]
9.0e-01
1.4e+00
2.2e+00
1.0e+50
1.8e+00
1.3e+00
1.3e+00
cases:9.73%
controls:4.19%
cases:4.23%
controls:1.08%
cases:0.76%
controls:0.08%
cases:0.38%
controls:0.00%
cases:0.70%
controls:0.12%
cases:3.74%
controls:1.01%
cases:8.34%
controls:2.40%
154
664
1429
15168
67
171
1516
15661
12
13
1571
15819
6
0
1577
15832
11
19
1568
15785
58
156
1491
15346
116
332
1275
13494
temazepam; oral
N05CD07 [21604642]
1.2e+00
1.4e+00
1.9e+00
—
1.7e+00
1.5e+00
1.2e+00
cases:5.75%
controls:1.89%
cases:3.54%
controls:0.92%
cases:1.64%
controls:0.24%
—
—
cases:1.52%
controls:0.27%
cases:3.81%
controls:0.88%
cases:5.97%
controls:1.83%
91
299
1492
15533
56
145
1527
15687
26
38
1557
15794
—
24
43
1555
15761
59
137
1490
15365
83
253
1308
13573
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
2.1e+00
2.5e+00
—
1.0e+50
—
2.2e+00
2.1e+00
cases:3.79%
controls:0.50%
cases:1.83%
controls:0.15%
—
—
cases:0.38%
controls:0.00%
—
—
cases:1.61%
controls:0.19%
cases:4.46%
controls:0.56%
60
79
1523
15753
29
24
1554
15808
—
6
0
1577
15832
—
25
29
1524
15473
62
78
1329
13748
tolfenamic acid; oral, rectal
M01AG02 [21603988]
1.7e+00
2.1e+00
—
—
2.3e+00
1.2e+00
1.5e+00
cases:5.62%
controls:1.12%
cases:1.77%
controls:0.21%
—
—
—
—
cases:0.38%
controls:0.04%
cases:0.97%
controls:0.30%
cases:3.16%
controls:0.70%
89
178
1494
15654
28
34
1555
15798
—
—
6
6
1573
15798
15
47
1534
15455
44
97
1347
13729
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
1.9e+00
2.4e+00
—
1.0e+50
1.0e+50
2.5e+00
2.0e+00
cases:3.41%
controls:0.52%
cases:1.90%
controls:0.18%
—
—
cases:1.14%
controls:0.00%
cases:0.51%
controls:0.00%
cases:2.39%
controls:0.21%
cases:3.74%
controls:0.50%
54
82
1529
15750
30
29
1553
15803
—
18
0
1565
15832
8
0
1571
15804
37
32
1512
15470
52
69
1339
13757
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
6.7e-01
8.7e-01
1.4e+00
3.1e+00
1.1e+00
9.4e-01
7.4e-01
cases:20.66%
controls:11.74%
cases:13.08%
controls:5.91%
cases:3.16%
controls:0.83%
cases:0.69%
controls:0.03%
cases:2.28%
controls:0.77%
cases:13.36%
controls:5.71%
cases:29.26%
controls:16.48%
327
1858
1256
13974
207
936
1376
14896
50
131
1533
15701
11
5
1572
15827
36
122
1543
15682
207
885
1342
14617
407
2278
984
11548
Psychologist
Z2445 [2001311558]
1.7e+00
2.6e+00
—
—
—
2.2e+00
2.3e+00
cases:1.96%
controls:0.37%
cases:1.07%
controls:0.08%
—
—
—
—
—
—
cases:0.77%
controls:0.08%
cases:1.73%
controls:0.18%
31
58
1552
15774
17
13
1566
15819
—
—
—
12
13
1537
15489
24
25
1367
13801
naproxen; oral, rectal
M01AE02 [21603968]
1.2e+00
1.5e+00
2.0e+00
—
2.1e+00
1.2e+00
9.3e-01
cases:25.08%
controls:9.50%
cases:11.88%
controls:2.99%
cases:2.02%
controls:0.28%
—
—
cases:2.15%
controls:0.28%
cases:8.33%
controls:2.76%
cases:18.26%
controls:8.10%
397
1504
1186
14328
188
473
1395
15359
32
45
1551
15787
—
34
44
1545
15760
129
428
1420
15074
254
1120
1137
12706
naproxcinod
M01AE18 [40254094]
1.2e+00
1.5e+00
2.0e+00
—
2.1e+00
1.2e+00
9.3e-01
cases:25.08%
controls:9.50%
cases:11.88%
controls:2.99%
cases:2.02%
controls:0.28%
—
—
cases:2.15%
controls:0.28%
cases:8.33%
controls:2.76%
cases:18.26%
controls:8.10%
397
1504
1186
14328
188
473
1395
15359
32
45
1551
15787
—
34
44
1545
15760
129
428
1420
15074
254
1120
1137
12706
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
R5110 [2001310246]
1.9e+00
2.2e+00
—
—
—
2.6e+00
2.1e+00
cases:2.02%
controls:0.31%
cases:0.88%
controls:0.10%
—
—
—
—
—
—
cases:1.48%
controls:0.11%
cases:3.45%
controls:0.45%
32
49
1551
15783
14
16
1569
15816
—
—
—
23
17
1526
15485
48
62
1343
13764
Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 [3008230]
1.2e+00
2.0e+00
—
—
2.8e+00
1.6e+00
1.2e+00
cases:2.53%
controls:0.74%
cases:1.90%
controls:0.27%
—
—
—
—
cases:0.51%
controls:0.03%
cases:1.29%
controls:0.27%
cases:2.95%
controls:0.93%
40
117
1543
15715
30
42
1553
15790
—
—
8
5
1571
15799
20
42
1529
15460
41
128
1350
13698
apixaban; oral
B01AF02 [43534762]
1.1e+00
1.4e+00
2.0e+00
—
1.9e+00
1.2e+00
1.0e+00
cases:0.95%
controls:0.32%
cases:1.26%
controls:0.30%
cases:0.76%
controls:0.10%
—
—
cases:0.63%
controls:0.09%
cases:1.29%
controls:0.37%
cases:1.87%
controls:0.69%
15
50
1568
15782
20
48
1563
15784
12
16
1571
15816
—
10
15
1569
15789
20
58
1529
15444
26
95
1365
13731
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
4.4e-01
7.0e-01
1.3e+00
3.7e+00
1.1e+00
8.4e-01
5.9e-01
cases:21.86%
controls:15.30%
cases:20.66%
controls:11.41%
cases:7.08%
controls:2.01%
cases:3.54%
controls:0.09%
cases:5.83%
controls:1.97%
cases:24.08%
controls:12.08%
cases:38.82%
controls:26.02%
346
2423
1237
13409
327
1806
1256
14026
112
319
1471
15513
56
14
1527
15818
92
312
1487
15492
373
1872
1176
13630
540
3598
851
10228
propranolol; oral, parenteral
C07AA05 [21601670]
1.2e+00
1.3e+00
2.1e+00
—
1.5e+00
1.5e+00
1.0e+00
cases:11.75%
controls:3.79%
cases:6.89%
controls:1.91%
cases:2.15%
controls:0.28%
—
—
cases:1.65%
controls:0.37%
cases:7.75%
controls:1.84%
cases:11.93%
controls:4.58%
186
600
1397
15232
109
303
1474
15529
34
44
1549
15788
—
26
58
1553
15746
120
285
1429
15217
166
633
1225
13193
codeine and paracetamol
N02AJ06 [1123647]
1.1e+00
1.4e+00
2.0e+00
—
1.9e+00
1.2e+00
1.0e+00
cases:25.77%
controls:10.57%
cases:13.64%
controls:3.83%
cases:3.73%
controls:0.54%
—
—
cases:3.61%
controls:0.53%
cases:12.07%
controls:3.79%
cases:27.61%
controls:11.77%
408
1674
1175
14158
216
606
1367
15226
59
86
1524
15746
—
57
84
1522
15720
187
588
1362
14914
384
1628
1007
12198
Radiculopathy
M54.1 [45577287]
1.6e+00
2.8e+00
—
—
—
2.3e+00
1.9e+00
cases:1.07%
controls:0.21%
cases:0.76%
controls:0.04%
—
—
—
—
—
—
cases:0.45%
controls:0.05%
cases:1.22%
controls:0.19%
17
34
1566
15798
12
7
1571
15825
—
—
—
7
7
1542
15495
17
26
1374
13800
Ocular pain
H57.1 [45596140]
2.2e+00
3.2e+00
1.0e+50
1.0e+50
—
2.1e+00
1.2e+00
cases:1.96%
controls:0.23%
cases:1.77%
controls:0.08%
cases:0.76%
controls:0.00%
cases:0.44%
controls:0.00%
—
—
cases:0.65%
controls:0.08%
cases:1.37%
controls:0.43%
31
36
1552
15796
28
12
1555
15820
12
0
1571
15832
7
0
1576
15832
—
10
12
1539
15490
19
59
1372
13767
Dizziness and giddiness
R42 [45568132]
1.6e+00
1.6e+00
—
—
3.0e+00
1.2e+00
1.3e+00
cases:5.75%
controls:1.26%
cases:2.15%
controls:0.45%
—
—
—
—
cases:0.63%
controls:0.03%
cases:1.94%
controls:0.61%
cases:6.69%
controls:2.00%
91
200
1492
15632
34
72
1549
15760
—
—
10
5
1569
15799
30
94
1519
15408
93
276
1298
13550
oxazepam; oral
N05BA04 [21604569]
1.2e+00
1.3e+00
1.7e+00
—
1.6e+00
1.5e+00
1.3e+00
cases:11.12%
controls:3.70%
cases:6.70%
controls:1.94%
cases:2.53%
controls:0.46%
—
—
cases:2.34%
controls:0.48%
cases:7.49%
controls:1.85%
cases:13.66%
controls:4.15%
176
585
1407
15247
106
307
1477
15525
40
73
1543
15759
—
37
76
1542
15728
116
287
1433
15215
190
574
1201
13252
Short MRI examination of brain with median intensity magnet
AA1AG [2001300107]
2.9e+00
—
—
1.0e+50
—
2.5e+00
3.1e+00
cases:0.82%
controls:0.04%
—
—
—
—
cases:0.44%
controls:0.00%
—
—
cases:0.39%
controls:0.03%
cases:0.79%
controls:0.04%
13
7
1570
15825
—
—
7
0
1576
15832
—
6
5
1543
15497
11
5
1380
13821
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
9.3e-01
1.0e+00
1.7e+00
—
1.8e+00
1.6e+00
1.4e+00
cases:6.82%
controls:2.80%
cases:3.92%
controls:1.48%
cases:1.07%
controls:0.19%
—
—
cases:1.14%
controls:0.20%
cases:5.87%
controls:1.19%
cases:12.08%
controls:3.32%
108
444
1475
15388
62
235
1521
15597
17
30
1566
15802
—
18
31
1561
15773
91
185
1458
15317
168
459
1223
13367
clonazepam; oral, parenteral
N03AE01 [21604415]
1.7e+00
1.8e+00
1.1e+00
—
1.5e+00
1.6e+00
1.8e+00
cases:2.72%
controls:0.51%
cases:1.90%
controls:0.33%
cases:0.32%
controls:0.10%
—
—
cases:0.70%
controls:0.15%
cases:1.55%
controls:0.32%
cases:3.24%
controls:0.54%
43
81
1540
15751
30
52
1553
15780
5
16
1578
15816
—
11
24
1568
15780
24
50
1525
15452
45
74
1346
13752
Emergency Medicine
93 [38004510]
7.5e-01
1.1e+00
2.3e+00
—
2.1e+00
1.2e+00
8.5e-01
cases:17.18%
controls:8.91%
cases:12.95%
controls:4.55%
cases:4.99%
controls:0.51%
—
—
cases:4.50%
controls:0.58%
cases:14.20%
controls:4.60%
cases:29.04%
controls:14.86%
272
1411
1311
14421
205
720
1378
15112
79
81
1504
15751
—
71
92
1508
15712
220
713
1329
14789
404
2055
987
11771
candesartan; oral
C09CA06 [21601829]
1.7e+00
1.5e+00
1.1e+00
—
1.6e+00
1.3e+00
1.2e+00
cases:11.81%
controls:2.49%
cases:9.10%
controls:2.25%
cases:2.27%
controls:0.77%
—
—
cases:2.98%
controls:0.59%
cases:8.97%
controls:2.57%
cases:13.23%
controls:4.46%
187
394
1396
15438
144
357
1439
15475
36
122
1547
15710
—
47
93
1532
15711
139
399
1410
15103
184
617
1207
13209
Observation for suspected nervous system disorder
Z03.3 [45609903]
1.9e+00
2.7e+00
—
—
—
2.5e+00
1.3e+00
cases:1.77%
controls:0.28%
cases:0.63%
controls:0.04%
—
—
—
—
—
—
cases:0.77%
controls:0.06%
cases:1.22%
controls:0.33%
28
44
1555
15788
10
7
1573
15825
—
—
—
12
10
1537
15492
17
45
1374
13781
tizanidine; oral
M03BX02 [21604116]
1.1e+00
1.4e+00
2.1e+00
—
1.7e+00
1.1e+00
9.7e-01
cases:31.78%
controls:13.31%
cases:15.10%
controls:4.33%
cases:3.47%
controls:0.46%
—
—
cases:3.10%
controls:0.56%
cases:12.20%
controls:4.41%
cases:28.83%
controls:13.34%
503
2108
1080
13724
239
686
1344
15146
55
73
1528
15759
—
49
89
1530
15715
189
684
1360
14818
401
1845
990
11981
Moderate depressive episode without somatic syndrome
F32.10 [2000501980]
1.5e+00
1.6e+00
1.3e+00
1.0e+50
2.0e+00
1.9e+00
1.3e+00
cases:3.41%
controls:0.80%
cases:1.52%
controls:0.30%
cases:0.38%
controls:0.11%
cases:0.38%
controls:0.00%
cases:0.63%
controls:0.08%
cases:1.94%
controls:0.30%
cases:3.38%
controls:0.95%
54
127
1529
15705
24
48
1559
15784
6
17
1577
15815
6
0
1577
15832
10
13
1569
15791
30
46
1519
15456
47
132
1344
13694
Other specified special examinations
Z01.8 [45581003]
1.1e+00
9.2e-01
1.9e+00
—
2.1e+00
1.4e+00
9.0e-01
cases:5.43%
controls:1.90%
cases:1.83%
controls:0.74%
cases:0.44%
controls:0.06%
—
—
cases:0.44%
controls:0.06%
cases:2.13%
controls:0.55%
cases:5.54%
controls:2.32%
86
301
1497
15531
29
117
1554
15715
7
10
1576
15822
—
7
9
1572
15795
33
86
1516
15416
77
321
1314
13505
Myalgia
M79.1 [45587062]
1.5e+00
1.1e+00
2.6e+00
—
2.0e+00
1.8e+00
1.3e+00
cases:3.92%
controls:0.92%
cases:1.33%
controls:0.44%
cases:0.51%
controls:0.04%
—
—
cases:0.32%
controls:0.04%
cases:2.32%
controls:0.41%
cases:5.82%
controls:1.65%
62
145
1521
15687
21
69
1562
15763
8
6
1575
15826
—
5
7
1574
15797
36
63
1513
15439
81
228
1310
13598
ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]
1.1e+00
1.4e+00
2.0e+00
1.0e+50
1.7e+00
1.1e+00
1.1e+00
cases:11.18%
controls:4.18%
cases:4.49%
controls:1.19%
cases:1.39%
controls:0.20%
cases:0.38%
controls:0.00%
cases:0.51%
controls:0.09%
cases:2.84%
controls:0.94%
cases:7.98%
controls:2.91%
177
661
1406
15171
71
188
1512
15644
22
31
1561
15801
6
0
1577
15832
8
15
1571
15789
44
145
1505
15357
111
402
1280
13424
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
1.3e+00
1.4e+00
—
—
2.2e+00
1.8e+00
1.6e+00
cases:3.35%
controls:0.94%
cases:1.45%
controls:0.35%
—
—
—
—
cases:0.44%
controls:0.05%
cases:1.94%
controls:0.34%
cases:4.60%
controls:0.98%
53
149
1530
15683
23
55
1560
15777
—
—
7
8
1572
15796
30
52
1519
15450
64
135
1327
13691
General Practice
1 [38004446]
8.8e-01
1.1e+00
2.2e+00
—
1.6e+00
1.3e+00
1.1e+00
cases:16.80%
controls:7.71%
cases:7.58%
controls:2.58%
cases:2.40%
controls:0.27%
—
—
cases:1.77%
controls:0.35%
cases:8.65%
controls:2.56%
cases:20.49%
controls:8.12%
266
1220
1317
14612
120
408
1463
15424
38
42
1545
15790
—
28
55
1551
15749
134
397
1415
15105
285
1122
1106
12704
CBC panel - Blood by Automated count
58410-2 [40761511]
3.7e-01
6.0e-01
1.2e+00
3.8e+00
1.2e+00
6.8e-01
3.7e-01
cases:31.21%
controls:23.88%
cases:24.26%
controls:14.92%
cases:7.45%
controls:2.39%
cases:3.98%
controls:0.09%
cases:6.71%
controls:2.23%
cases:26.28%
controls:15.27%
cases:43.49%
controls:34.62%
494
3780
1089
12052
384
2362
1199
13470
118
379
1465
15453
63
14
1520
15818
106
352
1473
15452
407
2367
1142
13135
605
4786
786
9040
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
8.6e-01
1.0e+00
1.9e+00
1.0e+50
1.7e+00
1.4e+00
1.3e+00
cases:3.41%
controls:1.47%
cases:1.90%
controls:0.69%
cases:0.44%
controls:0.07%
cases:0.57%
controls:0.00%
cases:0.51%
controls:0.09%
cases:2.45%
controls:0.63%
cases:8.27%
controls:2.29%
54
232
1529
15600
30
110
1553
15722
7
11
1576
15821
9
0
1574
15832
8
14
1571
15790
38
97
1511
15405
115
317
1276
13509
Pulmonary Disease
29 [38004472]
1.4e+00
1.5e+00
7.5e-01
—
1.7e+00
1.8e+00
1.8e+00
cases:11.69%
controls:3.15%
cases:6.32%
controls:1.50%
cases:0.69%
controls:0.33%
—
—
cases:1.84%
controls:0.33%
cases:8.13%
controls:1.51%
cases:17.25%
controls:3.33%
185
499
1398
15333
100
238
1483
15594
11
52
1572
15780
—
29
52
1550
15752
126
234
1423
15268
240
460
1151
13366
Lumbar puncture
TAB00 [2001300538]
2.3e+00
1.7e+00
—
1.0e+50
—
2.4e+00
1.8e+00
cases:2.02%
controls:0.21%
cases:0.57%
controls:0.10%
—
—
cases:0.32%
controls:0.00%
—
—
cases:0.84%
controls:0.08%
cases:1.29%
controls:0.22%
32
33
1551
15799
9
16
1574
15816
—
5
0
1578
15832
—
13
12
1536
15490
18
31
1373
13795
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
4.3e-01
6.9e-01
1.2e+00
3.5e+00
1.1e+00
8.2e-01
4.4e-01
cases:31.90%
controls:23.31%
cases:29.12%
controls:17.13%
cases:9.67%
controls:3.06%
cases:5.24%
controls:0.17%
cases:8.30%
controls:2.94%
cases:32.99%
controls:17.78%
cases:48.17%
controls:37.52%
505
3691
1078
12141
461
2712
1122
13120
153
484
1430
15348
83
27
1500
15805
131
464
1448
15340
511
2757
1038
12745
670
5188
721
8638
Diplopia
H53.2 [45576792]
1.7e+00
2.3e+00
—
—
—
2.0e+00
2.2e+00
cases:0.51%
controls:0.09%
cases:0.44%
controls:0.04%
—
—
—
—
—
—
cases:0.39%
controls:0.05%
cases:0.93%
controls:0.11%
8
15
1575
15817
7
7
1576
15825
—
—
—
6
8
1543
15494
13
15
1378
13811
Brachial plexus disorders
G54.0 [45586302]
1.5e+00
2.1e+00
—
—
—
2.2e+00
2.4e+00
cases:0.95%
controls:0.22%
cases:0.51%
controls:0.06%
—
—
—
—
—
—
cases:0.52%
controls:0.06%
cases:1.58%
controls:0.15%
15
35
1568
15797
8
10
1575
15822
—
—
—
8
9
1541
15493
22
21
1369
13805
Low back pain
M54.5 [45553207]
1.2e+00
9.9e-01
1.7e+00
2.3e+00
2.0e+00
1.2e+00
1.0e+00
cases:11.37%
controls:3.85%
cases:3.92%
controls:1.49%
cases:0.95%
controls:0.18%
cases:0.32%
controls:0.03%
cases:0.82%
controls:0.11%
cases:4.91%
controls:1.50%
cases:14.38%
controls:5.68%
180
610
1403
15222
62
236
1521
15596
15
28
1568
15804
5
5
1578
15827
13
18
1566
15786
76
233
1473
15269
200
786
1191
13040
Erythrocytes [#/volume] in Cerebral spinal fluid
26454-9 [3027475]
2.0e+00
1.7e+00
—
—
1.0e+50
2.3e+00
2.0e+00
cases:1.52%
controls:0.20%
cases:0.63%
controls:0.11%
—
—
—
—
cases:0.32%
controls:0.00%
cases:0.71%
controls:0.07%
cases:1.65%
controls:0.23%
24
32
1559
15800
10
18
1573
15814
—
—
5
0
1574
15804
11
11
1538
15491
23
32
1368
13794
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
4.2e-01
6.6e-01
1.2e+00
3.5e+00
9.7e-01
7.7e-01
4.7e-01
cases:24.89%
controls:17.92%
cases:22.93%
controls:13.31%
cases:8.72%
controls:2.69%
cases:4.42%
controls:0.14%
cases:6.65%
controls:2.63%
cases:25.69%
controls:13.83%
cases:38.53%
controls:28.22%
394
2837
1189
12995
363
2108
1220
13724
138
426
1445
15406
70
22
1513
15810
105
416
1474
15388
398
2144
1151
13358
536
3902
855
9924
Glucose [Moles/volume] in Cerebral spinal fluid
14744-7 [3020044]
2.1e+00
1.8e+00
—
—
—
2.2e+00
2.0e+00
cases:1.39%
controls:0.18%
cases:0.63%
controls:0.11%
—
—
—
—
—
—
cases:0.65%
controls:0.07%
cases:1.51%
controls:0.22%
22
28
1561
15804
10
17
1573
15815
—
—
—
10
11
1539
15491
21
30
1370
13796
General Practice Dentistry
1223G0001X [38003675]
1.8e+00
2.1e+00
—
—
-1.0e+50
2.0e+00
2.2e+00
cases:1.64%
controls:0.27%
cases:0.95%
controls:0.12%
—
—
—
—
cases:0.00%
controls:0.03%
cases:1.23%
controls:0.17%
cases:2.52%
controls:0.30%
26
43
1557
15789
15
19
1568
15813
—
—
0
5
1579
15799
19
27
1530
15475
35
41
1356
13785
Subjective visual disturbances
H53.1 [45557467]
1.6e+00
2.4e+00
—
—
—
2.3e+00
1.6e+00
cases:1.58%
controls:0.31%
cases:1.07%
controls:0.09%
—
—
—
—
—
—
cases:1.03%
controls:0.10%
cases:2.66%
controls:0.54%
25
49
1558
15783
17
15
1566
15817
—
—
—
16
16
1533
15486
37
75
1354
13751
Cervical disc disorder with radiculopathy
M50.1 [45596588]
1.9e+00
2.3e+00
—
1.0e+50
—
2.1e+00
1.7e+00
cases:2.15%
controls:0.34%
cases:0.95%
controls:0.09%
—
—
cases:0.38%
controls:0.00%
—
—
cases:1.03%
controls:0.12%
cases:2.16%
controls:0.41%
34
54
1549
15778
15
15
1568
15817
—
6
0
1577
15832
—
16
19
1533
15483
30
56
1361
13770
Leukocytes [#/volume] in Cerebral spinal fluid
26465-5 [3016543]
2.0e+00
1.7e+00
—
—
1.0e+50
2.3e+00
1.9e+00
cases:1.52%
controls:0.20%
cases:0.63%
controls:0.11%
—
—
—
—
cases:0.32%
controls:0.00%
cases:0.71%
controls:0.07%
cases:1.51%
controls:0.22%
24
32
1559
15800
10
18
1573
15814
—
—
5
0
1574
15804
11
11
1538
15491
21
31
1370
13795
Cell count panel - Cerebral spinal fluid
34563-7 [3044290]
2.0e+00
1.8e+00
—
—
—
2.1e+00
2.0e+00
cases:1.20%
controls:0.16%
cases:0.57%
controls:0.09%
—
—
—
—
—
—
cases:0.65%
controls:0.08%
cases:1.44%
controls:0.20%
19
25
1564
15807
9
15
1574
15817
—
—
—
10
12
1539
15490
20
27
1371
13799
Acute maxillary sinusitis
J01.0 [45601112]
1.1e+00
1.4e+00
1.5e+00
—
1.7e+00
1.3e+00
9.6e-01
cases:7.83%
controls:2.77%
cases:3.85%
controls:1.00%
cases:0.63%
controls:0.14%
—
—
cases:0.57%
controls:0.11%
cases:4.07%
controls:1.10%
cases:10.42%
controls:4.25%
124
439
1459
15393
61
158
1522
15674
10
22
1573
15810
—
9
17
1570
15787
63
170
1486
15332
145
587
1246
13239
Special examination of mouth
SAA04 [2001310277]
1.8e+00
2.0e+00
—
—
—
2.4e+00
1.6e+00
cases:2.15%
controls:0.37%
cases:0.82%
controls:0.11%
—
—
—
—
—
—
cases:0.52%
controls:0.05%
cases:1.44%
controls:0.29%
34
59
1549
15773
13
17
1570
15815
—
—
—
8
7
1541
15495
20
40
1371
13786
Supplier / Service Provider
OMOP5117446 [33004]
-7.8e-01
-7.3e-01
-4.7e-01
—
2.5e+00
3.1e+00
3.7e+00
cases:14.78%
controls:27.41%
cases:4.55%
controls:9.00%
cases:0.57%
controls:0.91%
—
—
cases:0.70%
controls:0.06%
cases:4.71%
controls:0.21%
cases:17.90%
controls:0.54%
234
4340
1349
11492
72
1425
1511
14407
9
144
1574
15688
—
11
9
1568
15795
73
33
1476
15469
249
74
1142
13752
Protein [Mass/volume] in Cerebral spinal fluid
2880-3 [3019473]
2.0e+00
1.7e+00
—
—
—
2.1e+00
2.0e+00
cases:1.58%
controls:0.21%
cases:0.69%
controls:0.13%
—
—
—
—
—
—
cases:0.71%
controls:0.09%
cases:1.87%
controls:0.25%
25
34
1558
15798
11
20
1572
15812
—
—
—
11
14
1538
15488
26
34
1365
13792
Cervicalgia
M54.2 [45591867]
1.6e+00
2.3e+00
—
—
—
2.3e+00
1.7e+00
cases:2.27%
controls:0.46%
cases:1.26%
controls:0.13%
—
—
—
—
—
—
cases:1.16%
controls:0.12%
cases:3.24%
controls:0.61%
36
73
1547
15759
20
21
1563
15811
—
—
—
18
19
1531
15483
45
85
1346
13741
Paranasal sinuses X-ray examination in one projection
DM1QA [2001301761]
1.5e+00
2.0e+00
—
—
—
2.7e+00
1.6e+00
cases:1.20%
controls:0.28%
cases:0.51%
controls:0.07%
—
—
—
—
—
—
cases:0.58%
controls:0.04%
cases:1.15%
controls:0.22%
19
44
1564
15788
8
11
1575
15821
—
—
—
9
6
1540
15496
16
31
1375
13795
agomelatine; oral
N06AX22 [21604750]
1.3e+00
1.7e+00
—
—
—
2.7e+00
2.1e+00
cases:0.76%
controls:0.21%
cases:0.51%
controls:0.09%
—
—
—
—
—
—
cases:1.03%
controls:0.07%
cases:1.94%
controls:0.23%
12
33
1571
15799
8
15
1575
15817
—
—
—
16
11
1533
15491
27
32
1364
13794
Office Visit
OMOP4822458 [581477]
1.0e+00
7.3e-01
1.4e+00
—
2.2e+00
1.4e+00
1.0e+00
cases:14.97%
controls:5.91%
cases:3.98%
controls:1.96%
cases:0.88%
controls:0.23%
—
—
cases:2.28%
controls:0.27%
cases:6.65%
controls:1.70%
cases:12.51%
controls:4.89%
237
935
1346
14897
63
310
1520
15522
14
36
1569
15796
—
36
42
1543
15762
103
263
1446
15239
174
676
1217
13150
Bipolar affective disorder
F31 [45595902]
1.3e+00
2.4e+00
—
—
—
2.1e+00
1.8e+00
cases:0.69%
controls:0.18%
cases:0.51%
controls:0.04%
—
—
—
—
—
—
cases:0.52%
controls:0.06%
cases:0.93%
controls:0.15%
11
29
1572
15803
8
7
1575
15825
—
—
—
8
10
1541
15492
13
21
1378
13805
Pain general/multiple sites
A01 [2002000142]
1.5e+00
2.3e+00
—
—
—
2.2e+00
1.6e+00
cases:1.83%
controls:0.40%
cases:1.20%
controls:0.12%
—
—
—
—
—
—
cases:1.23%
controls:0.14%
cases:3.24%
controls:0.65%
29
64
1554
15768
19
19
1564
15813
—
—
—
19
21
1530
15481
45
90
1346
13736
venlafaxine; oral
N06AX16 [21604745]
1.6e+00
1.6e+00
1.0e+00
—
1.4e+00
1.5e+00
1.6e+00
cases:7.64%
controls:1.66%
cases:4.93%
controls:1.02%
cases:0.88%
controls:0.32%
—
—
cases:1.33%
controls:0.34%
cases:4.84%
controls:1.09%
cases:8.70%
controls:1.96%
121
263
1462
15569
78
162
1505
15670
14
51
1569
15781
—
21
53
1558
15751
75
169
1474
15333
121
271
1270
13555
Other healthcare associate professional
Z3229 [2001311561]
1.2e+00
1.7e+00
2.0e+00
—
—
1.8e+00
9.5e-01
cases:2.15%
controls:0.68%
cases:0.88%
controls:0.16%
cases:0.38%
controls:0.05%
—
—
—
—
cases:0.97%
controls:0.15%
cases:1.29%
controls:0.51%
34
107
1549
15725
14
26
1569
15806
6
8
1577
15824
—
—
15
24
1534
15478
18
70
1373
13756
Telehealth
OMOP5556618 [722455]
6.1e-01
8.6e-01
1.3e+00
2.2e+00
1.2e+00
8.2e-01
6.8e-01
cases:29.88%
controls:18.87%
cases:15.98%
controls:7.43%
cases:3.79%
controls:1.03%
cases:0.38%
controls:0.04%
cases:3.80%
controls:1.16%
cases:14.40%
controls:6.87%
cases:29.33%
controls:17.40%
473
2988
1110
12844
253
1177
1330
14655
60
163
1523
15669
6
7
1577
15825
60
184
1519
15620
223
1065
1326
14437
408
2406
983
11420
pH of Serum or Plasma
2753-2 [3018418]
9.7e-01
1.1e+00
1.8e+00
—
1.3e+00
1.2e+00
1.3e+00
cases:6.76%
controls:2.67%
cases:4.30%
controls:1.48%
cases:1.39%
controls:0.23%
—
—
cases:0.89%
controls:0.23%
cases:4.78%
controls:1.50%
cases:12.65%
controls:3.93%
107
423
1476
15409
68
234
1515
15598
22
37
1561
15795
—
14
37
1565
15767
74
233
1475
15269
176
543
1215
13283
Neck symptom/complaint
L01 [2002000626]
1.5e+00
1.1e+00
2.4e+00
—
1.8e+00
1.5e+00
1.1e+00
cases:5.05%
controls:1.14%
cases:1.07%
controls:0.37%
cases:0.63%
controls:0.06%
—
—
cases:0.32%
controls:0.05%
cases:1.87%
controls:0.43%
cases:4.89%
controls:1.64%
80
181
1503
15651
17
58
1566
15774
10
9
1573
15823
—
5
8
1574
15796
29
67
1520
15435
68
227
1323
13599
Otolaryngology
4 [38004449]
1.1e+00
1.1e+00
1.4e+00
—
1.6e+00
1.4e+00
1.1e+00
cases:18.51%
controls:7.23%
cases:6.70%
controls:2.44%
cases:1.77%
controls:0.44%
—
—
cases:1.65%
controls:0.34%
cases:9.23%
controls:2.47%
cases:20.27%
controls:7.78%
293
1145
1290
14687
106
386
1477
15446
28
70
1555
15762
—
26
53
1553
15751
143
383
1406
15119
282
1076
1109
12750
lidocaine; ointment
D04AB01 [21602020]
1.5e+00
1.8e+00
—
—
—
2.3e+00
2.0e+00
cases:1.20%
controls:0.26%
cases:0.63%
controls:0.11%
—
—
—
—
—
—
cases:1.03%
controls:0.11%
cases:2.16%
controls:0.30%
19
41
1564
15791
10
17
1573
15815
—
—
—
16
17
1533
15485
30
41
1361
13785
Written specialist consultation based on a referral from a dentist or a physician
WZC10 [2001310887]
1.9e+00
2.2e+00
—
—
—
2.1e+00
1.4e+00
cases:1.52%
controls:0.24%
cases:0.69%
controls:0.08%
—
—
—
—
—
—
cases:0.58%
controls:0.07%
cases:0.79%
controls:0.20%
24
38
1559
15794
11
12
1572
15820
—
—
—
9
11
1540
15491
11
28
1380
13798
lidocaine
C05AD01 [21601618]
1.5e+00
1.7e+00
—
—
—
2.3e+00
2.0e+00
cases:1.20%
controls:0.26%
cases:0.63%
controls:0.11%
—
—
—
—
—
—
cases:1.03%
controls:0.11%
cases:2.16%
controls:0.30%
19
41
1564
15791
10
18
1573
15814
—
—
—
16
17
1533
15485
30
41
1361
13785
Social worker
Z2446 [2001311559]
1.6e+00
2.4e+00
—
—
—
2.1e+00
1.4e+00
cases:2.34%
controls:0.49%
cases:1.39%
controls:0.13%
—
—
—
—
—
—
cases:0.90%
controls:0.11%
cases:1.44%
controls:0.36%
37
78
1546
15754
22
20
1561
15812
—
—
—
14
17
1535
15485
20
50
1371
13776
Procedure duration 60 to 89 minutes
ZXE11 [2001311402]
1.2e+00
1.4e+00
1.9e+00
—
—
1.4e+00
1.7e+00
cases:1.64%
controls:0.52%
cases:1.20%
controls:0.30%
cases:0.44%
controls:0.07%
—
—
—
—
cases:1.03%
controls:0.26%
cases:1.58%
controls:0.30%
26
82
1557
15750
19
47
1564
15785
7
11
1576
15821
—
—
16
40
1533
15462
22
42
1369
13784
Lumbago with sciatica
M54.4 [45553205]
1.4e+00
1.4e+00
—
—
1.6e+00
1.8e+00
1.3e+00
cases:5.87%
controls:1.50%
cases:2.72%
controls:0.71%
—
—
—
—
cases:0.51%
controls:0.10%
cases:2.84%
controls:0.46%
cases:6.76%
controls:2.03%
93
238
1490
15594
43
112
1540
15720
—
—
8
16
1571
15788
44
72
1505
15430
94
280
1297
13546
Rheumatism, unspecified
M79.0 [45567658]
2.1e+00
—
—
1.0e+50
—
3.3e+00
2.1e+00
cases:1.71%
controls:0.22%
—
—
—
—
cases:0.51%
controls:0.00%
—
—
cases:0.84%
controls:0.03%
cases:1.58%
controls:0.19%
27
35
1556
15797
—
—
8
0
1575
15832
—
13
5
1536
15497
22
26
1369
13800
Physiotherapy
R4110 [2001310233]
1.1e+00
1.6e+00
1.0e+00
—
1.5e+00
1.7e+00
1.5e+00
cases:8.09%
controls:2.80%
cases:5.12%
controls:1.08%
cases:0.63%
controls:0.23%
—
—
cases:0.89%
controls:0.20%
cases:4.71%
controls:0.94%
cases:10.06%
controls:2.48%
128
444
1455
15388
81
171
1502
15661
10
36
1573
15796
—
14
31
1565
15773
73
145
1476
15357
140
343
1251
13483
Dentistry
C5 [903277]
9.8e-01
1.4e+00
1.7e+00
—
1.4e+00
1.8e+00
1.5e+00
cases:4.30%
controls:1.65%
cases:2.27%
controls:0.57%
cases:0.51%
controls:0.09%
—
—
cases:0.38%
controls:0.09%
cases:2.97%
controls:0.53%
cases:6.76%
controls:1.55%
68
261
1515
15571
36
90
1547
15742
8
15
1575
15817
—
6
15
1573
15789
46
82
1503
15420
94
214
1297
13612
Pain in limb
M79.6 [45587063]
1.3e+00
1.1e+00
1.4e+00
—
1.7e+00
1.1e+00
8.7e-01
cases:11.75%
controls:3.67%
cases:4.36%
controls:1.48%
cases:0.76%
controls:0.20%
—
—
cases:1.01%
controls:0.20%
cases:5.55%
controls:1.92%
cases:15.10%
controls:6.93%
186
581
1397
15251
69
235
1514
15597
12
31
1571
15801
—
16
31
1563
15773
86
297
1463
15205
210
958
1181
12868
Other specified headache syndromes
G44.8 [45547741]
3.6e+00
—
1.0e+50
1.0e+50
1.0e+50
—
3.7e+00
cases:1.58%
controls:0.04%
—
—
cases:1.20%
controls:0.00%
cases:0.32%
controls:0.00%
cases:0.57%
controls:0.00%
—
—
cases:3.52%
controls:0.09%
25
7
1558
15825
—
19
0
1564
15832
5
0
1578
15832
9
0
1570
15804
—
49
12
1342
13814
Cerebral infarction, unspecified
I63.9 [45596216]
1.1e+00
2.2e+00
—
1.0e+50
—
2.3e+00
1.7e+00
cases:0.88%
controls:0.29%
cases:0.57%
controls:0.06%
—
—
cases:0.51%
controls:0.00%
—
—
cases:0.71%
controls:0.07%
cases:1.44%
controls:0.27%
14
46
1569
15786
9
10
1574
15822
—
8
0
1575
15832
—
11
11
1538
15491
20
37
1371
13789
esomeprazole; oral, parenteral
A02BC05 [21600100]
1.2e+00
1.2e+00
1.3e+00
—
1.4e+00
1.2e+00
1.0e+00
cases:16.36%
controls:5.75%
cases:9.03%
controls:2.86%
cases:1.83%
controls:0.53%
—
—
cases:2.47%
controls:0.60%
cases:9.36%
controls:2.95%
cases:16.61%
controls:6.60%
259
911
1324
14921
143
453
1440
15379
29
84
1554
15748
—
39
95
1540
15709
145
458
1404
15044
231
913
1160
12913
Moderate depressive episode with somatic syndrome
F32.11 [2000501981]
2.0e+00
2.0e+00
—
—
—
3.2e+00
2.1e+00
cases:0.88%
controls:0.12%
cases:0.32%
controls:0.04%
—
—
—
—
—
—
cases:0.90%
controls:0.04%
cases:1.80%
controls:0.22%
14
19
1569
15813
5
7
1578
15825
—
—
—
14
6
1535
15496
25
30
1366
13796
Sedation and analgesia
WX002 [2001310758]
9.0e-01
1.0e+00
2.3e+00
—
—
1.8e+00
1.3e+00
cases:3.60%
controls:1.49%
cases:1.14%
controls:0.42%
cases:0.38%
controls:0.04%
—
—
—
—
cases:1.61%
controls:0.28%
cases:4.10%
controls:1.21%
57
236
1526
15596
18
67
1565
15765
6
6
1577
15826
—
—
25
43
1524
15459
57
167
1334
13659
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
9.2e-01
1.1e+00
1.5e+00
—
1.3e+00
1.3e+00
1.2e+00
cases:9.85%
controls:4.16%
cases:6.19%
controls:2.25%
cases:1.64%
controls:0.38%
—
—
cases:1.27%
controls:0.35%
cases:7.36%
controls:2.20%
cases:17.76%
controls:6.00%
156
658
1427
15174
98
356
1485
15476
26
60
1557
15772
—
20
56
1559
15748
114
341
1435
15161
247
830
1144
12996
clopidogrel; oral
B01AC04 [21600989]
9.4e-01
1.1e+00
1.0e+00
—
2.0e+00
1.8e+00
1.3e+00
cases:1.96%
controls:0.77%
cases:1.33%
controls:0.44%
cases:0.38%
controls:0.14%
—
—
cases:0.82%
controls:0.11%
cases:2.19%
controls:0.38%
cases:3.74%
controls:1.01%
31
122
1552
15710
21
69
1562
15763
6
22
1577
15810
—
13
18
1566
15786
34
59
1515
15443
52
139
1339
13687
Mixed personality disorders
F61.0 [2000502024]
1.7e+00
2.1e+00
—
—
—
2.0e+00
1.5e+00
cases:0.82%
controls:0.16%
cases:0.44%
controls:0.06%
—
—
—
—
—
—
cases:0.45%
controls:0.06%
cases:0.65%
controls:0.14%
13
25
1570
15807
7
9
1576
15823
—
—
—
7
10
1542
15492
9
20
1382
13806
montelukast; oral
R03DC03 [21603356]
1.1e+00
1.1e+00
1.3e+00
—
1.2e+00
1.2e+00
1.3e+00
cases:6.38%
controls:2.19%
cases:3.10%
controls:1.09%
cases:0.82%
controls:0.22%
—
—
cases:0.76%
controls:0.23%
cases:3.81%
controls:1.21%
cases:8.20%
controls:2.49%
101
346
1482
15486
49
172
1534
15660
13
35
1570
15797
—
12
36
1567
15768
59
188
1490
15314
114
344
1277
13482
dexketoprofen; oral, parenteral
M01AE17 [21603983]
1.8e+00
—
—
—
—
2.7e+00
2.6e+00
cases:0.44%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.58%
controls:0.04%
cases:1.01%
controls:0.07%
7
12
1576
15820
—
—
—
—
9
6
1540
15496
14
10
1377
13816
Occupational therapy
R4120 [2001310234]
1.5e+00
2.1e+00
—
—
—
2.1e+00
1.4e+00
cases:1.58%
controls:0.37%
cases:1.14%
controls:0.14%
—
—
—
—
—
—
cases:1.29%
controls:0.15%
cases:1.22%
controls:0.30%
25
59
1558
15773
18
22
1565
15810
—
—
—
20
24
1529
15478
17
42
1374
13784
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
1.3e+00
2.3e+00
—
—
—
2.2e+00
1.3e+00
cases:1.39%
controls:0.40%
cases:1.14%
controls:0.11%
—
—
—
—
—
—
cases:0.71%
controls:0.08%
cases:1.94%
controls:0.54%
22
63
1561
15769
18
18
1565
15814
—
—
—
11
12
1538
15490
27
74
1364
13752
Platelets [#/volume] in Blood
26515-7 [3007461]
3.0e-01
5.4e-01
1.1e+00
3.3e+00
9.3e-01
6.4e-01
2.7e-01
cases:35.19%
controls:28.59%
cases:32.41%
controls:21.79%
cases:11.43%
controls:4.23%
cases:5.75%
controls:0.22%
cases:9.82%
controls:4.12%
cases:35.89%
controls:22.76%
cases:50.75%
controls:44.05%
557
4526
1026
11306
513
3450
1070
12382
181
669
1402
15163
91
35
1492
15797
155
651
1424
15153
556
3528
993
11974
706
6091
685
7735
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
1.4e+00
1.6e+00
—
—
—
2.3e+00
1.7e+00
cases:1.64%
controls:0.39%
cases:1.20%
controls:0.23%
—
—
—
—
—
—
cases:1.16%
controls:0.12%
cases:2.37%
controls:0.46%
26
62
1557
15770
19
37
1564
15795
—
—
—
18
18
1531
15484
33
63
1358
13763
12 lead EKG panel
34534-8 [3044889]
6.3e-01
8.8e-01
1.8e+00
—
1.9e+00
1.1e+00
8.1e-01
cases:16.11%
controls:9.32%
cases:11.05%
controls:4.92%
cases:2.97%
controls:0.52%
—
—
cases:3.42%
controls:0.53%
cases:13.04%
controls:4.81%
cases:27.97%
controls:14.73%
255
1475
1328
14357
175
779
1408
15053
47
83
1536
15749
—
54
84
1525
15720
202
746
1347
14756
389
2036
1002
11790
Predominantly allergic asthma
J45.0 [45557624]
1.1e+00
1.3e+00
—
—
2.0e+00
1.4e+00
1.2e+00
cases:2.97%
controls:1.02%
cases:0.95%
controls:0.27%
—
—
—
—
cases:0.38%
controls:0.05%
cases:1.74%
controls:0.42%
cases:3.59%
controls:1.06%
47
161
1536
15671
15
43
1568
15789
—
—
6
8
1573
15796
27
65
1522
15437
50
147
1341
13679
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
3.0e-01
5.5e-01
1.1e+00
3.3e+00
9.2e-01
6.4e-01
2.6e-01
cases:35.19%
controls:28.68%
cases:32.53%
controls:21.85%
cases:11.43%
controls:4.23%
cases:5.75%
controls:0.23%
cases:9.82%
controls:4.14%
cases:36.02%
controls:22.87%
cases:50.90%
controls:44.32%
557
4540
1026
11292
515
3459
1068
12373
181
670
1402
15162
91
36
1492
15796
155
654
1424
15150
558
3546
991
11956
708
6128
683
7698
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
3.0e-01
5.4e-01
1.1e+00
3.3e+00
9.2e-01
6.4e-01
2.6e-01
cases:35.19%
controls:28.68%
cases:32.47%
controls:21.86%
cases:11.43%
controls:4.23%
cases:5.75%
controls:0.23%
cases:9.82%
controls:4.14%
cases:36.02%
controls:22.87%
cases:50.90%
controls:44.33%
557
4540
1026
11292
514
3461
1069
12371
181
670
1402
15162
91
36
1492
15796
155
654
1424
15150
558
3546
991
11956
708
6129
683
7697
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
3.0e-01
5.4e-01
1.1e+00
3.3e+00
9.2e-01
6.4e-01
2.6e-01
cases:35.19%
controls:28.68%
cases:32.47%
controls:21.85%
cases:11.43%
controls:4.23%
cases:5.75%
controls:0.23%
cases:9.82%
controls:4.14%
cases:35.96%
controls:22.85%
cases:50.90%
controls:44.31%
557
4540
1026
11292
514
3460
1069
12372
181
670
1402
15162
91
36
1492
15796
155
654
1424
15150
557
3542
992
11960
708
6126
683
7700
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
3.0e-01
5.4e-01
1.1e+00
3.3e+00
9.2e-01
6.4e-01
2.6e-01
cases:35.19%
controls:28.75%
cases:32.53%
controls:21.89%
cases:11.50%
controls:4.26%
cases:5.75%
controls:0.23%
cases:9.82%
controls:4.14%
cases:36.02%
controls:22.93%
cases:50.90%
controls:44.40%
557
4551
1026
11281
515
3465
1068
12367
182
674
1401
15158
91
36
1492
15796
155
655
1424
15149
558
3555
991
11947
708
6139
683
7687
MCH [Entitic mass]
28539-5 [3035941]
3.0e-01
5.4e-01
1.1e+00
3.3e+00
9.2e-01
6.4e-01
2.6e-01
cases:35.19%
controls:28.64%
cases:32.34%
controls:21.85%
cases:11.37%
controls:4.23%
cases:5.75%
controls:0.23%
cases:9.75%
controls:4.14%
cases:35.89%
controls:22.84%
cases:50.90%
controls:44.30%
557
4534
1026
11298
512
3460
1071
12372
180
669
1403
15163
91
36
1492
15796
154
654
1425
15150
556
3541
993
11961
708
6125
683
7701
Leukocytes [#/volume] in Blood
26464-8 [3010813]
3.0e-01
5.4e-01
1.1e+00
3.3e+00
9.3e-01
6.4e-01
2.6e-01
cases:35.19%
controls:28.76%
cases:32.60%
controls:21.94%
cases:11.50%
controls:4.24%
cases:5.75%
controls:0.23%
cases:9.88%
controls:4.14%
cases:36.09%
controls:22.91%
cases:50.90%
controls:44.34%
557
4553
1026
11279
516
3473
1067
12359
182
672
1401
15160
91
37
1492
15795
156
654
1423
15150
559
3551
990
11951
708
6130
683
7696
Care involving use of rehabilitation procedure, unspecified
Z50.9 [45595525]
1.3e+00
2.1e+00
—
—
—
1.8e+00
1.7e+00
cases:0.82%
controls:0.22%
cases:0.69%
controls:0.08%
—
—
—
—
—
—
cases:0.71%
controls:0.12%
cases:1.80%
controls:0.32%
13
35
1570
15797
11
13
1572
15819
—
—
—
11
19
1538
15483
25
44
1366
13782
Benign neoplasm: Pituitary gland
D35.2 [45581304]
1.6e+00
1.7e+00
—
—
—
2.2e+00
1.5e+00
cases:0.57%
controls:0.12%
cases:0.51%
controls:0.09%
—
—
—
—
—
—
cases:0.77%
controls:0.09%
cases:0.65%
controls:0.14%
9
19
1574
15813
8
14
1575
15818
—
—
—
12
14
1537
15488
9
20
1382
13806
Emergency Room and Inpatient Visit
ERIP [262]
8.6e-01
6.4e-01
1.6e+00
—
1.8e+00
1.1e+00
9.8e-01
cases:5.50%
controls:2.40%
cases:2.72%
controls:1.45%
cases:0.63%
controls:0.13%
—
—
cases:1.08%
controls:0.17%
cases:3.81%
controls:1.34%
cases:11.72%
controls:4.77%
87
380
1496
15452
43
229
1540
15603
10
21
1573
15811
—
17
27
1562
15777
59
208
1490
15294
163
659
1228
13167
Car occupant [any] injured in unspecified traffic accident
V49.9 [45566025]
1.0e+00
1.9e+00
—
—
—
2.3e+00
1.6e+00
cases:0.95%
controls:0.33%
cases:0.44%
controls:0.06%
—
—
—
—
—
—
cases:0.65%
controls:0.06%
cases:1.08%
controls:0.22%
15
53
1568
15779
7
10
1576
15822
—
—
—
10
10
1539
15492
15
30
1376
13796
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
1.2e+00
1.0e+00
2.1e+00
—
—
1.3e+00
1.3e+00
cases:7.58%
controls:2.32%
cases:2.27%
controls:0.85%
cases:0.44%
controls:0.06%
—
—
—
—
cases:2.32%
controls:0.63%
cases:8.27%
controls:2.42%
120
368
1463
15464
36
134
1547
15698
7
9
1576
15823
—
—
36
98
1513
15404
115
335
1276
13491
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
2.4e-01
5.0e-01
1.1e+00
3.3e+00
9.1e-01
5.9e-01
2.5e-01
cases:26.60%
controls:22.18%
cases:23.25%
controls:15.58%
cases:8.09%
controls:2.90%
cases:3.92%
controls:0.15%
cases:6.59%
controls:2.76%
cases:25.56%
controls:15.93%
cases:39.68%
controls:33.94%
421
3512
1162
12320
368
2466
1215
13366
128
459
1455
15373
62
23
1521
15809
104
436
1475
15368
396
2469
1153
13033
552
4693
839
9133
Extensive CT of neck arteries
PA6BD [2001308697]
2.7e+00
—
—
—
—
2.3e+00
1.9e+00
cases:1.33%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.45%
controls:0.05%
cases:0.65%
controls:0.10%
21
14
1562
15818
—
—
—
—
7
7
1542
15495
9
14
1382
13812
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
4.6e-01
7.2e-01
1.1e+00
2.3e+00
1.1e+00
7.0e-01
5.1e-01
cases:26.03%
controls:18.12%
cases:19.58%
controls:10.62%
cases:4.36%
controls:1.48%
cases:0.38%
controls:0.04%
cases:3.80%
controls:1.33%
cases:19.88%
controls:11.00%
cases:39.18%
controls:27.87%
412
2869
1171
12963
310
1681
1273
14151
69
235
1514
15597
6
6
1577
15826
60
210
1519
15594
308
1705
1241
13797
545
3853
846
9973
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
8.2e-01
9.1e-01
1.7e+00
—
1.2e+00
1.1e+00
1.1e+00
cases:9.73%
controls:4.54%
cases:6.19%
controls:2.58%
cases:2.27%
controls:0.40%
—
—
cases:1.46%
controls:0.45%
cases:7.23%
controls:2.48%
cases:16.89%
controls:6.47%
154
718
1429
15114
98
409
1485
15423
36
64
1547
15768
—
23
71
1556
15733
112
384
1437
15118
235
895
1156
12931
Chronic maxillary sinusitis
J32.0 [45586667]
1.7e+00
1.7e+00
—
—
—
1.8e+00
1.7e+00
cases:3.03%
controls:0.59%
cases:0.95%
controls:0.17%
—
—
—
—
—
—
cases:1.42%
controls:0.24%
cases:3.24%
controls:0.62%
48
94
1535
15738
15
27
1568
15805
—
—
—
22
37
1527
15465
45
86
1346
13740
theophylline; oral, parenteral, rectal
R03DA04 [21603332]
1.7e+00
1.7e+00
—
—
—
2.0e+00
1.4e+00
cases:0.95%
controls:0.17%
cases:0.69%
controls:0.13%
—
—
—
—
—
—
cases:0.77%
controls:0.11%
cases:0.79%
controls:0.19%
15
27
1568
15805
11
20
1572
15812
—
—
—
12
17
1537
15485
11
26
1380
13800
platelet aggregation inhibitors excl. heparin - combinations
B01AC30 [21601005]
1.8e+00
1.6e+00
—
—
—
1.6e+00
1.8e+00
cases:0.82%
controls:0.13%
cases:0.69%
controls:0.14%
—
—
—
—
—
—
cases:0.65%
controls:0.14%
cases:1.37%
controls:0.22%
13
21
1570
15811
11
22
1572
15810
—
—
—
10
21
1539
15481
19
31
1372
13795
ECG with 12 standard connections
XF400 [2001303368]
1.4e+00
2.0e+00
—
1.0e+50
—
1.8e+00
1.7e+00
cases:3.10%
controls:0.81%
cases:1.77%
controls:0.25%
—
—
cases:1.01%
controls:0.00%
—
—
cases:1.61%
controls:0.27%
cases:4.17%
controls:0.79%
49
128
1534
15704
28
40
1555
15792
—
16
0
1567
15832
—
25
42
1524
15460
58
109
1333
13717
bisoprolol; oral
C07AB07 [21601689]
9.5e-01
7.9e-01
6.5e-01
2.1e+00
7.6e-01
7.1e-01
8.9e-01
cases:16.36%
controls:7.02%
cases:12.63%
controls:6.18%
cases:3.35%
controls:1.77%
cases:0.44%
controls:0.06%
cases:3.61%
controls:1.73%
cases:12.40%
controls:6.50%
cases:20.49%
controls:9.54%
259
1111
1324
14721
200
978
1383
14854
53
281
1530
15551
7
9
1576
15823
57
273
1522
15531
192
1008
1357
14494
285
1319
1106
12507
acetylsalicylic acid, combinations excl. psycholeptics
N02BA51 [21604320]
1.8e+00
1.6e+00
—
—
—
1.6e+00
1.8e+00
cases:0.82%
controls:0.14%
cases:0.69%
controls:0.14%
—
—
—
—
—
—
cases:0.65%
controls:0.14%
cases:1.37%
controls:0.22%
13
22
1570
15810
11
22
1572
15810
—
—
—
10
21
1539
15481
19
31
1372
13795
Persistent somatoform pain disorder
F45.4 [45605498]
3.7e+00
—
—
—
1.0e+50
—
3.1e+00
cases:1.71%
controls:0.04%
—
—
—
—
—
—
cases:0.32%
controls:0.00%
—
—
cases:1.44%
controls:0.07%
27
7
1556
15825
—
—
—
5
0
1574
15804
—
20
9
1371
13817
Other psychiatric treatment contact
IGY99 [2001304323]
—
2.3e+00
—
—
—
2.4e+00
2.0e+00
—
—
cases:0.38%
controls:0.04%
—
—
—
—
—
—
cases:0.58%
controls:0.05%
cases:1.15%
controls:0.15%
—
6
6
1577
15826
—
—
—
9
8
1540
15494
16
21
1375
13805
Other specified extrapyramidal and movement disorders
G25.8 [45542878]
1.7e+00
2.9e+00
—
—
—
—
2.1e+00
cases:0.51%
controls:0.09%
cases:0.69%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.86%
controls:0.11%
8
14
1575
15818
11
6
1572
15826
—
—
—
—
12
15
1379
13811
azithromycin; oral, parenteral
J01FA10 [21602978]
7.1e-01
9.8e-01
1.8e+00
—
1.5e+00
9.9e-01
8.3e-01
cases:17.88%
controls:9.66%
cases:6.00%
controls:2.34%
cases:1.01%
controls:0.18%
—
—
cases:0.82%
controls:0.19%
cases:5.68%
controls:2.19%
cases:15.53%
controls:7.41%
283
1530
1300
14302
95
370
1488
15462
16
28
1567
15804
—
13
30
1566
15774
88
339
1461
15163
216
1025
1175
12801
Thorax X-ray examination
GD1AA [2001303617]
1.2e+00
1.0e+00
1.2e+00
1.0e+50
1.9e+00
1.4e+00
1.2e+00
cases:11.31%
controls:3.80%
cases:3.92%
controls:1.42%
cases:0.69%
controls:0.20%
cases:1.07%
controls:0.00%
cases:0.95%
controls:0.14%
cases:5.68%
controls:1.43%
cases:13.23%
controls:4.59%
179
602
1404
15230
62
225
1521
15607
11
32
1572
15800
17
0
1566
15832
15
22
1564
15782
88
221
1461
15281
184
634
1207
13192
Tachycardia, unspecified
R00.0 [45606790]
1.4e+00
2.3e+00
—
—
—
1.8e+00
1.2e+00
cases:1.07%
controls:0.26%
cases:0.51%
controls:0.05%
—
—
—
—
—
—
cases:0.52%
controls:0.08%
cases:0.93%
controls:0.30%
17
41
1566
15791
8
8
1575
15824
—
—
—
8
13
1541
15489
13
41
1378
13785
Pain localized to other parts of lower abdomen
R10.3 [45534426]
1.1e+00
1.2e+00
1.7e+00
—
—
1.5e+00
1.3e+00
cases:8.46%
controls:3.01%
cases:3.03%
controls:0.97%
cases:0.57%
controls:0.11%
—
—
—
—
cases:3.62%
controls:0.81%
cases:10.42%
controls:3.22%
134
477
1449
15355
48
154
1535
15678
9
17
1574
15815
—
—
56
126
1493
15376
145
445
1246
13381
FEV1/FVC
19926-5 [3011505]
1.4e+00
1.3e+00
—
—
—
1.6e+00
2.3e+00
cases:3.85%
controls:0.95%
cases:0.95%
controls:0.25%
—
—
—
—
—
—
cases:1.10%
controls:0.21%
cases:4.96%
controls:0.54%
61
151
1522
15681
15
40
1568
15792
—
—
—
17
33
1532
15469
69
74
1322
13752
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
1.4e+00
1.3e+00
—
—
—
1.6e+00
2.3e+00
cases:3.85%
controls:0.95%
cases:0.95%
controls:0.25%
—
—
—
—
—
—
cases:1.10%
controls:0.21%
cases:4.96%
controls:0.54%
61
151
1522
15681
15
40
1568
15792
—
—
—
17
33
1532
15469
69
74
1322
13752
FEV1
20150-9 [3024653]
1.4e+00
1.3e+00
—
—
—
1.6e+00
2.3e+00
cases:3.85%
controls:0.95%
cases:0.95%
controls:0.25%
—
—
—
—
—
—
cases:1.10%
controls:0.21%
cases:4.96%
controls:0.54%
61
151
1522
15681
15
40
1568
15792
—
—
—
17
33
1532
15469
69
74
1322
13752
Telephone, letter or other consultation without direct patient contact
ZY020 [2001311600]
1.1e+00
2.0e+00
—
—
—
2.1e+00
1.5e+00
cases:1.45%
controls:0.47%
cases:0.82%
controls:0.11%
—
—
—
—
—
—
cases:0.77%
controls:0.10%
cases:1.80%
controls:0.43%
23
74
1560
15758
13
18
1570
15814
—
—
—
12
15
1537
15487
25
59
1366
13767
Outpatient Hospital
22 [8756]
7.9e-01
7.7e-01
1.4e+00
—
1.7e+00
1.1e+00
9.4e-01
cases:33.80%
controls:18.78%
cases:10.68%
controls:5.26%
cases:2.15%
controls:0.56%
—
—
cases:2.53%
controls:0.49%
cases:12.85%
controls:4.50%
cases:28.68%
controls:13.55%
535
2973
1048
12859
169
832
1414
15000
34
88
1549
15744
—
40
78
1539
15726
199
698
1350
14804
399
1874
992
11952
Chest pain NOS
A11 [2002000152]
1.8e+00
1.7e+00
—
—
—
1.5e+00
1.7e+00
cases:2.08%
controls:0.35%
cases:0.51%
controls:0.09%
—
—
—
—
—
—
cases:0.71%
controls:0.15%
cases:3.02%
controls:0.59%
33
56
1550
15776
8
15
1575
15817
—
—
—
11
24
1538
15478
42
81
1349
13745
Cerebral aneurysm, nonruptured
I67.1 [45538401]
1.8e+00
—
—
—
—
2.5e+00
2.4e+00
cases:0.88%
controls:0.15%
—
—
—
—
—
—
—
—
cases:0.84%
controls:0.07%
cases:1.15%
controls:0.11%
14
23
1569
15809
—
—
—
—
13
11
1536
15491
16
15
1375
13811
Case Management Agency
251B00000X [38004193]
2.4e-01
4.1e-01
9.2e-01
3.6e+00
8.4e-01
4.0e-01
2.3e-01
cases:59.51%
controls:53.52%
cases:56.60%
controls:46.51%
cases:34.05%
controls:17.05%
cases:29.25%
controls:1.15%
cases:32.49%
controls:17.15%
cases:59.20%
controls:49.26%
cases:74.41%
controls:69.75%
942
8473
641
7359
896
7363
687
8469
539
2699
1044
13133
463
182
1120
15650
513
2710
1066
13094
917
7637
632
7865
1035
9643
356
4183
alprazolam; oral
N05BA12 [21604577]
1.3e+00
1.1e+00
1.1e+00
—
1.8e+00
1.1e+00
1.3e+00
cases:3.41%
controls:0.94%
cases:1.83%
controls:0.60%
cases:0.57%
controls:0.19%
—
—
cases:0.89%
controls:0.15%
cases:1.61%
controls:0.55%
cases:3.24%
controls:0.93%
54
149
1529
15683
29
95
1554
15737
9
30
1574
15802
—
14
23
1565
15781
25
85
1524
15417
45
129
1346
13697
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
8.2e-01
9.8e-01
1.3e+00
—
1.2e+00
1.2e+00
1.1e+00
cases:10.17%
controls:4.75%
cases:6.70%
controls:2.63%
cases:1.58%
controls:0.43%
—
—
cases:1.33%
controls:0.42%
cases:8.59%
controls:2.65%
cases:18.91%
controls:7.22%
161
752
1422
15080
106
416
1477
15416
25
68
1558
15764
—
21
67
1558
15737
133
411
1416
15091
263
998
1128
12828
Anxiety disorder, unspecified
F41.9 [45542849]
9.0e-01
1.6e+00
1.3e+00
—
1.7e+00
1.5e+00
9.7e-01
cases:2.84%
controls:1.18%
cases:2.40%
controls:0.51%
cases:0.44%
controls:0.12%
—
—
cases:0.51%
controls:0.09%
cases:2.71%
controls:0.63%
cases:4.53%
controls:1.77%
45
187
1538
15645
38
81
1545
15751
7
19
1576
15813
—
8
15
1571
15789
42
98
1507
15404
63
245
1328
13581
Upper gastrointestinal surgery
106 [44777669]
8.2e-01
8.7e-01
1.2e+00
—
1.2e+00
1.4e+00
1.1e+00
cases:12.32%
controls:5.83%
cases:5.50%
controls:2.37%
cases:1.01%
controls:0.31%
—
—
cases:1.08%
controls:0.33%
cases:7.55%
controls:2.01%
cases:17.18%
controls:6.44%
195
923
1388
14909
87
375
1496
15457
16
49
1567
15783
—
17
52
1562
15752
117
312
1432
15190
239
890
1152
12936
Child and Adolescent Psychiatry
OMOP4821986 [45756756]
1.3e+00
1.5e+00
—
—
—
2.3e+00
1.4e+00
cases:1.45%
controls:0.39%
cases:0.57%
controls:0.13%
—
—
—
—
—
—
cases:0.71%
controls:0.07%
cases:1.22%
controls:0.30%
23
62
1560
15770
9
20
1574
15812
—
—
—
11
11
1538
15491
17
42
1374
13784
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
6.0e-01
8.9e-01
1.5e+00
—
1.8e+00
1.1e+00
5.8e-01
cases:2.84%
controls:1.57%
cases:1.90%
controls:0.79%
cases:0.69%
controls:0.15%
—
—
cases:0.63%
controls:0.10%
cases:1.94%
controls:0.66%
cases:3.74%
controls:2.13%
45
249
1538
15583
30
125
1553
15707
11
24
1572
15808
—
10
16
1569
15788
30
103
1519
15399
52
294
1339
13532
Inpatient Hospital
21 [8717]
7.7e-01
7.1e-01
1.4e+00
—
1.7e+00
1.0e+00
8.9e-01
cases:42.26%
controls:25.28%
cases:14.53%
controls:7.70%
cases:3.35%
controls:0.86%
—
—
cases:4.50%
controls:0.82%
cases:16.07%
controls:6.56%
cases:35.66%
controls:18.57%
669
4002
914
11830
230
1219
1353
14613
53
136
1530
15696
—
71
130
1508
15674
249
1017
1300
14485
496
2568
895
11258
Lactate [Moles/volume] in Arterial blood
2518-9 [3018405]
1.5e+00
2.6e+00
—
—
—
2.4e+00
1.0e+00
cases:0.82%
controls:0.19%
cases:0.51%
controls:0.04%
—
—
—
—
—
—
cases:0.58%
controls:0.05%
cases:0.79%
controls:0.28%
13
30
1570
15802
8
6
1575
15826
—
—
—
9
8
1540
15494
11
39
1380
13787
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
8.9e-01
9.6e-01
1.2e+00
—
1.4e+00
1.0e+00
1.0e+00
cases:9.10%
controls:3.95%
cases:4.93%
controls:1.95%
cases:1.01%
controls:0.30%
—
—
cases:1.01%
controls:0.26%
cases:4.84%
controls:1.77%
cases:13.44%
controls:5.35%
144
626
1439
15206
78
308
1505
15524
16
48
1567
15784
—
16
41
1563
15763
75
275
1474
15227
187
739
1204
13087
zopiclone; oral
N05CF01 [21604654]
1.1e+00
1.0e+00
9.3e-01
—
1.3e+00
1.1e+00
1.0e+00
cases:11.75%
controls:4.34%
cases:6.95%
controls:2.56%
cases:1.64%
controls:0.66%
—
—
cases:2.85%
controls:0.76%
cases:7.30%
controls:2.64%
cases:13.87%
controls:5.56%
186
687
1397
15145
110
405
1473
15427
26
104
1557
15728
—
45
120
1534
15684
113
410
1436
15092
193
769
1198
13057
Implantation of spinal stimulation device
ABD30 [2001300488]
2.9e+00
—
—
—
—
—
3.6e+00
cases:0.57%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
cases:1.51%
controls:0.04%
9
5
1574
15827
—
—
—
—
—
21
6
1370
13820
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
8.7e-01
9.5e-01
1.2e+00
—
1.4e+00
9.6e-01
1.1e+00
cases:7.52%
controls:3.30%
cases:4.23%
controls:1.67%
cases:0.88%
controls:0.28%
—
—
cases:0.89%
controls:0.22%
cases:4.13%
controls:1.63%
cases:12.44%
controls:4.69%
119
522
1464
15310
67
265
1516
15567
14
44
1569
15788
—
14
35
1565
15769
64
252
1485
15250
173
648
1218
13178
Very extensive MRI examination of brain with high intensity magnet
AA1DG [2001300120]
2.0e+00
2.2e+00
—
1.0e+50
—
—
2.2e+00
cases:0.95%
controls:0.13%
cases:0.76%
controls:0.09%
—
—
cases:0.32%
controls:0.00%
—
—
—
—
cases:1.08%
controls:0.12%
15
20
1568
15812
12
14
1571
15818
—
5
0
1578
15832
—
—
15
17
1376
13809
Lumbar spine MRI examination with high intensity magnet
NA3BG [2001307034]
1.6e+00
1.6e+00
—
—
—
1.3e+00
1.8e+00
cases:3.16%
controls:0.65%
cases:1.33%
controls:0.28%
—
—
—
—
—
—
cases:0.84%
controls:0.22%
cases:4.17%
controls:0.68%
50
103
1533
15729
21
45
1562
15787
—
—
—
13
34
1536
15468
58
94
1333
13732
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
9.1e-01
1.0e+00
2.5e+00
—
—
1.0e+00
9.2e-01
cases:5.94%
controls:2.49%
cases:3.10%
controls:1.12%
cases:1.33%
controls:0.11%
—
—
—
—
cases:3.55%
controls:1.33%
cases:8.91%
controls:3.77%
94
394
1489
15438
49
177
1534
15655
21
18
1562
15814
—
—
55
206
1494
15296
124
521
1267
13305
Special examination, unspecified
Z01.9 [45576123]
1.5e+00
1.6e+00
—
—
—
1.9e+00
1.3e+00
cases:1.26%
controls:0.28%
cases:0.51%
controls:0.10%
—
—
—
—
—
—
cases:0.58%
controls:0.09%
cases:1.15%
controls:0.30%
20
45
1563
15787
8
16
1575
15816
—
—
—
9
14
1540
15488
16
42
1375
13784
Sequelae of cerebral infarction
I69.3 [45533476]
—
2.3e+00
—
1.0e+50
—
2.3e+00
1.7e+00
—
—
cases:0.82%
controls:0.08%
—
—
cases:0.32%
controls:0.00%
—
—
cases:1.16%
controls:0.12%
cases:1.37%
controls:0.25%
—
13
13
1570
15819
—
5
0
1578
15832
—
18
18
1531
15484
19
35
1372
13791
Cervical spine CT examination
NA1AD [2001306982]
2.0e+00
—
—
—
—
2.3e+00
2.0e+00
cases:1.45%
controls:0.20%
—
—
—
—
—
—
—
—
cases:0.45%
controls:0.05%
cases:1.29%
controls:0.17%
23
32
1560
15800
—
—
—
—
7
7
1542
15495
18
24
1373
13802
Pain localized to upper abdomen
R10.1 [45568111]
1.2e+00
1.9e+00
—
—
—
1.7e+00
1.5e+00
cases:4.86%
controls:1.45%
cases:2.53%
controls:0.39%
—
—
—
—
—
—
cases:2.65%
controls:0.50%
cases:6.61%
controls:1.63%
77
229
1506
15603
40
61
1543
15771
—
—
—
41
77
1508
15425
92
225
1299
13601
Abdominal pain/cramps general
D01 [2002000300]
1.3e+00
1.8e+00
1.8e+00
—
—
1.9e+00
1.3e+00
cases:3.35%
controls:0.97%
cases:1.64%
controls:0.28%
cases:0.32%
controls:0.05%
—
—
—
—
cases:1.48%
controls:0.23%
cases:3.74%
controls:1.01%
53
153
1530
15679
26
45
1557
15787
5
8
1578
15824
—
—
23
36
1526
15466
52
139
1339
13687
Potassium [Moles/volume] in Arterial blood
32713-0 [3043409]
1.6e+00
2.5e+00
—
—
—
2.2e+00
1.1e+00
cases:0.82%
controls:0.17%
cases:0.44%
controls:0.04%
—
—
—
—
—
—
cases:0.45%
controls:0.05%
cases:0.79%
controls:0.26%
13
27
1570
15805
7
6
1576
15826
—
—
—
7
8
1542
15494
11
36
1380
13790
oxcarbazepine; oral
N03AF02 [21604418]
3.5e+00
—
1.0e+50
—
—
—
2.7e+00
cases:1.64%
controls:0.05%
—
—
cases:0.38%
controls:0.00%
—
—
—
—
—
—
cases:1.37%
controls:0.09%
26
8
1557
15824
—
6
0
1577
15832
—
—
—
19
13
1372
13813
Other somatoform disorders
F45.8 [45600750]
1.4e+00
1.6e+00
—
—
—
1.8e+00
1.4e+00
cases:3.10%
controls:0.82%
cases:1.20%
controls:0.25%
—
—
—
—
—
—
cases:1.10%
controls:0.19%
cases:3.38%
controls:0.82%
49
130
1534
15702
19
39
1564
15793
—
—
—
17
29
1532
15473
47
113
1344
13713
Pain in thoracic spine
M54.6 [45606247]
1.5e+00
1.8e+00
—
—
—
1.6e+00
1.2e+00
cases:1.77%
controls:0.40%
cases:1.07%
controls:0.17%
—
—
—
—
—
—
cases:0.84%
controls:0.17%
cases:2.59%
controls:0.78%
28
63
1555
15769
17
27
1566
15805
—
—
—
13
27
1536
15475
36
108
1355
13718
Post-traumatic stress disorder
F43.1 [45595909]
1.1e+00
1.3e+00
—
1.0e+50
—
1.8e+00
1.9e+00
cases:0.88%
controls:0.28%
cases:0.76%
controls:0.21%
—
—
cases:0.32%
controls:0.00%
—
—
cases:1.16%
controls:0.19%
cases:2.30%
controls:0.36%
14
45
1569
15787
12
33
1571
15799
—
5
0
1578
15832
—
18
29
1531
15473
32
50
1359
13776
3-Methoxytyramine [Moles/volume] in Serum or Plasma
50140-3 [3030408]
1.5e+00
1.5e+00
—
—
—
2.5e+00
2.1e+00
cases:0.63%
controls:0.14%
cases:0.38%
controls:0.09%
—
—
—
—
—
—
cases:0.39%
controls:0.03%
cases:1.15%
controls:0.14%
10
22
1573
15810
6
14
1577
15818
—
—
—
6
5
1543
15497
16
19
1375
13807
diclofenac; oral, parenteral, rectal
M01AB05 [21603945]
9.5e-01
1.0e+00
1.4e+00
—
1.2e+00
7.9e-01
8.1e-01
cases:30.26%
controls:14.33%
cases:10.68%
controls:4.21%
cases:2.27%
controls:0.57%
—
—
cases:1.58%
controls:0.50%
cases:9.55%
controls:4.57%
cases:26.10%
controls:13.59%
479
2269
1104
13563
169
666
1414
15166
36
90
1547
15742
—
25
79
1554
15725
148
709
1401
14793
363
1879
1028
11947
Stomatognathic treatment, demanding
SHA03 [2001310407]
1.3e+00
1.8e+00
—
—
—
2.5e+00
2.3e+00
cases:1.07%
controls:0.29%
cases:0.38%
controls:0.06%
—
—
—
—
—
—
cases:0.77%
controls:0.06%
cases:2.44%
controls:0.25%
17
46
1566
15786
6
10
1577
15822
—
—
—
12
10
1537
15492
34
35
1357
13791
Spinal stenosis
M48.0 [45557888]
1.6e+00
1.6e+00
1.8e+00
—
—
1.4e+00
1.4e+00
cases:2.08%
controls:0.45%
cases:1.14%
controls:0.22%
cases:0.32%
controls:0.05%
—
—
—
—
cases:0.77%
controls:0.19%
cases:3.24%
controls:0.78%
33
71
1550
15761
18
35
1565
15797
5
8
1578
15824
—
—
12
29
1537
15473
45
108
1346
13718
Irritable bowel syndrome with diarrhoea
K58.0 [45596336]
1.1e+00
1.6e+00
—
—
—
1.9e+00
1.4e+00
cases:1.14%
controls:0.37%
cases:0.82%
controls:0.16%
—
—
—
—
—
—
cases:1.16%
controls:0.17%
cases:1.65%
controls:0.43%
18
58
1565
15774
13
26
1570
15806
—
—
—
18
26
1531
15476
23
59
1368
13767
Pain, unspecified
R52.9 [45544151]
1.3e+00
1.7e+00
—
—
—
1.9e+00
1.1e+00
cases:1.77%
controls:0.49%
cases:1.26%
controls:0.23%
—
—
—
—
—
—
cases:1.36%
controls:0.20%
cases:2.66%
controls:0.89%
28
77
1555
15755
20
36
1563
15796
—
—
—
21
31
1528
15471
37
123
1354
13703
Electrocardiogram with exercise test
46136006 [4261794]
1.2e+00
1.5e+00
—
—
—
2.1e+00
1.3e+00
cases:2.02%
controls:0.64%
cases:0.69%
controls:0.16%
—
—
—
—
—
—
cases:0.52%
controls:0.06%
cases:2.44%
controls:0.67%
32
101
1551
15731
11
25
1572
15807
—
—
—
8
10
1541
15492
34
92
1357
13734
Endometriosis of pelvic peritoneum
N80.3 [45606506]
1.1e+00
1.6e+00
—
—
—
1.7e+00
1.7e+00
cases:1.01%
controls:0.35%
cases:0.51%
controls:0.10%
—
—
—
—
—
—
cases:0.52%
controls:0.10%
cases:1.22%
controls:0.22%
16
56
1567
15776
8
16
1575
15816
—
—
—
8
15
1541
15487
17
31
1374
13795
Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7817-0 [3016888]
1.3e+00
2.0e+00
—
—
—
1.5e+00
1.2e+00
cases:2.40%
controls:0.66%
cases:1.83%
controls:0.24%
—
—
—
—
—
—
cases:1.16%
controls:0.27%
cases:2.80%
controls:0.84%
38
104
1545
15728
29
38
1554
15794
—
—
—
18
42
1531
15460
39
116
1352
13710
lansoprazole; oral
A02BC03 [21600098]
1.1e+00
1.1e+00
1.0e+00
—
1.5e+00
1.2e+00
1.1e+00
cases:9.10%
controls:3.12%
cases:3.92%
controls:1.36%
cases:0.69%
controls:0.25%
—
—
cases:1.01%
controls:0.22%
cases:4.13%
controls:1.34%
cases:9.06%
controls:3.12%
144
494
1439
15338
62
216
1521
15616
11
39
1572
15793
—
16
35
1563
15769
64
208
1485
15294
126
431
1265
13395
CT of paranasal sinuses and face area
DM1AD [2001301741]
1.5e+00
—
—
—
—
2.0e+00
2.5e+00
cases:0.95%
controls:0.21%
—
—
—
—
—
—
—
—
cases:0.58%
controls:0.08%
cases:1.87%
controls:0.16%
15
33
1568
15799
—
—
—
—
9
12
1540
15490
26
22
1365
13804
Other specified intervertebral disc degeneration
M51.3 [45591865]
1.3e+00
1.4e+00
—
—
—
1.6e+00
1.7e+00
cases:2.46%
controls:0.69%
cases:1.14%
controls:0.27%
—
—
—
—
—
—
cases:0.90%
controls:0.18%
cases:3.74%
controls:0.73%
39
110
1544
15722
18
43
1565
15789
—
—
—
14
28
1535
15474
52
101
1339
13725
Person consulting for explanation of investigation findings
Z71.2 [45552100]
8.5e-01
1.2e+00
1.3e+00
—
1.7e+00
1.3e+00
1.0e+00
cases:6.63%
controls:2.94%
cases:3.79%
controls:1.23%
cases:0.38%
controls:0.11%
—
—
cases:0.63%
controls:0.11%
cases:4.39%
controls:1.27%
cases:11.07%
controls:4.35%
105
465
1478
15367
60
195
1523
15637
6
17
1577
15815
—
10
18
1569
15786
68
197
1481
15305
154
602
1237
13224
Other cervical disc degeneration
M50.3 [45582167]
2.0e+00
—
—
—
—
2.3e+00
1.7e+00
cases:0.82%
controls:0.11%
—
—
—
—
—
—
—
—
cases:0.39%
controls:0.04%
cases:0.58%
controls:0.11%
13
18
1570
15814
—
—
—
—
6
6
1543
15496
8
15
1383
13811
Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
56764-4 [40759883]
1.7e+00
—
—
—
—
2.3e+00
2.0e+00
cases:0.57%
controls:0.11%
—
—
—
—
—
—
—
—
cases:0.45%
controls:0.05%
cases:0.58%
controls:0.08%
9
17
1574
15815
—
—
—
—
7
7
1542
15495
8
11
1383
13815
EKG study
11524-6 [3013512]
8.1e-01
5.7e-01
1.5e+00
—
2.0e+00
9.7e-01
6.7e-01
cases:5.94%
controls:2.74%
cases:2.53%
controls:1.45%
cases:0.63%
controls:0.14%
—
—
cases:0.82%
controls:0.11%
cases:3.87%
controls:1.50%
cases:9.13%
controls:4.90%
94
434
1489
15398
40
229
1543
15603
10
22
1573
15810
—
13
18
1566
15786
60
233
1489
15269
127
678
1264
13148
Ambulatory ECG
XF404 [2001303370]
1.1e+00
1.8e+00
—
—
—
1.7e+00
1.4e+00
cases:1.58%
controls:0.54%
cases:0.63%
controls:0.11%
—
—
—
—
—
—
cases:0.52%
controls:0.10%
cases:2.01%
controls:0.51%
25
85
1558
15747
10
17
1573
15815
—
—
—
8
15
1541
15487
28
70
1363
13756
Paraesthesia of skin
R20.2 [45568120]
1.3e+00
1.7e+00
—
1.0e+50
—
1.9e+00
1.0e+00
cases:1.90%
controls:0.51%
cases:0.88%
controls:0.17%
—
—
cases:0.38%
controls:0.00%
—
—
cases:1.23%
controls:0.19%
cases:1.87%
controls:0.67%
30
81
1553
15751
14
27
1569
15805
—
6
0
1577
15832
—
19
29
1530
15473
26
93
1365
13733
Remote contact by phone
ZYC01 [2001311579]
3.1e-01
1.2e+00
3.0e+00
—
—
1.6e+00
1.3e+00
cases:0.57%
controls:0.42%
cases:0.69%
controls:0.21%
cases:0.63%
controls:0.03%
—
—
—
—
cases:1.16%
controls:0.23%
cases:1.87%
controls:0.53%
9
66
1574
15766
11
33
1572
15799
10
5
1573
15827
—
—
18
36
1531
15466
26
73
1365
13753
salmeterol and fluticasone
R03AK06 [21603280]
1.1e+00
1.2e+00
1.1e+00
—
8.6e-01
1.2e+00
1.2e+00
cases:4.36%
controls:1.54%
cases:3.16%
controls:0.93%
cases:0.95%
controls:0.30%
—
—
cases:0.76%
controls:0.32%
cases:3.23%
controls:0.99%
cases:5.75%
controls:1.76%
69
244
1514
15588
50
147
1533
15685
15
48
1568
15784
—
12
51
1567
15753
50
153
1499
15349
80
243
1311
13583
Respiratory and circulatory monitoring
WX700 [2001310817]
1.0e+00
1.4e+00
2.3e+00
—
—
2.0e+00
1.4e+00
cases:3.41%
controls:1.24%
cases:1.71%
controls:0.42%
cases:0.32%
controls:0.03%
—
—
—
—
cases:1.68%
controls:0.22%
cases:4.74%
controls:1.24%
54
197
1529
15635
27
66
1556
15766
5
5
1578
15827
—
—
26
34
1523
15468
66
171
1325
13655
Implementation of physical therapy rehabilitation plan
SPAT1223 [2001700324]
1.0e+00
1.0e+00
1.4e+00
—
1.9e+00
1.1e+00
8.9e-01
cases:6.25%
controls:2.35%
cases:2.08%
controls:0.76%
cases:0.51%
controls:0.12%
—
—
cases:0.70%
controls:0.11%
cases:2.13%
controls:0.75%
cases:6.25%
controls:2.65%
99
372
1484
15460
33
120
1550
15712
8
19
1575
15813
—
11
17
1568
15787
33
116
1516
15386
87
367
1304
13459
doxylamine; oral
R06AA09 [21603453]
1.1e+00
2.1e+00
—
—
—
2.2e+00
1.6e+00
cases:0.57%
controls:0.18%
cases:0.44%
controls:0.06%
—
—
—
—
—
—
cases:0.71%
controls:0.08%
cases:1.15%
controls:0.24%
9
29
1574
15803
7
9
1576
15823
—
—
—
11
12
1538
15490
16
33
1375
13793
Lumbar spine X-ray examination without contrast
NA3AA [2001307026]
1.6e+00
8.8e-01
—
—
—
2.0e+00
2.2e+00
cases:2.46%
controls:0.51%
cases:0.38%
controls:0.16%
—
—
—
—
—
—
cases:0.84%
controls:0.11%
cases:3.45%
controls:0.39%
39
80
1544
15752
6
25
1577
15807
—
—
—
13
17
1536
15485
48
54
1343
13772
prochlorperazine; oral, parenteral, rectal
N05AB04 [21604503]
2.8e+00
—
—
—
—
—
3.1e+00
cases:2.15%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
cases:1.73%
controls:0.08%
34
22
1549
15810
—
—
—
—
—
24
11
1367
13815
Leukocytes [#/volume] in Urine
30405-5 [3018095]
8.1e-01
8.4e-01
1.0e+00
—
1.2e+00
9.3e-01
9.8e-01
cases:8.34%
controls:3.88%
cases:4.86%
controls:2.16%
cases:0.95%
controls:0.33%
—
—
cases:1.01%
controls:0.30%
cases:5.29%
controls:2.16%
cases:14.81%
controls:6.10%
132
614
1451
15218
77
342
1506
15490
15
53
1568
15779
—
16
48
1563
15756
82
335
1467
15167
206
843
1185
12983
Orthopedic Surgery
20 [38004465]
8.9e-01
9.1e-01
1.2e+00
—
1.1e+00
9.3e-01
8.2e-01
cases:20.97%
controls:9.79%
cases:8.65%
controls:3.69%
cases:1.64%
controls:0.51%
—
—
cases:1.71%
controls:0.59%
cases:8.91%
controls:3.70%
cases:24.30%
controls:12.35%
332
1550
1251
14282
137
584
1446
15248
26
81
1557
15751
—
27
93
1552
15711
138
574
1411
14928
338
1708
1053
12118
Chest pain, unspecified
R07.4 [45558450]
1.4e+00
1.2e+00
1.5e+00
—
—
1.8e+00
1.4e+00
cases:7.26%
controls:1.88%
cases:2.15%
controls:0.67%
cases:0.38%
controls:0.08%
—
—
—
—
cases:3.49%
controls:0.59%
cases:10.86%
controls:2.86%
115
298
1468
15534
34
106
1549
15726
6
13
1577
15819
—
—
54
92
1495
15410
151
395
1240
13431
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 [3034780]
1.1e+00
1.5e+00
—
—
—
2.0e+00
1.2e+00
cases:1.52%
controls:0.51%
cases:0.95%
controls:0.21%
—
—
—
—
—
—
cases:0.90%
controls:0.12%
cases:1.44%
controls:0.45%
24
81
1559
15751
15
33
1568
15799
—
—
—
14
19
1535
15483
20
62
1371
13764
Stomatognathic treatment, basic
SHA02 [2001310406]
1.4e+00
1.2e+00
—
—
—
1.9e+00
1.3e+00
cases:2.84%
controls:0.74%
cases:0.76%
controls:0.23%
—
—
—
—
—
—
cases:1.29%
controls:0.19%
cases:3.02%
controls:0.85%
45
117
1538
15715
12
36
1571
15796
—
—
—
20
30
1529
15472
42
118
1349
13708
Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
22126-7 [3010380]
1.6e+00
—
—
—
—
2.0e+00
2.1e+00
cases:0.51%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.39%
controls:0.05%
cases:0.79%
controls:0.09%
8
16
1575
15816
—
—
—
—
6
8
1543
15494
11
13
1380
13813
mirtazapine; oral
N06AX11 [21604740]
1.1e+00
8.3e-01
1.2e-01
—
1.6e+00
1.2e+00
1.1e+00
cases:11.24%
controls:4.15%
cases:4.86%
controls:2.17%
cases:0.69%
controls:0.62%
—
—
cases:2.03%
controls:0.42%
cases:7.10%
controls:2.25%
cases:14.45%
controls:5.55%
178
657
1405
15175
77
344
1506
15488
11
98
1572
15734
—
32
66
1547
15738
110
349
1439
15153
201
767
1190
13059
oxycodone and naloxone; oral
N02AA55 [21604265]
1.5e+00
1.1e+00
1.8e+00
—
—
1.8e+00
1.4e+00
cases:2.84%
controls:0.68%
cases:1.07%
controls:0.35%
cases:0.32%
controls:0.05%
—
—
—
—
cases:1.81%
controls:0.31%
cases:5.32%
controls:1.41%
45
107
1538
15725
17
55
1566
15777
5
8
1578
15824
—
—
28
48
1521
15454
74
195
1317
13631
doxycycline; oral, parenteral
J01AA02 [21602800]
8.6e-01
8.8e-01
1.2e+00
—
1.1e+00
8.1e-01
9.1e-01
cases:31.78%
controls:16.49%
cases:10.11%
controls:4.46%
cases:1.64%
controls:0.51%
—
—
cases:1.33%
controls:0.46%
cases:9.75%
controls:4.57%
cases:29.69%
controls:14.50%
503
2611
1080
13221
160
706
1423
15126
26
80
1557
15752
—
21
72
1558
15732
151
708
1398
14794
413
2005
978
11821
Obesity due to excess calories
E66.01 [2000501501]
6.5e-01
8.7e-01
—
1.0e+50
2.6e+00
1.7e+00
1.4e+00
cases:1.58%
controls:0.83%
cases:0.95%
controls:0.40%
—
—
cases:1.20%
controls:0.00%
cases:0.70%
controls:0.05%
cases:1.94%
controls:0.35%
cases:3.88%
controls:1.01%
25
131
1558
15701
15
63
1568
15769
—
19
0
1564
15832
11
8
1568
15796
30
54
1519
15448
54
140
1337
13686
Observation for other suspected diseases and conditions
Z03.80 [2000503756]
1.8e+00
1.5e+00
—
—
—
2.2e+00
1.7e+00
cases:1.01%
controls:0.16%
cases:0.44%
controls:0.10%
—
—
—
—
—
—
cases:0.45%
controls:0.05%
cases:1.22%
controls:0.22%
16
26
1567
15806
7
16
1576
15816
—
—
—
7
8
1542
15494
17
31
1374
13795
Cervicocranial syndrome
M53.0 [45562750]
1.4e+00
1.6e+00
—
—
—
1.6e+00
1.1e+00
cases:2.65%
controls:0.67%
cases:1.07%
controls:0.23%
—
—
—
—
—
—
cases:1.16%
controls:0.25%
cases:2.80%
controls:0.92%
42
106
1541
15726
17
36
1566
15796
—
—
—
18
38
1531
15464
39
127
1352
13699
Other spondylosis with radiculopathy
M47.2 [45591850]
1.5e+00
1.1e+00
—
—
—
2.4e+00
1.8e+00
cases:1.96%
controls:0.44%
cases:0.57%
controls:0.18%
—
—
—
—
—
—
cases:1.10%
controls:0.10%
cases:2.52%
controls:0.43%
31
70
1552
15762
9
29
1574
15803
—
—
—
17
16
1532
15486
35
60
1356
13766
doxepin; oral, parenteral
N06AA12 [21604699]
1.4e+00
1.7e+00
—
—
—
1.4e+00
1.1e+00
cases:1.71%
controls:0.42%
cases:1.07%
controls:0.20%
—
—
—
—
—
—
cases:0.71%
controls:0.17%
cases:1.08%
controls:0.35%
27
67
1556
15765
17
31
1566
15801
—
—
—
11
27
1538
15475
15
49
1376
13777
Dorsalgia, unspecified
M54.9 [45538791]
1.7e+00
1.3e+00
-1.0e+50
—
—
1.1e+00
1.5e+00
cases:4.17%
controls:0.79%
cases:1.07%
controls:0.29%
cases:0.00%
controls:0.06%
—
—
—
—
cases:0.90%
controls:0.32%
cases:4.53%
controls:1.00%
66
125
1517
15707
17
46
1566
15786
0
9
1583
15823
—
—
14
49
1535
15453
63
138
1328
13688
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
8.2e-01
8.1e-01
1.3e+00
—
1.3e+00
7.5e-01
6.3e-01
cases:15.35%
controls:7.42%
cases:4.36%
controls:1.98%
cases:0.82%
controls:0.22%
—
—
cases:0.82%
controls:0.23%
cases:4.84%
controls:2.35%
cases:13.66%
controls:7.75%
243
1175
1340
14657
69
314
1514
15518
13
35
1570
15797
—
13
36
1566
15768
75
365
1474
15137
190
1072
1201
12754
Bacteria [Presence] in Urine
87829-8 [36304419]
8.8e-01
1.0e+00
1.2e+00
—
1.6e+00
1.0e+00
1.1e+00
cases:6.70%
controls:2.89%
cases:3.73%
controls:1.36%
cases:0.69%
controls:0.21%
—
—
cases:0.95%
controls:0.20%
cases:3.62%
controls:1.31%
cases:10.78%
controls:3.86%
106
458
1477
15374
59
216
1524
15616
11
33
1572
15799
—
15
32
1564
15772
56
203
1493
15299
150
533
1241
13293
Creatine kinase.MB [Mass/volume] in Serum or Plasma
13969-1 [3005785]
1.3e+00
1.7e+00
—
—
—
1.4e+00
1.2e+00
cases:1.45%
controls:0.42%
cases:1.20%
controls:0.22%
—
—
—
—
—
—
cases:0.65%
controls:0.16%
cases:2.23%
controls:0.66%
23
66
1560
15766
19
35
1564
15797
—
—
—
10
25
1539
15477
31
91
1360
13735
Limited function/disability (L)
L28 [2002000647]
1.3e+00
1.3e+00
—
—
—
1.7e+00
1.3e+00
cases:2.91%
controls:0.84%
cases:1.39%
controls:0.37%
—
—
—
—
—
—
cases:1.55%
controls:0.30%
cases:3.74%
controls:1.07%
46
133
1537
15699
22
58
1561
15774
—
—
—
24
46
1525
15456
52
148
1339
13678
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
1.2e+00
7.3e-01
2.0e+00
—
—
1.2e+00
1.1e+00
cases:2.91%
controls:0.87%
cases:0.88%
controls:0.43%
cases:0.38%
controls:0.05%
—
—
—
—
cases:1.29%
controls:0.40%
cases:3.09%
controls:1.03%
46
138
1537
15694
14
68
1569
15764
6
8
1577
15824
—
—
20
62
1529
15440
43
142
1348
13684
Procedure duration 90 to 119 minutes
ZXE13 [2001311404]
4.3e-01
1.4e+00
—
—
—
1.8e+00
2.3e+00
cases:0.51%
controls:0.33%
cases:0.63%
controls:0.15%
—
—
—
—
—
—
cases:0.58%
controls:0.10%
cases:1.15%
controls:0.12%
8
52
1575
15780
10
24
1573
15808
—
—
—
9
15
1540
15487
16
16
1375
13810
Laboratory Visit
OMOP4822461 [32036]
1.4e-01
3.1e-01
9.0e-01
3.0e+00
9.3e-01
4.2e-01
1.5e-01
cases:37.59%
controls:34.30%
cases:37.90%
controls:30.87%
cases:18.19%
controls:8.27%
cases:8.28%
controls:0.46%
cases:17.92%
controls:7.93%
cases:42.29%
controls:32.47%
cases:54.57%
controls:50.89%
595
5430
988
10402
600
4888
983
10944
288
1309
1295
14523
131
73
1452
15759
283
1254
1296
14550
655
5033
894
10469
759
7036
632
6790
salbutamol; inhalant
R03AC02 [21603256]
9.4e-01
8.9e-01
6.9e-01
—
1.0e+00
1.0e+00
9.4e-01
cases:25.39%
controls:11.77%
cases:12.44%
controls:5.50%
cases:1.90%
controls:0.96%
—
—
cases:2.41%
controls:0.87%
cases:14.27%
controls:5.57%
cases:27.75%
controls:13.07%
402
1864
1181
13968
197
871
1386
14961
30
152
1553
15680
—
38
138
1541
15666
221
864
1328
14638
386
1807
1005
12019
Puncture of maxillary antrum
TDM10 [2001301819]
2.1e+00
1.7e+00
—
—
—
1.5e+00
1.7e+00
cases:1.33%
controls:0.16%
cases:0.51%
controls:0.09%
—
—
—
—
—
—
cases:0.32%
controls:0.07%
cases:1.29%
controls:0.25%
21
26
1562
15806
8
14
1575
15818
—
—
—
5
11
1544
15491
18
34
1373
13792
epinephrine; parenteral
C01CA24 [21600303]
1.2e+00
1.4e+00
—
—
—
1.4e+00
1.5e+00
cases:2.97%
controls:0.95%
cases:1.58%
controls:0.40%
—
—
—
—
—
—
cases:1.94%
controls:0.46%
cases:3.74%
controls:0.85%
47
150
1536
15682
25
63
1558
15769
—
—
—
30
72
1519
15430
52
118
1339
13708
epinephrine
S01EA01 [21603673]
1.2e+00
1.4e+00
—
—
—
1.4e+00
1.5e+00
cases:2.97%
controls:0.95%
cases:1.58%
controls:0.40%
—
—
—
—
—
—
cases:1.94%
controls:0.46%
cases:3.74%
controls:0.85%
47
150
1536
15682
25
63
1558
15769
—
—
—
30
72
1519
15430
52
118
1339
13708

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
712
3099
3.35
118.98
2.8
2.0
130.56
217.48
u/l
1.96
690
2960
874
4857
2.78
86.18
7.0
6.5
1.21
1.21
mmol/l
0.04
837
4557
946
5487
2.79
85.50
7.4
7.0
1.21
1.21
mmol/l
0.38
851
4811
330
1095
3.54
81.65
2.4
2.2
350.38
390.32
nmol/l
3.47
311
1028
591
2821
2.74
76.57
2.0
1.7
0.83
1.06
mg/l
1.43
442
2126
1074
6914
2.71
74.48
6.6
4.7
6.24
6.53
mmol/l
7.03
1042
6437
636
3227
2.62
71.95
3.9
4.2
7.40
7.40
ph
0.00
461
2232
857
5055
2.51
69.73
5.2
5.1
36.80
36.59
g/l
0.52
810
4792
817
4815
2.44
65.17
10.6
10.2
1.14
1.16
inr
0.76
685
3934
716
4002
2.44
64.00
4.6
2.9
36.87
50.78
ng/l
0.44
420
2361
1020
6715
2.45
62.32
6.7
6.6
0.04
0.04
e9/l
0.15
911
5839
678
3740
2.42
61.90
3.5
2.5
53.82
60.72
u/l
2.84
646
3509
1016
6712
2.43
61.04
6.7
6.6
0.56
0.56
e9/l
0.18
910
5843
1039
6944
2.44
60.62
6.8
6.9
0.18
0.19
e9/l
0.09
944
6132
1032
6888
2.42
60.21
6.7
6.6
2.04
1.93
e9/l
1.61
942
6138
362
1508
2.81
59.02
2.5
2.3
29.07
29.56
s
0.90
351
1463
116
222
5.56
58.28
1.4
1.3
246.24
1382.22
e6/l
0.77
89
174
1288
9637
2.78
56.92
9.6
7.9
75.35
76.67
u/l
0.64
1250
9215
960
6310
2.32
56.50
7.4
6.7
9.42
11.41
umol/l
11.94
910
6057
941
6135
2.31
56.44
6.9
6.8
8.38
8.71
%
3.38
909
5808
686
3922
2.32
56.35
2.9
3.7
2.35
2.35
mmol/l
0.81
640
3653
113
218
5.50
56.25
1.4
1.2
4.04
14.29
e6/l
1.47
83
165
939
6126
2.30
56.10
6.8
6.8
2.68
2.82
%
1.32
908
5790
949
6244
2.29
55.19
6.7
6.6
56.20
56.67
%
0.65
925
6007
513
2607
2.43
55.00
1.5
1.3
22.32
27.87
iu/ml
0.52
152
755
958
6344
2.29
54.62
6.9
6.7
29.32
28.79
%
0.85
930
6057
934
6124
2.28
54.51
7.0
6.8
0.70
0.70
%
0.06
901
5777
1078
7523
2.35
53.87
9.5
10.3
4.06
3.97
e9/l
0.64
968
6591
108
213
5.37
52.43
1.3
1.3
—
—
—
0
0
1129
8127
2.35
51.03
6.1
3.8
131.00
1647.75
e6/l
1.40
20
87
110
231
5.04
49.70
1.3
1.1
3.65
3.68
mmol/l
0.08
102
221
730
4497
2.15
47.66
4.9
3.5
46.93
74.64
e6/l
1.26
529
3024
641
3761
2.18
47.35
4.1
3.0
74.54
78.30
e6/l
0.03
493
2813
560
3123
2.23
46.90
3.9
2.8
—
0.00
estimate
—
0
7
237
890
2.95
46.04
2.5
2.4
19.70
20.99
au/ml
0.07
19
121
399
1947
2.40
45.64
1.5
1.4
451.51
493.27
titre
0.18
73
410
779
4979
2.11
45.53
2.4
1.9
95.66
96.69
pmol/l
0.27
438
2740
827
5434
2.09
44.56
3.8
3.0
6.22
6.20
ph
0.20
460
3153
224
831
2.97
44.40
1.3
1.3
39.22
46.54
au/ml
0.23
12
59
453
2383
2.26
43.16
1.4
1.3
6.86
13.02
u/ml
1.80
175
1017
379
1860
2.36
42.44
3.4
3.7
0.83
0.82
mmol/l
0.89
364
1790
375
1836
2.36
42.19
2.6
2.8
111.60
124.64
ug/g
0.30
310
1493
562
3246
2.13
42.14
4.0
2.9
0.34
0.42
e6/l
0.42
406
2318
545
3116
2.14
41.92
5.5
4.1
95.32
93.17
%
1.36
531
3057
963
6794
2.06
41.58
4.4
3.3
0.00
0.00
estimate
0.80
192
1367
401
2036
2.30
41.36
5.0
3.3
326.70
579.18
ng/l
0.87
245
1409
968
6859
2.05
41.08
4.5
3.3
18.85
5.69
estimate
0.47
196
1378
969
6900
2.04
40.16
4.5
3.3
0.00
0.01
estimate
1.08
187
1308
341
1634
2.38
40.09
1.4
1.2
—
—
—
0
0
65
102
6.60
39.86
1.3
1.4
—
—
—
0
0
709
4530
2.02
39.86
3.8
3.3
27.84
36.00
u/l
1.58
686
4309
520
2972
2.11
39.61
1.9
1.6
19.16
20.48
nmol/l
1.49
463
2608
565
3345
2.07
39.06
1.5
1.3
1.05
1.85
u/ml
1.73
153
966
528
3058
2.09
38.65
2.9
2.1
2.50
2.68
mg/l
1.36
464
2648
506
2913
2.08
37.43
5.0
4.2
—
—
—
0
0
841
5803
1.96
36.91
3.0
2.3
75.53
75.50
nmol/l
0.01
791
5421
1295
10429
2.31
36.85
5.6
4.1
14.49
14.53
pmol/l
0.24
1237
9761
497
2903
2.04
34.90
1.6
1.5
2.16
2.35
g/l
1.52
309
1936
445
2501
2.08
34.68
2.9
2.5
5.51
6.01
e6/l
0.34
401
2264
361
1876
2.20
34.45
3.8
2.7
4.73
2.79
e6/l
0.95
179
896
139
454
3.26
34.01
4.0
4.1
5.08
5.06
kpa
0.05
133
440
393
2122
2.13
33.96
3.1
2.7
529.77
538.19
mosm/kgh2o
0.31
341
1850
269
1244
2.40
33.79
3.0
2.6
31.19
40.89
u/l
2.18
232
1072
379
2027
2.14
33.52
3.7
2.6
1.05
1.11
e6/l
0.08
206
1047
135
439
3.27
33.26
4.0
4.2
7.42
7.42
ph
0.02
122
374
455
2615
2.04
33.13
2.9
2.9
652.42
1013.07
ng/l
1.75
367
2230
520
3134
1.98
33.09
3.4
2.5
—
—
—
0
0
114
337
3.57
32.62
1.5
1.3
300.65
298.02
ug/g
0.04
61
191
1512
13318
3.83
32.47
23.4
13.2
139.70
139.67
mmol/l
0.25
1495
13039
1513
13364
3.80
31.67
23.4
13.3
3.94
3.95
mmol/l
0.58
1496
13052
247
1131
2.40
31.60
8.6
9.4
7.43
7.42
ph
1.63
147
579
1516
13415
3.87
31.47
22.3
12.2
18.69
22.78
mg/l
6.43
1310
10630
67
137
5.06
31.14
3.2
7.2
315.02
384.10
umol/l
2.54
60
119
382
2102
2.08
31.06
2.5
3.0
2.42
2.43
mmol/l
1.35
345
1912
224
991
2.47
30.87
3.6
3.7
1.59
1.81
mmol/l
0.40
203
842
228
1018
2.45
30.80
3.7
3.7
7.38
7.38
ph
0.07
123
564
244
1130
2.37
30.36
8.7
9.4
12.28
12.97
kpa
1.26
239
1093
1435
12389
2.64
29.96
7.0
4.8
1.68
1.84
mu/l
5.59
1382
11674
294
1484
2.20
29.77
7.9
8.2
105.09
104.51
mmol/l
1.40
294
1484
241
1120
2.36
29.71
8.7
9.4
1.01
0.85
mmol/l
0.30
203
924
223
1002
2.43
29.65
2.2
2.9
9.77
10.82
g/l
4.58
206
937
223
1008
2.41
29.24
8.9
10.0
95.68
96.08
%
0.36
217
979
292
1486
2.18
28.90
1.8
1.6
1134.20
1174.03
nmol/l
0.31
231
1183
211
941
2.43
28.47
1.4
1.3
132.25
351.18
u/ml
1.52
200
882
596
3922
1.83
27.93
5.7
6.3
—
—
—
0
0
282
1449
2.15
27.10
2.8
2.9
5.51
7.95
umol/l
2.26
234
1283
141
538
2.78
26.11
1.1
1.1
—
—
—
0
0
814
5953
1.75
26.06
12.2
10.2
0.00
0.00
e9/l
0.54
674
4866
896
6805
1.73
24.42
4.4
3.0
96.79
109.84
ug/l
0.99
861
6497
110
381
3.03
24.28
1.9
1.8
0.23
0.24
g/l
0.58
105
362
269
1416
2.08
24.06
1.9
1.6
—
—
—
0
0
1198
9913
1.85
23.94
4.5
3.0
42.60
43.48
u/l
0.17
1140
9503
311
1738
1.98
23.53
2.7
2.4
2.38
2.36
g/l
0.34
295
1632
89
279
3.32
23.21
4.3
4.6
—
—
—
0
0
111
397
2.93
23.14
1.9
1.7
1.21
1.18
g/l
0.48
106
376
267
1422
2.06
23.08
1.3
1.4
—
—
—
0
0
132
522
2.67
22.77
1.3
1.2
1.15
1.53
u/ml
0.13
11
44
325
1865
1.93
22.67
2.8
2.5
13.63
14.32
umol/l
0.97
307
1761
183
849
2.31
22.38
2.6
3.6
4.53
4.60
pmol/l
0.33
163
765
194
929
2.24
21.99
9.2
11.0
—
—
—
0
0
810
6096
1.67
21.86
3.2
2.6
—
—
estimate
—
0
0
260
1402
2.02
21.62
4.9
6.5
1.02
1.03
mmol/l
0.15
242
1321
121
470
2.70
21.61
1.8
2.1
20.53
20.42
s
0.08
102
413
218
1106
2.13
21.35
1.2
1.2
—
—
—
0
0
153
674
2.41
21.02
1.1
1.1
—
0.84
—
0
8
1423
12639
2.21
20.99
5.3
4.1
5.77
5.75
mmol/l
0.25
1350
11873
459
3003
1.74
20.65
4.3
3.2
1.03
1.02
kg/l
0.48
314
1942
150
663
2.39
20.45
1.8
1.8
0.25
0.34
mg/l
0.95
69
338
97
347
2.91
20.21
2.0
3.1
—
—
—
0
0
45
95
4.85
20.17
1.2
1.1
28.00
44.99
mg/l
2.52
37
78
146
642
2.40
20.13
3.6
3.9
24.28
24.28
mmol/l
0.00
146
634
712
5262
1.64
20.03
4.3
3.1
3.03
0.03
estimate
0.49
166
1129
52
127
4.20
19.47
1.4
1.6
0.17
0.34
nmol/l
0.56
40
92
276
1584
1.90
18.96
2.9
2.5
22.67
24.43
%
1.50
262
1500
143
641
2.35
18.86
2.3
2.6
87.19
158.09
ng/l
3.32
125
572
149
680
2.31
18.86
2.4
1.6
283.59
305.22
mu/l
0.35
139
615
1393
12380
2.02
18.84
6.3
4.9
38.03
37.93
mmol/mol
0.17
1341
11801
42
89
4.82
18.75
1.2
1.1
227.44
253.28
mg/l
0.52
37
78
468
3147
1.69
18.73
2.5
2.5
316.76
329.57
umol/l
2.31
422
2861
167
803
2.21
18.65
1.7
2.1
1.22
1.33
g/l
0.47
153
751
556
3917
1.65
18.55
3.2
3.4
8.00
8.05
mmol/l
0.09
490
3436
49
120
4.18
18.29
1.2
1.3
2.71
3.12
g/l
0.86
34
87
49
120
4.18
18.29
1.2
1.3
0.30
0.40
g/l
1.08
35
86
49
120
4.18
18.29
1.2
1.3
6.26
6.76
g/l
0.70
35
87
71
226
3.24
18.08
1.3
1.8
0.62
0.83
g/l
1.10
53
181
478
3257
1.67
18.08
5.0
4.5
—
—
—
0
0
66
201
3.38
18.04
3.1
3.1
8.71
8.16
kpa
1.65
66
196
348
2193
1.75
17.47
1.8
1.6
70820077.47
30584973.09
pmol/l
0.45
305
1916
48
120
4.09
17.44
1.2
1.3
—
—
—
0
0
160
779
2.17
17.29
1.9
3.2
67.38
67.27
g/l
0.06
154
734
578
4180
1.60
16.98
2.5
2.2
—
—
—
0
0
131
606
2.27
16.03
10.3
13.1
24.41
24.29
mmol/l
0.19
131
598
178
932
2.02
15.85
1.4
1.2
—
—
—
0
0
188
1011
1.97
15.52
1.6
1.4
26.46
26.37
iu/l
0.01
158
878
110
479
2.39
15.47
1.4
1.3
11.35
9.91
u/l
0.49
94
393
689
5282
1.54
15.20
2.1
2.0
—
—
—
0
0
149
746
2.10
14.96
2.7
2.2
5.37
9.14
ug/l
1.41
127
681
502
3598
1.58
14.89
4.7
3.4
0.04
0.01
estimate
0.76
190
1295
260
1573
1.78
14.82
1.5
1.4
—
—
—
0
0
33
70
4.79
14.74
1.3
1.3
0.48
0.65
ratio
3.61
18
38
120
556
2.25
14.63
1.8
1.8
3.82
6.11
iu/ml
0.79
20
143
274
1691
1.75
14.56
2.5
2.0
—
—
—
0
0
127
608
2.18
14.29
2.4
2.9
—
—
—
0
0
1539
14490
3.01
14.15
25.7
14.8
73.11
73.67
umol/l
0.39
1529
14334
127
612
2.17
14.06
1.7
2.8
—
—
—
0
0
174
943
1.95
14.00
6.4
8.2
6.56
8.40
mmol/l
4.86
169
916
83
336
2.55
13.66
2.0
2.4
287.58
294.14
ug/l
0.02
77
316
260
1613
1.73
13.50
2.6
3.3
4.91
5.02
e9/l
0.05
227
1441
47
140
3.43
13.34
1.4
1.5
—
—
nmol/l
—
0
0
60
208
2.96
13.27
1.3
1.2
3.33
3.45
u/ml
0.04
24
93
80
323
2.56
13.24
1.8
2.9
9.20
10.47
g/l
2.34
74
295
529
3919
1.52
13.19
3.8
2.7
0.09
0.06
estimate
0.16
167
1093
72
278
2.67
13.04
6.3
4.5
1.34
1.26
mmol/l
0.29
64
238
72
282
2.63
12.68
3.1
2.9
58.79
64.31
%
1.31
72
273
193
1117
1.83
12.66
2.6
3.0
1.62
1.76
%
1.60
172
1018
27
56
4.89
12.39
8.7
1.4
93.12
74.15
umol/l
0.43
17
26
115
564
2.12
12.18
1.2
1.3
—
—
—
0
0
24
46
5.28
12.03
1.5
1.2
—
71.17
%
—
0
6
132
685
2.01
12.01
2.0
2.2
—
—
—
0
0
109
527
2.15
11.97
1.7
1.7
17.87
14.42
u/ml
0.17
24
141
82
354
2.39
11.79
2.3
2.5
—
—
—
0
0
700
5586
1.45
11.66
2.0
1.8
1.49
1.36
mmol/l
2.30
598
4903
1526
14441
2.45
11.42
15.1
10.2
27.50
26.77
u/l
0.91
1505
14111
93
432
2.22
11.29
1.3
1.3
—
—
—
0
0
458
3381
1.50
11.27
3.4
3.5
50.87
46.10
mg/l
0.15
290
2179
116
590
2.04
11.16
1.1
1.1
—
—
—
0
0
73
308
2.44
11.05
1.4
1.2
30.82
42.21
u/ml
—
9
38
31
79
3.98
11.04
1.2
1.2
1.05
1.05
ratio
0.01
25
67
145
801
1.89
10.99
3.1
3.6
1.22
1.23
mmol/l
0.35
127
700
147
817
1.88
10.93
2.6
3.1
66.88
71.27
e9/l
0.95
105
591
136
738
1.92
10.88
1.3
1.2
—
—
—
0
0
160
917
1.83
10.80
2.7
2.3
0.12
0.43
e6/l
2.89
150
860
1298
11766
1.56
10.56
25.2
15.3
13.46
13.41
%
0.99
1288
11606
182
1093
1.75
10.49
1.3
1.2
85.80
140.05
u/ml
1.41
67
419
37
111
3.39
10.44
1.1
1.2
0.12
1.05
u/ml
1.49
24
56
458
3427
1.47
10.39
4.0
4.1
9.21
8.11
mg/mmol
0.17
279
2185
51
187
2.78
10.25
4.2
3.5
2.29
2.42
mmol/l
0.13
32
116
82
377
2.24
10.22
1.3
1.1
—
—
—
0
0
100
500
2.07
10.09
2.3
2.1
—
—
—
0
0
182
1106
1.73
10.06
2.1
2.4
0.22
0.22
g/l
0.00
170
1045
197
1231
1.69
9.82
2.5
2.1
13.38
14.05
nmol/l
0.53
183
1161
43
147
2.98
9.81
1.5
1.4
29.59
47.15
mu/l
0.98
37
128
66
284
2.38
9.60
2.6
3.0
1.50
2.30
index
0.87
46
146
41
139
3.00
9.50
1.5
1.3
316.29
343.07
pmol/l
0.18
35
116
142
817
1.81
9.46
2.0
2.2
—
—
—
0
0
50
190
2.68
9.41
1.1
1.2
—
—
—
0
0
24
57
4.26
9.39
1.4
1.5
2.16
1.94
umol/l
0.58
24
49
473
3621
1.44
9.34
2.2
2.0
—
—
—
0
0
151
889
1.77
9.31
1.9
2.1
—
—
—
0
0
35
111
3.20
9.07
1.2
1.2
—
—
—
0
0
34
106
3.26
9.06
2.3
1.8
91.84
90.03
%
1.61
34
106
50
195
2.61
8.96
4.8
3.3
—
—
—
0
0
33
102
3.28
8.92
1.2
1.2
—
—
—
0
0
43
156
2.81
8.85
1.5
1.6
—
—
—
0
0
43
156
2.81
8.85
1.5
1.6
—
—
—
0
0
43
156
2.81
8.85
1.5
1.6
—
—
—
0
0
43
156
2.81
8.85
1.5
1.6
—
—
—
0
0
77
367
2.15
8.82
1.5
1.3
36.82
1.99
u/ml
—
5
29
150
897
1.74
8.77
1.9
2.1
—
—
—
0
0
71
331
2.20
8.60
1.6
1.4
0.25
0.43
nmol/l
2.32
56
276
150
902
1.73
8.60
1.9
2.1
—
—
—
0
0
148
888
1.74
8.55
1.9
2.1
—
—
—
0
0
131
759
1.79
8.53
3.5
4.0
80.81
81.71
ng/l
0.04
120
691
126
725
1.80
8.40
1.1
1.1
—
112.00
—
0
23
83
416
2.05
8.35
1.5
1.3
—
—
—
0
0
173
1108
1.63
7.82
2.1
2.0
0.08
0.03
estimate
0.26
37
257
28
85
3.34
7.81
1.9
2.0
—
—
—
0
0
54
235
2.34
7.71
2.9
2.2
135.86
129.55
g/l
0.95
42
185
154
961
1.67
7.70
4.4
4.1
7.33
7.35
ph
0.35
110
719
40
151
2.69
7.67
2.5
2.3
—
—
—
0
0
76
384
2.03
7.51
2.1
1.9
2.64
1.83
ug/l
0.30
68
348
18
41
4.43
7.43
1.2
1.5
64.76
91.84
nmol/24h
0.77
18
41
107
611
1.81
7.34
2.8
1.9
—
—
—
0
0
1450
13729
1.65
7.24
5.9
4.7
2.84
2.84
mmol/l
0.10
1390
13070
167
1089
1.60
7.01
4.5
4.8
0.57
1.00
%
1.81
48
304
161
1042
1.61
6.97
4.2
4.6
0.39
0.72
%
1.23
44
288
1434
13572
1.58
6.80
5.2
4.2
1.41
1.48
mmol/l
7.61
1376
12912
40
161
2.52
6.79
1.5
1.3
63.29
66.69
mmol/l
0.18
35
137
28
94
3.01
6.67
2.5
3.3
10.50
7.15
mmol/l
0.38
28
79
88
489
1.85
6.61
2.0
1.8
—
—
—
0
0
162
1066
1.58
6.55
4.6
5.2
0.03
0.47
%
0.75
37
245
1436
13616
1.57
6.51
5.3
4.3
4.74
4.76
mmol/l
0.51
1381
13005
58
280
2.11
6.50
1.7
5.0
27.28
43.50
mg/l
0.89
48
245
58
281
2.10
6.45
1.7
5.0
40.06
82.11
mg/l
0.95
49
243
130
815
1.65
6.40
3.6
2.9
—
—
—
0
0
155
1021
1.57
6.24
2.2
2.2
6.23
6.07
ph
1.20
92
651
158
1046
1.57
6.22
4.6
4.9
0.00
0.13
%
5.40
38
259
51
240
2.16
6.12
4.0
3.2
31.93
37.14
umol/l
0.58
46
220
129
818
1.63
6.08
2.3
2.2
4823.62
6010.33
u/l
0.17
42
326
47
218
2.19
5.85
1.2
1.1
2917.55
2468.33
iu/ml
0.04
11
52
39
167
2.37
5.84
1.3
1.3
—
52.30
—
0
11
18
50
3.63
5.76
1.3
1.3
121.22
137.32
nmol/l
0.89
18
50
64
336
1.94
5.74
1.3
1.3
212.40
234.57
u/ml
0.39
43
207
1359
12804
1.43
5.73
4.4
3.7
1.40
1.25
mmol/l
8.58
1299
12122
1557
15161
2.38
5.72
31.9
18.6
90.96
90.57
fl
3.00
1552
15035
16
31
5.20
5.70
1.3
1.2
0.02
0.15
u/ml
0.67
16
31
1557
15162
2.38
5.70
31.8
18.6
30.37
30.27
pg
1.77
1552
15037
1557
15165
2.37
5.64
32.8
19.1
41.19
41.65
%
0.46
1551
15034
1557
15165
2.37
5.64
31.9
18.7
4.56
4.56
e12/l
0.13
1542
14871
32
127
2.55
5.64
2.2
2.2
—
—
—
0
0
1557
15168
2.36
5.59
32.0
18.7
6.90
6.63
e9/l
4.35
1541
14864
1556
15155
2.33
5.57
32.1
18.7
263.12
255.57
e9/l
4.71
1544
14888
73
406
1.84
5.51
1.9
2.1
2.61
4.72
iu/l
2.98
32
178
1557
15172
2.34
5.51
32.2
18.8
137.55
137.08
g/l
0.70
1550
15049
30
117
2.59
5.48
1.5
2.6
1450.23
1215.78
e6/l
0.61
22
106
22
74
3.00
5.26
1.4
1.8
0.85
2.00
u/field
0.90
13
42
50
250
2.03
5.17
1.8
4.8
2.45
2.72
ratio
0.08
27
146
24
86
2.82
5.15
1.3
1.2
—
—
—
0
0
148
1014
1.51
5.01
4.6
3.4
—
—
—
0
0
12
20
6.04
4.91
1.0
1.0
6.33
6.26
mg/g
0.02
12
20
264
2025
1.36
4.81
1.9
1.7
—
—
—
0
0
19
62
3.09
4.80
2.1
4.0
0.58
0.89
index
1.19
19
62
20
68
2.97
4.72
1.1
1.5
4.40
8.41
u/l
1.74
15
57
77
459
1.71
4.65
1.2
1.2
—
—
—
0
0
25
98
2.58
4.56
1.0
1.0
—
—
—
0
0
42
207
2.06
4.55
1.9
3.2
8.22
8.07
pmol/l
0.03
42
207
16
49
3.29
4.47
1.4
1.2
122.31
166.43
mmol/24h
1.25
16
49
67
389
1.75
4.45
1.0
1.1
3.19
5.27
eliau/ml
—
7
66
34
157
2.19
4.35
1.4
1.3
—
—
—
0
0
9
12
7.54
4.35
1.1
1.1
—
—
—
0
0
23
89
2.61
4.31
1.3
3.0
153.67
210.44
e6/l
1.18
15
79
15
38
3.97
4.30
1.4
2.1
0.28
0.20
e9/l
—
5
19
67
394
1.73
4.27
1.2
1.1
—
—
—
0
0
29
127
2.31
4.21
1.6
1.6
284.10
281.41
mosm/kgh2o
0.25
21
100
57
325
1.78
4.05
1.4
1.5
—
—
—
0
0
151
1087
1.43
4.00
3.3
4.9
10.22
26.24
ug/l
0.80
118
878
9
14
6.46
3.98
1.2
3.4
—
—
—
0
0
22
88
2.52
3.89
1.4
2.8
492.07
526.29
e6/l
0.11
14
75
1289
12233
1.29
3.71
26.9
15.3
333.09
333.18
g/l
0.14
1284
12157
14
39
3.61
3.70
1.0
1.1
—
43.55
—
0
11
38
196
1.96
3.69
2.0
1.6
326.84
347.98
mu/l
0.25
31
165
9
16
5.65
3.66
1.0
1.1
—
—
—
0
0
14
46
3.06
3.53
1.1
1.8
—
—
—
0
0
10
22
4.57
3.43
4.0
1.6
10.54
15.08
umol/l
—
10
22
149
1977
0.73
3.37
1.3
1.3
—
—
—
0
0
422
3601
1.23
3.31
4.7
4.5
1.73
2.23
ug/l
2.02
380
3335
13
43
3.04
3.25
1.4
1.6
—
—
—
0
0
44
251
1.77
3.18
2.3
2.2
5.49
5.79
umol/l
0.06
30
189
25
117
2.15
3.17
4.0
3.0
—
—
—
0
0
13
44
2.97
3.14
1.5
1.2
27.00
28.86
s
0.74
13
44
9
21
4.30
2.99
1.1
1.0
57.18
7.72
u/ml
—
9
21
5
5
10.03
2.98
1.0
1.0
0.27
0.62
u/ml
—
5
5
7
13
5.40
2.87
1.6
4.7
—
—
—
0
0
33
179
1.86
2.83
1.4
1.8
—
—
—
0
0
66
437
1.53
2.73
1.3
1.3
—
—
—
0
0
46
279
1.67
2.72
1.2
1.1
20.50
14.85
au/ml
0.21
11
83
67
446
1.52
2.71
1.5
2.0
1.39
1.49
g/l
0.49
58
393
53
339
1.58
2.56
1.2
1.1
—
—
—
0
0
59
387
1.54
2.56
1.1
1.1
1.74
2.63
u/ml
0.35
34
188
49
311
1.59
2.46
1.6
1.5
151.25
154.71
au/ml
0.08
12
98
42
259
1.64
2.37
1.3
1.4
24.88
23.21
u/l
0.14
36
225
5
8
6.27
2.37
2.2
2.5
34.40
35.25
umol/l
—
5
8
14
58
2.43
2.37
1.3
1.6
30.57
27.20
umol/l
0.78
14
50
8
22
3.65
2.36
1.0
1.1
—
—
—
0
0
35
206
1.71
2.35
2.7
4.1
3.97
3.75
e9/l
0.30
35
206
38
230
1.67
2.31
1.0
1.1
1.98
2.48
eliau/ml
—
10
118
18
85
2.13
2.29
1.3
1.2
—
—
—
0
0
25
134
1.88
2.27
1.2
1.1
—
—
—
0
0
6
13
4.63
2.27
1.0
1.0
0.03
0.23
u/ml
—
6
8
20
99
2.03
2.26
1.2
1.6
46.11
58.72
%
—
9
67
58
392
1.50
2.23
10.8
7.0
—
—
—
0
0
37
225
1.66
2.22
1.2
1.2
—
—
—
0
0
45
288
1.58
2.21
1.8
1.8
—
—
—
0
0
10
35
2.87
2.21
1.0
1.2
18.14
16.99
umol/l
—
10
28
79
569
1.41
2.20
1.8
2.1
0.13
0.01
estimate
0.44
24
212
171
1381
1.27
2.19
1.7
1.5
—
—
—
0
0
51
337
1.53
2.18
1.2
1.1
—
—
—
0
0
42
266
1.59
2.16
2.7
3.7
55.78
57.14
%
0.28
42
266
54
363
1.50
2.14
1.1
1.1
4.86
6.26
u/ml
0.31
35
197
18
88
2.06
2.11
2.2
2.5
—
—
—
0
0
58
398
1.47
2.09
2.6
3.2
1.21
1.34
mg/l
0.60
49
365
74
532
1.41
2.09
3.7
2.7
1.02
1.02
ratio
0.02
68
487
5
10
5.01
2.07
1.0
1.0
—
—
—
0
0
10
37
2.71
2.07
1.1
1.1
—
—
—
0
0
10
37
2.71
2.07
1.1
1.1
—
—
—
0
0
10
37
2.71
2.07
1.1
1.1
—
—
—
0
0
42
270
1.57
2.04
2.6
2.5
1.12
0.86
nmol/l
0.88
36
234
18
90
2.01
2.00
2.3
2.1
1.20
1.19
mmol/l
0.08
18
90
17
84
2.03
1.96
3.1
3.1
962.00
1021.21
u/ml
0.03
17
84
57
400
1.44
1.86
3.0
3.8
5216.87
502.83
mg/l
0.47
31
196
18
93
1.95
1.85
2.9
2.1
26.67
36.51
mg/l
—
9
61
18
94
1.93
1.80
2.3
2.1
4.07
3.98
mmol/l
0.51
18
94
18
94
1.93
1.80
2.3
2.1
106.06
105.57
mmol/l
0.25
18
94
17
87
1.96
1.80
1.2
1.1
—
—
—
0
0
50
346
1.46
1.77
1.1
1.1
0.42
1.23
u/ml
1.00
26
141
186
2208
0.82
1.77
2.1
1.9
3.56
3.51
ratio
0.24
129
1683
6
18
3.34
1.74
10.5
1.4
—
—
—
0
0
8
30
2.67
1.72
1.3
1.2
—
—
—
0
0
483
4388
1.14
1.70
1.6
1.6
—
—
—
0
0
8
31
2.59
1.66
1.9
1.5
—
—
—
0
0
8
31
2.59
1.66
1.3
1.5
—
—
—
0
0
38
253
1.51
1.64
1.2
1.1
—
—
—
0
0
8
32
2.51
1.59
1.0
1.9
43.89
41.87
g/l
—
8
32
6
20
3.01
1.58
3.3
1.5
4.38
526672.45
nmol/l
—
6
15
7
26
2.70
1.58
4.0
2.3
—
—
—
0
0
56
760
0.73
1.56
1.1
1.1
0.56
0.64
ratio
—
7
82
33
218
1.52
1.49
4.5
3.6
—
—
—
0
0
57
419
1.37
1.49
2.8
4.3
113.75
3343.69
u/ml
0.76
46
360
38
259
1.48
1.49
1.1
1.1
1.08
0.27
u/ml
0.37
14
76
60
797
0.74
1.47
1.1
1.1
1.55
1.53
g/l
0.19
60
797
86
675
1.29
1.45
1.5
1.3
234.97
225.58
miu/ml
0.08
40
343
5
16
3.13
1.44
1.0
1.2
—
—
—
0
0
21
125
1.69
1.44
1.1
1.0
0.21
4.08
u/ml
—
10
42
334
2995
1.15
1.41
1.8
1.7
—
—
—
0
0
25
157
1.60
1.41
1.1
1.1
—
—
—
0
0
19
114
1.67
1.28
1.1
1.0
0.06
3.48
u/ml
—
5
24
10
48
2.09
1.27
1.5
1.4
0.00
0.00
estimate
—
10
48
11
55
2.01
1.27
1.4
2.9
6.92
7.84
mmol/l
0.54
11
55
17
99
1.72
1.27
1.1
1.1
107.53
112.13
pmol/l
0.16
17
99
29
194
1.50
1.27
1.3
1.5
—
—
—
0
0
15
84
1.79
1.27
1.5
1.7
7.23
6.14
mmol/l
—
9
65
38
270
1.42
1.24
1.2
1.1
—
—
—
0
0
10
49
2.05
1.22
1.0
1.1
—
9.01
—
0
9
39
280
1.40
1.21
1.1
1.1
3.42
4.23
u/ml
0.20
20
117
194
1703
1.16
1.12
1.2
1.3
—
—
—
0
0
5
21
2.39
1.09
5.4
5.0
5.76
5.25
kpa
—
5
21
143
1655
0.85
1.08
1.9
1.7
3.51
3.53
mmol/l
0.07
87
1129
33
236
1.41
1.07
3.4
4.2
512.60
1366.44
u/ml
0.35
27
220
24
161
1.50
1.07
2.5
1.9
—
—
—
0
0
16
97
1.66
1.06
1.1
1.1
—
—
—
0
0
11
60
1.84
1.03
1.0
1.1
81.68
228.80
iu/ml
2.13
11
60
45
342
1.32
1.02
1.0
1.1
0.54
1.80
u/ml
2.86
24
166
9
49
1.84
0.98
1.7
1.2
—
—
—
0
0
5
23
2.18
0.98
2.0
3.3
51.10
56.26
%
—
5
23
16
100
1.61
0.97
1.2
1.2
—
—
—
0
0
14
85
1.65
0.94
2.4
1.4
71.07
76.13
umol/l
0.52
14
85
17
109
1.57
0.93
2.1
1.8
—
—
—
0
0
23
324
0.71
0.89
1.4
1.6
—
—
—
0
0
13
79
1.65
0.88
1.6
1.7
—
—
—
0
0
17
111
1.54
0.87
1.6
1.4
166.49
181.82
pmol/l
0.18
17
111
8
48
1.67
0.78
1.8
1.9
26.75
28.46
%
—
8
48
8
48
1.67
0.78
2.1
2.5
—
—
—
0
0
233
2129
1.11
0.77
1.6
1.4
—
—
—
0
0
19
132
1.44
0.76
1.5
2.3
32.74
32.55
pg
0.10
19
132
15
99
1.52
0.75
2.1
2.9
49.14
43.45
%
—
7
49
9
53
1.70
0.75
2.0
2.4
—
—
—
0
0
5
24
2.09
0.74
1.0
3.7
43.00
109.58
u/l
—
5
24
14
92
1.53
0.72
1.1
1.3
—
—
—
0
0
5
26
1.93
0.70
1.0
1.2
—
36.53
—
0
16
13
85
1.53
0.69
1.7
1.5
—
—
—
0
0
18
127
1.42
0.68
1.3
1.5
—
—
—
0
0
235
2168
1.10
0.66
2.0
1.8
—
—
—
0
0
35
277
1.27
0.65
1.2
1.1
—
—
—
0
0
19
137
1.39
0.64
1.4
2.3
0.83
0.94
%
—
9
94
15
104
1.45
0.62
1.6
1.7
—
—
—
0
0
11
72
1.53
0.59
1.5
1.4
—
—
—
0
0
100
1124
0.88
0.57
1.5
1.6
1067.26
1027.85
mu/l
0.12
82
933
12
81
1.49
0.57
1.4
1.6
20.60
29.05
%
—
5
56
16
116
1.38
0.54
1.1
1.1
—
—
—
0
0
18
134
1.35
0.53
3.2
5.9
53.14
77.65
u/ml
—
5
44
6
39
1.54
0.53
1.0
1.0
20.37
37.42
iu/ml
—
6
39
6
99
0.60
0.52
1.0
1.1
1628.83
1475.02
miu/ml
—
6
99
9
136
0.66
0.51
1.3
1.2
—
—
—
0
0
9
64
1.41
0.51
1.4
1.0
—
—
—
0
0
10
67
1.50
0.49
1.0
1.1
—
—
—
0
0
34
281
1.21
0.47
1.4
1.7
12651.64
14447.13
e6/l
0.11
25
196
7
47
1.49
0.47
1.6
1.9
8.86
8.74
%
—
7
47
17
129
1.32
0.45
1.1
1.1
8.00
13.21
u/ml
—
8
58
7
50
1.40
0.45
1.0
1.1
—
4.40
—
0
5
36
303
1.19
0.43
1.1
1.1
4.83
2.88
u/ml
0.23
18
141
239
2255
1.07
0.43
2.6
2.8
0.66
0.71
ug/l
0.40
140
1310
0
17
0.00
0.40
0.0
2.4
—
0.99
—
0
12
614
6316
0.95
0.39
3.0
2.7
—
—
—
0
0
29
244
1.19
0.36
4.1
2.8
21.68
25.57
mg/l
0.23
16
158
12
157
0.76
0.36
1.2
1.7
8.45
7.63
mmol/l
0.51
12
151
7
54
1.30
0.30
6.3
5.4
—
—
—
0
0
100
1075
0.93
0.30
1.3
1.5
—
—
—
0
0
7
56
1.25
0.29
1.4
1.6
—
—
—
0
0
60
647
0.92
0.21
1.6
1.5
56.81
61.21
ug/l
0.37
48
541
5
43
1.16
0.21
1.6
3.1
0.64
0.60
mmol/l
—
5
43
6
48
1.25
0.20
66.5
27.9
105.17
135.22
ug/l
—
6
40
6
48
1.25
0.20
1.0
3.1
17.47
16.28
%
—
6
48
9
112
0.80
0.20
1.8
3.3
19.26
56.94
u/ml
—
9
112
6
51
1.18
0.19
1.0
1.0
—
—
—
0
0
6
51
1.18
0.19
1.0
1.1
—
—
—
0
0
18
207
0.87
0.19
1.2
1.2
—
—
—
0
0
25
223
1.12
0.18
1.7
2.4
197.67
97.06
ug/min
0.39
14
133
23
205
1.12
0.17
1.1
1.3
—
—
—
0
0
7
88
0.79
0.14
1.0
1.1
486.14
403.49
nmol/l
—
7
83
12
103
1.17
0.13
1.2
1.0
—
—
—
0
0
23
250
0.92
0.11
1.3
1.2
—
—
—
0
0
11
96
1.15
0.10
1.7
2.3
—
—
—
0
0
52
498
1.05
0.09
1.6
1.5
1.38
1.28
mm
0.70
37
350
5
65
0.77
0.08
1.0
1.0
—
—
—
0
0
96
985
0.97
0.07
1.8
1.6
—
—
—
0
0
9
88
1.02
0.07
1.1
1.2
—
—
—
0
0
12
132
0.91
0.06
1.1
1.2
—
—
—
0
0
12
131
0.92
0.05
1.9
2.6
4.81
1.27
g/24h
—
6
76
36
354
1.02
0.00
1.2
1.3
—
—
—
0
0
51
508
1.00
0.00
1.6
1.5
—
—
—
0
0
52
518
1.00
0.00
1.6
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.22
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
0.71
—
0
6
0
5
0.00
-0.00
0.0
8.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
19.25
—
0
8
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
5.3
—
16.78
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
8861.20
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
8
86
0.93
-0.00
1.9
1.4
0.38
0.47
e9/l
—
8
86
0
9
0.00
-0.00
0.0
4.9
—
103.00
—
0
9
8
89
0.90
-0.00
1.0
1.1
6.63
8.33
mm/h
—
8
89
0
7
0.00
-0.00
0.0
2.0
—
0.47
—
0
7
0
5
0.00
-0.00
0.0
1.8
—
258.40
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
31.28
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: G6_CLUSTHEADACHE_STRICT – Cluster headache, strict

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).